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CONSENSUS STATEMENT
The first indexed scientific publication about immunonutri-
tion is almost 70 years old (103). Since 1947, more than
10,000 scientific articles have been published in that field rep-
resenting a consistent body of knowledge. Within this field,
exercise (acute or chronic) modalities are of recent interest,
and only approximately 400 publications exist so far. One
third of them has been published during the last three years
showing that immunonutrition and exercise is a fast develop-
ing area of research. This can be explained on the one hand by
the considerable development of the global sports nutrition
market. On the other hand, it is also due to high levels of
expectation from both elite athletes and those who are keen on
the concept of “Exercise is Medicine”. High level athletes are
very frequently exposed to high intensity or exhausting train-
ing programmes, travel, sleep disturbances, psycho-social and
environmental stressors. All these factors are potential
immune disruptors sometimes leading to immunodepression
and increased likelihood of illness. 
In order to minimise these phenomena and to optimise recov-
ery, nutritional interventions are often considered by athletes
and their entourages as possible countermeasures to the train-
ing-related immunodepression. However, among the numer-
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ous nutrients available, only a few of them have so far shown
any positive effects in maintaining athlete immune health.
Moreover, elderly and overweight/obese individuals who
demonstrate increased inflammatory status and immune dys-
function are often prescribed physical training programmes as
a countermeasure. In such circumstances, nutrition appears as
a possible valuable additional support to these populations. As
significant biotechnological progress has been achieved dur-
ing the last fifteen years, it is of critical importance, when
designing an experiment in the field of immunonutrition and
exercise, to select adequate biomarkers which fit best to the
research aim and the experimental design.
In this consensus statement on immunonutrition and exercise,
a panel of knowledgeable contributors from across the globe
provides a consensus of updated science, including the back-
ground, the aspects for which a consensus actually exists, the
controversies and, when possible, suggested directions for
future research.
This consensus statement series includes an introduction sec-
tion (Stephane Bermon and Philip Calder) followed by sec-
tions on: carbohydrates (Nicolette Bishop); fatty acids (Philip
Calder); branched chain amino acids (Eva Blomstrand); gluta-
mine (Lindy Castell); polyphenols (David Nieman) and herbal
supplements (David Senchina); antioxidants (Andreas
Kavazis and John Quindry); minerals (Frank Mooren and
Karsten Krüger); probiotics and prebiotics (Michael Gleeson
and David Pyne); vitamin D (Graeme Close and Enette Lar-
son-Meyer) and bovine colostrum (Cecilia Kitic). It also con-
tains some specific sections on: immunonutrition in competi-
tive athletes and military personnel (Neil Walsh), exercising
obese and overweight (Ascension Marcos, and elderly (Simin
Meydani and Dayong Wu) individuals; biomarkers used in
immunonutrition, and exercise science (Neil Walsh, Simin
Meydani, Dayong Wu, and Ryochi Nagatomi).
Carbohydrates are fuel for the immune cells. As far as
immune functions are concerned, carbohydrates appear to be
more effective when ingested during exercise rather than
increasing their relative content in the daily diet. Carbohy-
drates have been shown to minimise some of the immune per-
turbations that are associated with strenuous or lasting physi-
cal exercise and can be considered as a partial countermeasure
for exercise-induced immunodepression. However, carbohy-
drates have failed so far to demonstrate any reduction in the
incidence of upper respiratory tract illness (URTI) after pro-
longed exercise.
There is evidence from in vitro, animal and epidemiological
studies that several saturated fatty acids promote inflammato-
ry processes through the omega-6 (n-6) polyunsaturated fatty
acids (PUFA) and arachidonic acid pathway. n-6 PUFAs have
also shown some immunodepressive effects. These phenome-
na occur whatever the origin of arachidonic acid: meat, eggs
or plants. In untrained individuals, eicosapentaenoic acid
(EPA) and docosahexaenoic acid (DHA) appear to decrease
the exercise-induced inflammation and muscle soreness.
However, most of the studies on fatty acids and immune func-
tions and inflammation in the context of exercise have provid-
ed data which is difficult to interpret. 
Similar to recommendations in sports nutrition, there is no
scientific ground for an athlete to consume an excessive
amount of proteins (more than 2 g/kg body weight per day) in
order to boost his or her immune system or limit an exercise-
induced inflammation. Despite a good rationale for glutamine
(Gln) supplementation based on sound biochemical investiga-
tion, laboratory-based exercise studies have proved mainly
negative in terms of providing any direct enhancement of
immune function due to Gln feeding. More studies need to
investigate the apparent link between glutamine and the
decreased incidence of self-reported URTI. During prolonged
exercise branched chain amino acids (BCAA; leucine,
isoleucine, valine) are oxidized as substrates and their plasma
concentration decreases. An increase in BCAA plasma con-
centration can help to prevent a decrease in the plasma Gln
concentration, and might therefore have the capacity to influ-
ence the immune response indirectly. However, the evidence
for such an effect is weak.
Zinc (Zn), magnesium (Mg) and iron (Fe) are important min-
erals for immune function. As these minerals often show
reduced concentration or availability during exercise or train-
ing, it is important to check that the athlete’s diet contains suf-
ficient quantity of these elements. However, there is no evi-
dence showing that supplementing non-deficient athletes
might boost the immune system or prevent exercise-induced
immunodepression. Selenium (Se) and manganese (Mn) can-
not be classified as immunonutrients for exercise.
Prolonged, exhaustive exercise and immune system activation
are associated with an increased production of reactive oxy-
gen species (ROS), leading to a potential increase in oxidative
stress. However, there is no data to support links between
exercise-induced oxidative stress and immune dysfunction or
the postulated benefits of dietary antioxidant supplementation
in preventing immune dysfunction during exercise, or in
reducing the risk of respiratory illness in athletes. Emerging
evidence indicating that antioxidant supplementation miti-
gates important exercise-induced adaptations (including the
immune system) contributes to the debate for and against
antioxidant supplementation in athletes.
Herbal supplements are widely used by athletes either to
improve their performance or to boost their immune system.
However, few human in vivo studies focusing on specific
immune parameters are available and most of the available
studies use ex vivo or in vitro conditions. Results from these
studies are conflicting and are often not in full agreement with
the purported immunomodulatory claims from the food sup-
plement industry. For example, as therapeutic immunomodu-
lators for athletes, there is some evidence that echinacea may
be efficacious whereas the evidence for ginseng is poor.
Polyphenols, including flavonoids are mostly found in tea,
coffee, fruits and wine. They exhibit strong anti-inflammato-
ry, antioxidant, anti-pathogenic, and immuno-regulatory prop-
erties in vitro. Epidemiological data in general support that
polyphenol-rich plant extracts and unique polyphenol-nutrient
mixtures have small but significant effects in increasing anti-
oxidant capacity, with inconsistent, short-term effects on miti-
gating exercise-induced oxidative stress, inflammation, and
immune dysfunction. Quercetin consumed at high doses (500
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to 1,000 mg/day) has been linked to reduced incidence of self-
reported URTI in athletes.
Probiotics are interesting immunonutrients since they demon-
strate immunomodulation properties on both local and sys-
temic (some aspects of both innate and acquired immune
responses) immunity. In non-athletic populations, a recent
systematic review concluded that probiotic use resulted in a
lower incidence of URTI, reduced numbers of illness days,
and fewer days of absence from day care/school/work.
Despite a lower number of studies, the same benefits seem to
exist in athletic populations. Although a daily dose of ~1010
live bacteria is widely promoted, there is still some debate
about the optimal duration of supplementation and the poten-
tial benefits of selecting and mixing specific bacterial strains
with or without prebiotics.
Bovine colostrum exhibits antibacterial, anti-inflammatory and
anti-viral properties. Several investigations have reported a
reduction (not always statistically significant) in self-reported
URTI incidence in athletes following a period greater than four
weeks of bovine colostrum supplementation. However, the
effect of bovine colostrum on illness duration is less conclusive. 
A large number of different immune cells and functions are
influenced by vitamin D. These effects are mainly mediated
through modulation of the expression of several genes. Opti-
mal circulating 25-hydroxy vitamin D concentration is possi-
bly beyond 75 nmol/l as individuals with such a vitamin D
concentration demonstrated a lower incidence of URTI than
those with an actually recommended vitamin D concentration
(of around 50 nmol/l). Optimal vitamin D concentrations for
immune cells require further study before they can be recom-
mended to athletes who would like to maintain their immune
function at the highest level without compromising their
health. 
As long as the diet meets the energy demands and provides
sufficient macro- and micro- nutrients to support the immune
system, there is probably no need for consumption of
“immune boosting” supplements. However, there are specific
scenarios when elite athletes or military personnel might ben-
efit from nutritional supplements to bolster immunity. More
randomized controlled trials in these individuals with suffi-
cient participant numbers and rigorous designs are required
to investigate whether the nutritional practices adopted by
elite athletes impair immunity and increase infection; and,
whether purported “immune boosting” supplements benefit
immune health without blunting the desired training adapta-
tions.
Obesity is related to immune dysfunction and chronic low
grade inflammation. There is a consistent body of biological
evidence attesting to the anti-inflammatory effects of regular
physical training in obese or overweight individuals. Indeed,
regular physical activity decreases toll-like receptor (TLR)-4
expression and induces shift from M1-type macrophages to
M-2 type macrophages; both of these phenomenon promoting
anti-inflammatory patterns. The anti-inflammatory effects of
regular exercise are also partly mediated through interleukin
(IL)-6 production at the muscle level. IL-6 triggers an anti-
inflammatory cascade via the induction of the anti-inflamma-
tory cytokines interleukin-1 receptor antagonist (IL-1ra) and
IL-10, and also inhibits tumour necrosis factor (TNF)-α and
its associated insulin resistance pattern. IL-6 also promotes fat
oxidation which is beneficial to obese individuals. These
immunological changes associated with training have been
proven to be clinically relevant in many studies including
obese adults and adolescents.
A decrease in cell-mediated immune function in the elderly
(immunosenescence) contributes to higher morbidity and
mortality. Nevertheless, aging appears to be linked with an
increased inflammatory response. Given the focus on exer-
cise-induced immunodepression in this series and the journal,
it seems likely that extreme exercise will exacerbate immune
system impairment in aging. Moderate regular exercise, how-
ever, may even enhance immune function in the elderly. For
example, calisthenic exercise increases the function of natural
killer (NK) cells and T-cells in older women. It is not known
whether the exercising elderly have specific nutritional needs,
although many appear deficient in micronutrients essential for
immune function. In addition, increased inflammation, oxida-
tive stress and muscle damage suggest that exercising older
adults might require nutrients with immune enhancing and/or
anti-inflammatory properties. In terms of energy provision,
total calorie intake should be adjusted to avoid conversion of
excess caloric intake to body fat. Moreover, glucose tolerance
and insulin sensitivity decrease with aging. 
Currently, a single marker able to predict the effect of a
dietary and/or exercise intervention on different aspects of
immune function does not exist. The range of available bio-
markers is quite wide from in vitro tests to clinical symp-
toms. However, each biomarker should be carefully chosen
according to its intrinsic characteristics (links with causal
pathway and clinical endpoint, biological sensitivity and
specificity, feasibility, practicality, and cost) as well as the
designed study’s aim and primary outcome. Mechanistic
studies or studies aiming at testing hypotheses at molecular,
cellular or immune function levels should rather consider in
vitro or ex vivo biomarkers. Whereas in vivo biomarkers or
biomarkers relying on patient symptoms should be preferred
in experiments describing integrated response or clinical
studies.
INTRODUCTION: IMMUNONUTRITION,
INFLAMMATION AND EXERCISE
Physical exercise (chronic or acute) influences the immune
system and its functions. All immune components or func-
tions, systemic, local or mucosal, innate or adaptive, cellular
or cytokine-related are positively or negatively linked with
exercise regimens (406). This body of knowledge represents
the interdisciplinary field of Exercise Immunology. 
Similarly, the diet (macro and micronutrients, as well as non-
nutritive components) is known to influence the immune sys-
tem and its functions. Quantitative aspects (from protein-ener-
gy malnutrition to unbalanced Western diets) as well as quali-
tative aspects (oligo elements, vitamins, mineral, anti-oxi-
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dants, plant-derived immunomodulators, probiotics, amino
acids, and fatty acids) can either stimulate or inhibit selective
immune functions or inflammation. For instance, consump-
tion of dietary fibres reduces chronic inflammation by
decreasing lipid oxidation (124). Fibres also interact with the
gut microbiota via short-chain fatty acids produced during
colonic fermentation (251). Fibres from oats or barley smooth
the rate of appearance of glucose in the blood, reducing the
glycaemic index and glycaemic load, and as a consequence
production of nitric oxide, superoxide and peroxynitrite which
are powerful pro-oxidant and pro-inflammatory molecules
(80). Whole-grain foods also exert anti-inflammatory proper-
ties, such as free radical scavenging, antioxidant enzyme acti-
vation, or modification of the redox status of tissues and cells
(124). These close interactions between diet and the immune
system are the genesis of the term “Immunonutrition” which
represents another new interdisciplinary field of basic and
applied research.
As the immune system and inflammation, one of its major
effectors, are regulated by both exercise and nutrition, it is of
particular interest to address how nutrients can affect immuni-
ty in an exercise perspective. However, when nutrition is con-
cerned, it appears that the commitment and the goals to
achieve are very different when comparing a sedentary over-
weight individual to a high-level athlete. Indeed, as inappro-
priate exercise regimens or training programmes may alter
some immune functions and promote illnesses (306), elite ath-
letes are always considering diet and nutrition plans as possi-
ble countermeasures to the so-called exercise-induced
immunodepression. This latter term is more appropriate than
the traditionally used term “immunosuppression” which
means specific manipulation of the immune system, e.g. via
cyclosporin.
However, among the numerous nutrients and foods promoted
for their purported immuno-modulating effects, only a very
limited number has proved to be effective in maintaining or
restoring some immune functions or preventing illnesses. This
consensus statement series addresses the issue of macronutri-
ents, probiotics, vitamin D, antioxidants and plant-derived
immunomodulators, minerals and some promising dietary
compounds as immune support for exercising humans. It also
deals with immunonutrition in exercising overweight or elder-
ly individuals and explores the relevance of selected
immune/inflammation markers commonly used when design-
ing a nutrition study in exercise immunology.
When the diet is inappropriate (more likely excessive high
glycaemic index foods and/or caloric intakes), a part of the
innate immune system is overreacting to the excessive amount
of visceral fat leading to a chronic, low grade inflammation
and potential subsequent inflammation-related diseases. Here,
regular exercise is considered as a potential countermeasure to
the inflammatory-driven morbidities such as cardiovascular
diseases, chronic obstructive pulmonary diseases, colon and
breast cancers, insulin resistance, type II diabetes, and some
neurodegenerative diseases (307,326).
The anti-inflammatory effects of exercise are achieved
through several possible pathways (143). The reduction in
visceral fat mass associated with a secondary reduced release
of adipokines is one of the main mechanisms. Moreover, fol-
lowing each bout of exercise, the release of high amounts of
cortisol and adrenaline associated with an increased produc-
tion and release of IL 6 and other mediators now often
referred to as “myokines” from working skeletal muscles con-
tribute to the generation of an anti-inflammatory “milieu”. IL-
6 is pleiotropic: it may have different actions in different con-
texts, and thus may not always act in a manner that could be
described as pro-inflammatory. 
At the cellular level, a reduced expression of TLR on mono-
cytes and macrophages and a subsequent inhibition of down-
stream pro-inflammatory cytokines production are observed.
Within the adipose tissue quantitative and qualitative changes
in monocytes-macrophages are noted. The number of M1-
type macrophages is decreased as well as their associated pro-
inflammatory cytokines (IL-6 and TNF-α), whereas M2-type
macrophage numbers and their anti-inflammatory cytokines
(IL-10 and adiponectin) are increased (205). Franceschi and
colleagues (133) introduced the concept of ‘inflammaging’ as
part of the spectrum of immunosenescence. Inflammaging is
the chronic low-grade inflammatory state present in aging
individuals and is believed to be a consequence of a remodel-
ling of the innate and acquired immune system. It is character-
ized by increased systemic concentrations of pro-inflammato-
ry cytokines such as IL-1, IL-6, and TNF-α (398) as well as
increased C-reactive protein (CRP) concentration which are
used as clinical markers. Inflammaging increases the risk of
morbidities and age-related diseases, and is also associated
with increased skeletal muscle wasting, strength loss, and
functional impairments. In this particular context, both nutri-
tion (115) and exercise (219) interventions are proposed for
elderly or frail individuals as a countermeasure of the aging
process and its associated inflammation-related diseases. This
provides the rationale for producing the present consensus
statements.
Most athletes, whether recreational or elite, and in all parts of
the world, use sports foods and supplements. The popularity
of certain types of dietary supplements demonstrates that ath-
letes may often be more motivated by an interest in health
benefits rather than, for example, direct ergogenic effects. In
this series of consensus statements on immunonutrition, ath-
letes are therefore strongly advised not only to seek the advice
of a properly qualified nutritionist before embarking on sup-
plementation but also to pay careful attention to the impor-
tance of the recommended daily allowance (RDA). It is a
common misconception among athletes that, if x g of a prod-
uct works, then taking double that amount will be even better!
In fact, this approach is very likely to lead to health problems
rather than to solutions. Readers can find more detailed dis-
cussion on this topic in Castell et al. (78).
CARBOHYDRATES
Background
The role of carbohydrate as an ergogenic aid for performance
has long been recognised. The recommended daily carbohy-
drate intake for athletes who train for one to three hours each
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day is 6–10 g/kg body mass increasing to 8–12 g/kg body
mass for athletes training more than four hours each day, with
additional intake of 30-60 g/h during exercise lasting for 1
hour or more (384). This guidance is principally aimed at
restoring muscle and liver glycogen stores before exercise
and maintaining blood glucose levels during exercise to
ensure sufficient glucose availability for skeletal muscle con-
traction. However, carbohydrate availability also has the
potential to limit the degree of exercise-induced immune dys-
function through direct or indirect actions. Directly, glucose
acts as a fuel substrate for immune cells (12) therefore it
could be argued that post-exercise hypoglycaemia could
endanger immune cell function. However, the significance of
this alone is questionable given that immune cells do not rely
solely on glucose for energy. Conversely, since both cate-
cholamines (adrenaline, noradrenaline) and cortisol are
known to have potent modulatory effects on immune function
(208) increasing carbohydrate availability may more likely
act indirectly by reducing the stress hormone response to the
exercise, thereby limiting exercise-induced immune impair-
ments.
Consensus: carbohydrates, exercise and immune function
Dietary carbohydrates
Performing exercise at around 70% VO2max for at least 1
hour following several days on very low carbohydrate diets
(typically less than 10% of dietary energy intake from carbo-
hydrate) is associated with a greater adrenaline and cortisol
response, higher circulating neutrophil counts and modest
depressions in circulating lymphocyte counts. These effects
are diminished when exercising following a high (typically
more than 70% of energy intake) carbohydrate diet (36,259).
High carbohydrate diets prior to exercise are also associated
with a blunted cytokine response (e.g. IL-6, IL-10 and IL-1ra)
(37), thought to be related to a reduced need for IL-6 to exert
its glucoregulatory actions (309). 
In contrast, increasing dietary carbohydrate does not appear
to exert any beneficial effects on either resting or post-exer-
cise immune cell functions. A high or a low carbohydrate
diet for several days was associated with similar levels of
bacterially-stimulated neutrophil degranulation and mitogen-
stimulated lymphocyte proliferation before exercise, and
resulted in a similar magnitude of impairment post-exercise
(36,259).
Carbohydrate supplementation during exercise
Given the established association between cortisol and
immune cell function, nutritional measures that attenuate
exercise-induced elevations in plasma cortisol have been
hypothesized to be effective in minimizing post-exercise
immune impairments. Specifically, carbohydrate (compared
with placebo) ingestion during exercise is suggested to limit
exercise-induced falls in immune function by maintaining
plasma glucose levels, thereby blunting the plasma cortisol
response. While evidence from the literature largely supports
this, there is evidence to suggest that the beneficial effects of
consuming carbohydrate during exercise can also occur in the
absence of any effect on plasma cortisol levels (35,153). Con-
suming around 60 g/h of carbohydrate during prolonged exer-
cise attenuates the rise in plasma cytokines (270), attenuates
the trafficking of most leucocyte subsets, apart from NK cells
(174,285,289), prevents the exercise-induced fall in bacterial-
ly-stimulated neutrophil degranulation (38) and increases neu-
trophil respiratory burst activity (351). In addition, consuming
carbohydrate (compared with placebo) during prolonged exer-
cise prevents the decrease in both number and percentage of
anti-viral Type 1 helper T cells and the suppression of interfer-
on gamma (IFN-γ) production from these cells (224). Con-
suming carbohydrate during exercise also diminishes typical
post-exercise decreases in T lymphocyte proliferation follow-
ing mitogen or antigen (influenza) stimulation (34,174), an
effect that was still evident 24 hours later (34). This may be
partially related to lower T cell apoptosis within stimulated
cell cultures when carbohydrate is consumed during exercise
(153). Migration of immune cells to infected tissue is crucial
to host defence, and carbohydrate ingestion (60 g/h) during
prolonged exercise has been shown to attenuate post-exercise
falls in T-lymphocyte migration into human rhinovirus-infect-
ed airway epithelial tissue (35). 
Although carbohydrate feeding during exercise appears to be
effective in minimizing some of the immune perturbations
associated with prolonged strenuous exercise, it has minimal
effect on salivary secretory immunoglobulin A (SIgA) secre-
tion (32,284) or NK cell cytotoxic activity (285) but may
increase NK cell responsiveness to IL-2 (254). Consuming
carbohydrate seems less effective at minimizing more modest
alterations in immune function during intermittent exercise
with regular rest intervals (288), resistance exercise (279) and
exercise to fatigue (33). Furthermore, consuming more than
60 g carbohydrate per hour has negligible additional benefit
(224,350,351) most likely because the maximum rate of
exogenous carbohydrate oxidation is around 1 g/min (i.e. 60
g/h; (400)). Finally, carbohydrate supplementation does not
influence the decrease in in vivo immunity to a novel antigen
seen after 2 hours of moderate intensity exercise in non-fasted
runners (102).
There is insufficient evidence to date to support any beneficial
effect of carbohydrate ingestion on symptoms of upper respi-
ratory illness; one study of 93 runners who consumed placebo
or carbohydrate during a marathon reported that, of the six-
teen runners who reported illness in the fifteen days after the
race, ten had consumed placebo and six had consumed carbo-
hydrate (284). 
Conclusion
Carbohydrate ingestion is a partial countermeasure against
exercise-induced immune impairment and is more effective
when consumed as a supplement during exercise than by
increasing dietary content of carbohydrate on a routine basis.
However, evidence that carbohydrate ingestion reduces the
incidence of URTI after prolonged exercise is currently lack-
ing. 
FATTY ACIDS AS IMMUNOMODULATORS
Background
Fatty acids are a major component of most human diets and
most fatty acids can be synthesised endogenously in the
human body (54). Individual fatty acids are distinguished by
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the length of their hydrocarbon chain, and by the absence,
presence, number and configuration (cis or trans) of double
bonds within that chain. Saturated and monounsaturated fatty
acids can be synthesised de novo from precursors such as glu-
cose. The simplest polyunsaturated fatty acids (PUFAs),
linoleic acid (18:2n-6) and α-linolenic acid (18:3n-3), cannot
be synthesised in humans, but are synthesised in plants.
Humans can metabolise these two essential fatty acids further,
inserting additional double bonds (desaturation) and extend-
ing the hydrocarbon chain (elongation). Through these
processes, linoleic acid can be converted to arachidonic acid
(20:4n-6) and alpha-linolenic acid to eicosapentaenoic acid
(EPA; 20:5n-3). Further metabolism to longer chain, more
unsaturated derivatives is possible (e.g., of EPA to docosa-
hexaenoic acid (DHA; 22:6n-3)). 
The principal roles of fatty acids are as energy sources and
membrane constituents (54). Certain fatty acids have addi-
tional, specific roles, such as serving as precursors for the syn-
thesis of bioactive lipid mediators (e.g. prostaglandins), and
influencing membrane and intracellular signalling processes,
the activation of transcription factors and gene expression
(62). Through these different actions, fatty acids are able to
influence cellular functions and thus physiological responses,
including immune and inflammatory responses (59).
Consensus
There is evidence from in vitro, animal and epidemiological
studies that several saturated fatty acids promote inflammato-
ry processes (334). Lipid mediators, including prostaglandins
and leukotrienes, produced from the omega-6 (n-6) PUFA
arachidonic acid are intimately involved in inflammation and
many widely used anti-inflammatory drugs target arachidonic
acid metabolism (106). Several of the mediators produced
from arachidonic acid also suppress cell-mediated immune
responses by targeting antigen-presenting cell and helper T-
cell activities, acting in part via regulatory T-cells (106).
Arachidonic acid is consumed in the diet from meat, eggs and
organs such as liver, or it can be synthesised from the plant
essential fatty acid linoleic acid. Thus, there is a widely held
view that common n-6 PUFAs of both animal and plant origin
are pro-inflammatory and immunodepressive. However,
strong evidence that variations in dietary intake of linoleic
acid do affect inflammation is lacking (197). Older research
showed that γ-linolenic acid (18:3n-6) and its derivative diho-
mo-γ-linolenic acid (20:3n-6), which are both metabolic inter-
mediates between linoleic and arachidonic acids, exert anti-
inflammatory effects (360). There is limited exploration of the
influence of saturated or n-6 PUFAs on immune function or
inflammation in the context of exercise.
Oily fish and fish oil supplements contain the long-chain
omega-3 (n-3) PUFAs EPA and DHA (60). EPA and DHA are
also found in some algal oils and in krill oil. In each of these
sources both the absolute amounts of EPA and DHA and their
ratio can vary widely. There is substantial evidence from in
vitro, animal, epidemiological and human intervention studies
that the combination of EPA and DHA exerts anti-inflamma-
tory actions (58,61) and may enhance cell-mediated immune
function (59). The effects observed are dose-dependent and
may require an intake of >2 g per day the combination of EPA
and DHA (58,59,61). Both EPA and DHA can independently
exert anti-inflammatory effects (5), and they have been shown
to counter the effects of classic inflammatory stimuli like
endotoxin as well as saturated fatty acids and n-6 PUFAs (61).
EPA and DHA are readily incorporated into cell membranes,
partly replacing arachidonic acid. Thus, they result in
decreased production of pro-inflammatory and immunosup-
pressive omega-6-derived lipid mediators (61). In contrast,
the analogous mediators produced from EPA are often only
weakly bioactive (61). Importantly, both EPA and DHA are
substrates for the biosynthesis of potent mediators which
resolve inflammation and enhance immune function: these are
termed resolvins, protectins and maresins (19). EPA and DHA
act through several other mechanisms to decrease inflammato-
ry responses of neutrophils, macrophages and endothelial cells.
These mechanisms include reducing activation of the pro-
inflammatory transcription factor NFκB and activation of per-
oxisome proliferator activated receptor γ (61). Within antigen-
presenting cells, T-cells and B-cells EPA and DHA act by regu-
lating key signalling events within the cell membrane (184). 
Effects of the combination of EPA and DHA, usually as fish
oil, or of DHA alone, on inflammation and immune function
have been explored in a number of studies involving exercise
protocols in both athletes and non-athletes. Several studies
report that supplementation with EPA and DHA decreases the
degree of muscle soreness induced by a bout of exercise in
untrained individuals (201,382,383), although not all studies
saw this (151). This effect also occurred with DHA alone at a
supplemental intake of 3 g/day (91). Furthermore, in
untrained individuals, EPA and DHA have been reported to
diminish the exercise-induced elevation in pro-inflammatory
cytokines including TNF-α and IL-6 (383). Once again this
effect was also seen with DHA alone (108). Thus, the majority
of studies suggest that omega-3 PUFAs decrease the inflam-
matory response induced by exercise in untrained individuals
and that this translates to less muscle damage and soreness. In
contrast, Gray et al. (2012; (152)) and Da Boit et al. (2015;
(99)) both observed no effect of EPA and DHA on the plasma
IL-6 response to an exercise bout, although the production of
IL-2 by mitogen-stimulated blood mononuclear cells and nat-
ural killer cell activity were both enhanced post-exercise with
prior omega-3 PUFA treatment in both of these studies. These
observations suggest that omega-3 PUFAs might enhance
aspects of cell-mediated and innate immunity post-exercise.
Andrade et al. (2007; (10)) reported that elite swimmers who
took EPA and DHA for 45 days showed increased production
of IL-2 and increased T-cell proliferation when peripheral
blood mononuclear cells were stimulated with the mitogen
phytohaemagglutinin, although IFN-γ production was
decreased, making the findings difficult to interpret. There
was no effect of EPA and DHA over 6 weeks on salivary IgA
concentration prior to or after an exercise bout in trained
cyclists (287). There was also no effect on pre-or post-exer-
cise blood leucocyte numbers or the concentrations of C-reac-
tive protein, IL-1β, IL-6 or IL-8 (287). A study of high dose n-
3 PUFAs (3 g/day EPA plus 1.8 g/day DHA) given for 6
weeks to endurance trained males reported no effects on
marathon-induced changes in blood leucocyte numbers or
blood concentrations of TNF-α, IL-1ra, IL-6 or transforming
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growth factor beta (388). Likewise, high dose EPA and DHA
(2.2 g/day of each) for 6 weeks had no effect on treadmill
exercise induced changes in several blood inflammatory
markers in trained males (43). A small study in wheelchair
basketball athletes found that EPA and DHA prevented the
elevation in plasma IL-6, but not other pro-inflammatory
cytokines, induced by an exercise bout, and prevented damage
to neutrophils (244). Capo et al. (66) reported few effects of
EPA and DHA on several plasma cytokines in elite soccer
players undergoing an exercise bout, although there was a
weaker TNF-α and IL-6 response of peripheral blood
mononuclear cells to endotoxin in the n-3 group PUFA after
exercise. This was linked to a lower exercise-induced upregu-
lation of toll-like receptor 4 in the n-3 group (66). Other stud-
ies present results from studies of n-3 PUFAs on immune out-
comes in athletes that are difficult to interpret (105,346).  
Controversies and Future Directions
There is limited exploration of the influence of saturated or n-6
PUFAs on immune function or inflammation in the context of
exercise. There are a number of studies of the long chain n-3
PUFAs EPA and DHA, usually in combination, on immune
function or inflammation in the context of exercise in both
untrained and trained individuals. These studies have used
moderate (<1.0 g/day) to high (4 g/day) doses of EPA plus
DHA for a period of one week to several months; some publi-
cations are not sufficiently clear about the n-3 dose used and
many studies have involved a small number of subjects. Few
studies have used the same design and the immune and inflam-
matory outcomes reported are highly variable between studies,
although several report measurement of the same common
plasma inflammatory cytokines. This makes it difficult to draw
firm conclusions. However, EPA and DHA appear to decrease
exercise-induced inflammation and muscle damage and sore-
ness in untrained individuals. It is not yet clear whether EPA
and DHA affect inflammation or immune function in trained
individuals, although some studies suggest they might. Larger
studies of duration of several weeks to months are recom-
mended to explore better the effects of omega-3 PUFAs, and
other fatty acids, on inflammation and immune function in
trained individuals. Immune and inflammatory outcomes to be
measured should be more carefully considered (2,3). 
AMINO ACIDS
Amino acids are the building blocks for protein. Twenty
amino acids build up the body proteins, nine of these are con-
sidered essential, that is, they have to be supplied through the
diet; the remaining, non-essential, amino acids can be synthe-
sized by the body. Exercise increases the oxidation of amino
acids, and both synthesis and degradation of muscle protein
are increased after exercise (312). The rate of synthesis can be
elevated for up to 72 hours after exercise (258). Recent con-
sensus indicates that amino acid requirements are increased
with regular exercise training, suggesting that protein intakes
as high as ~150-200% of current recommendations might be
necessary for these individuals (313). 
Several amino acids also have other important roles, for
example serving as substrates in the synthesis of neurotrans-
mitters, stimulating protein synthesis or improving immune
function. A list of amino acids involved in immunology and
their roles can be found in a comprehensive review by Li et al.
(2007; (230)). The most studied amino acids in exercise
immunology are Gln, BCAA, alanine and arginine. Gln and
BCAA are the most studied in terms of supplementation
before and after exercise. 
Branched chain amino acids 
During prolonged, fatiguing exercise the branched chain
amino acids (BCAA) (leucine, isoleucine and valine) are
taken up by the working muscle and their plasma concentra-
tion decreases (41,397). The BCAA are oxidized to provide
energy but, more importantly, the metabolism of BCAA pro-
duces nitrogen for Gln synthesis. 
Intake of BCAA rapidly increases their plasma and muscle
concentration (42,154,260), and it is suggested that this will
increase the production of Gln. A fall in the plasma concen-
tration of Gln (p[Gln]) has been observed during/after sus-
tained exercise (104,332), and has been proposed to be linked
with exercise-induced immunodepression ((77,336); see Glu-
tamine chapter). BCAA intake could therefore indirectly
influence the immune response. However, despite the elevat-
ed levels of BCAA in plasma and muscle after intake of these
amino acids, the release of Gln from the exercising muscle
remains unchanged unless large amounts of BCAA are
ingested (42,236,237). In contrast to these findings, chronic
supplementation with BCAA to athletes was able to prevent
the decrease in p[Gln] and immunodepression following a
triathlon or a 30 km race (21). Furthermore, ten weeks of
BCAA supplementation to trained cyclists prevented the
increase in neutrophil number in trained cyclists which was
observed without supplementation (207). 
A direct effect of BCAA on cells of the immune system may
also be conceivable since these amino acids, in particularly
leucine, may stimulate protein synthesis and activate cytokine
and antibody production through a direct effect on mTOR sig-
nalling (see (230)). However, there is currently no evidence
for such an effect, and available data indicate that BCAA are
required to maintain the high rate of protein synthesis in these
cells rather than to stimulate the immune function (see
(57,97)).
Consensus
There are some indications that BCAA intake can reduce
exercise-induced immunodepression. However, there is cur-
rently not enough data from controlled studies to recommend
BCAA ingestion in combination with exercise to enhance
immune function. 
Glutamine 
Background
Glutamine is the most abundant amino acid in the body and
was originally classified as a non-essential amino acid (340).
However, since the 1990s there has been increasing evidence
that Gln becomes “conditionally essential” in specific condi-
tions of stress (73,220). 
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Gln is synthesized, stored and released predominantly by
skeletal muscle and, to a lesser extent, by adipocytes, liver
and lung. It is taken up by intestinal cells, such as enterocytes
and colonocytes, by the kidney, liver and immune cells such
as lymphocytes, macrophages and neutrophils. It has been
suggested that Gln supplementation might improve the diges-
tive and defence mechanisms of the intestine (100,410).
Gln is required by rapidly-dividing cells (213), providing
nitrogen for purine and pyrimidine nucleotide synthesis,
enabling synthesis of new DNA and RNA, for mRNA synthe-
sis and DNA repair. Ardawi and Newsholme (1985; (12,13))
observed a high Gln utilisation by human lymphocytes at rest.
Subsequent in vitro work (303) showed that when Gln was
reduced in culture medium a decrease occurred in the prolifer-
ative ability of human lymphocytes. Gln and BCAA (see
Amino acids section) are the most studied amino acids in
terms of supplementation before and after exercise. 
The p[Gln] is increased in athletes after short-term exercise
(316). However, after prolonged, exhaustive exercise such as
a marathon, the p[Gln] can be decreased by 20-25% (77,104).
Similar decreases have been observed after repeated bouts of
prolonged exercise (336). In two studies at moderate altitude
(athletes, in summer) and high altitude (military personnel, in
winter) a significant decrease in p[Gln] occurred after inten-
sive training and coincided with a high incidence of URTI
(16,79).
The post-exercise decrease in p[Gln] is often concomitant
with a decrease in circulating lymphocyte numbers which
transiently increase initially as part of the well-known leuco-
cytosis observed after exhaustive exercise. Immune cell
function is also decreased at this stage, for example, in both
lymphocytes and NK cells. Rohde et al. (1996; (336))
observed a marked decrease in p[Gln] in triathletes at 2
hours after prolonged exercise, paralleled by changes in lym-
phokine activated killer (LAK) cell activities. A decrease in
p[Gln] in marathon runners coincided with increases in acute
phase markers such as the cytokine IL-6 and complement
C5a, as well as an increased incidence of self-reported URTI
(76,77). 
There is some evidence that Gln, or a Gln precursor (BCAA),
can lessen the incidence of exercise-induced URTI after
marathon running (21,77). However, several studies, mostly
laboratory-based, have shown no effect of maintaining a nor-
mal or high p[Gln] on various aspects of immune function.
These included: LAK cell activity, lymphocyte numbers,
some leucocyte subsets, salivary IgA, CD3 T-cell receptors,
NK cells, leucocytosis, plasma elastase release from
lipopolysaccharide (LPS)-stimulated neutrophils
(216,335,337,403); CD8, CD4 with/without CD28 & 9 sur-
face receptors (215), although the latter study also showed
less neutrocytosis in the Gln group than the placebo group. 
In a recent study Caris et al. (2014; (67)) observed a positive
effect of both Gln and carbohydrate in modulating the
Th1/Th2 (helper cells) balance after exercise. The post-exer-
cise ratio of CD4+ helper/ CD8+ cytotoxic/suppressor cells
has been seen to be higher in athletes provided with Gln rather
than placebo after both marathon running (75) and heavy load
training (373).
It has been suggested that muscle Gln is not markedly
decreased as a result of exercise, although Rennie et al. (1981;
(332)) did see a decrease in muscle Gln in their study, which
also produced a biphasic response of p[Gln] to 3.75 hours of
exercise. The decrease is markedly less than the pathological-
ly low Gln concentrations observed in the muscle of critically
ill patients (341). Current opinion considers that, in general,
the body has sufficient stores of Gln to replenish post-exercise
plasma reductions readily (see (139)). The time frame for this
is not known. Interestingly, Hiscock et al. (2002; (180)) meas-
ured the intracellular content of Gln in peripheral blood
mononucleocytes (PBMC), and found good availability of
Gln for the cells after exercise. 
The presence of glutaminase, the major degradation enzyme
of Gln, was established in human neutrophils by Castell et al.
(2004; (74)). There appears to be a link between production of
the major neutrophil chemoattractant, IL-8, and Gln. In in
vitro studies the provision of Gln results in a decrease in IL-8
production in athletes (73), and in clinical studies in patients
with acute pancreatitis (23). Provision of exogenous Gln
might therefore lead to a decrease in the requirement for IL-8
secretion to attract more neutrophils to the site of tissue dam-
age, though this is speculative. 
IL-6 is probably the most studied cytokine (myokine) in exer-
cise immunology. The plasma concentration of IL-6 increases
markedly after strenuous and prolonged exercise and this
increase was further enhanced after Gln supplementation
(181). This might prove beneficial if, as has been suggested,
IL-6 acts as an anti-inflammatory cytokine in exercise (311).
In regard to leucocytosis after endurance exercise, Fehren-
bach et al. (1999; (126)) described a possible protective effect
of heat-shock protein (HSP) in athletes. There is substantial
evidence that Gln is important for HSP generation in both in
vitro and in vivo studies (200,423,426). Zuhl et al., 2014 (433)
observed anti-inflammatory effects of Gln via HSP70 on
intestinal permeability and peripheral blood mononuclear
cells. Raizel et al. (2016; (327)) recently showed that treating
rats with oral free L-Gln (with L-alanine or as a dipeptide)
induced cytoprotective effects via HSP70 after resistance
exercise. HSP facilitates neutrophil activity (179,296): given
the presence of glutaminase on the secretory granules of
human neutrophils (74), the effect of Gln on the heat shock
response might induce changes in neutrophil function. 
Consensus
Despite a good rationale for Gln supplementation based on
sound biochemical investigation, laboratory-based exercise
studies have proved disappointing in terms of providing any
direct enhancement of immune function due to Gln feeding
(see Controversies). Recently, it has been suggested that there
is sufficient Gln availability in body stores to combat post-
exercise decreases in immune function after endurance
events. Nevertheless, a decrease in p[Gln] may act as a mark-
er for immunodepression and increased incidence of minor ill-
nesses. Thus, a marked decrease in p[Gln] may indicate
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decreased immunocompetence, in particular in the individual
who is vulnerable to opportunistic infections. There are some
indications that provision of Gln or a Gln precursor can lessen
the incidence of exercise-induced URTI.
Controversies
Since p[Gln] decreases by approximately 20-25% after pro-
longed, exhaustive exercise, given its role in some key
immune cells, this might be expected to have ramifications for
immune function in athletes. There was a sound biochemical
and clinical rationale for thinking that Gln provision might be
a simple panacea for minor illnesses and for exercise-induced
immunodepression. Despite the evidence that Gln or a Gln
precursor can lessen the incidence of exercise-induced URTI,
several laboratory-based studies have shown no effect of
maintaining a normal or high p[Gln] on some specific aspects
of immune function. 
Future Directions
Data on the effects of supplementation with Gln or Gln pre-
cursors on neutrophil function in exercise have become
increasingly interesting, and further investigation in humans
should prove to be useful. Gln has a role in generating heat
shock protein: this might have a protective effect on immun-
odepression in exercise, and more studies are required. There
may also be other aspects of immune function as yet unstud-
ied, which might respond more effectively to the provision of
Gln before or after prolonged, exhaustive exercise.
MINERALS
Background
Several minerals are known to exert modulatory effects on
immune function, including Zn, Mg, Fe, Se, and Mn. With the
exception of Zn and Fe, isolated deficiencies are rare. Regard-
ing exercise, requirements for some of these minerals are cer-
tainly higher in athletes compared with sedentary people. On
the one hand, exercise has a pronounced effect on mineral
metabolism; on the other hand, exercise increases losses in
sweat and urine. However, excess intakes of some minerals
are known to impair immune function. Earlier reviews have
discussed mineral supplementation comprehensively
(63,138). The present consensus statement considers supple-
mentation of five specific minerals (Zn, Mg, Fe, Se and Mn)
in relation to exercise. 
Consensus
Zinc
The essential trace element Zn is an important co-factor of
several enzymes and transcription factors and thereby
involved in various physiological processes during growth,
metabolism, and development. Studies with hereditary dis-
eases of Zn deficiencies such as acrodermatitis enteropathica
have demonstrated the importance of proper Zn levels for
immune function of both adaptive and non-adaptive systems
(187). Severe Zn deficiency in these patients is accompanied
by several symptoms including enhanced susceptibility to
infections. But even mild Zn deficiency occurring in popula-
tions at risk such as elderly people or vegetarians may result
in impairment of NK cell lytic activity and T cell mediated
functions (319). Intracellular Zn levels in T cells seem to be
highly regulated and involved during T cell activation. In
macrophages Zn seems to play a part in important anti-inflam-
matory roles by inhibiting NF-κB signalling. Beside its action
on immune cells Zn seems to have direct anti-viral properties
via Intercellular Adhesion Molecule (ICAM)-1 receptors on
respiratory epithelial cells of the nasal epithelium (186).
The RDA of Zn for men and women in the US is 11 and 8 mg,
respectively; in the EU a gender independent value of 10 mg
is given. Zn can be found in a wide variety of foods like cer-
tain types of sea food such as oysters, crabs and lobsters, red
meat, poultry, beans, nuts and whole grains. In contrast,
bioavailabilty of Zn is impaired by phytates which are present
in whole-grain breads, cereals, and legumes, and by Fe sup-
plementation.
There is considerable mobilization of Zn during exercise into
the blood, which is re-distributed soon after termination of
exercise. Nevertheless losses of Zn via sweat and urine, in
addition to reduced dietary intake, have been identified as
major risk factors for Zn deficiency in athletes. Therefore a
number of studies reported Zn deficiency (serum levels < 70
µg/dl) in elite athletes, especially in endurance athletes (257).
However, the impact of these alterations on athletes’ immune
system/function remains to be shown. Therefore regular sup-
plementation of Zn cannot be recommended. Nevertheless,
there is some evidence from general population studies that
Zn supplementation might be effective in the prevention and
therapy of the common cold, which represents the major dis-
ease form of athletes during transient immunodepression in
the early post-exercise period. A recent study presented weak
evidence for Zn in the prevention of the common cold in chil-
dren (6). In addition, recent meta-analysis including 17 trials
and a total of 2121 participants presented moderate evidence
that oral Zn formulations may shorten the duration of symp-
toms of the common cold (354). It has been suggested that
supplementation should start within 24 hours of the onset of
symptoms (367). Based on these studies, a transient supple-
mentation during periods of intensive exercise bouts together
with psychological stress such as during competition might be
beneficial, especially if a history of recurrent infections exists.
Side effects of Zn supplementation include bad taste and nau-
sea.
Magnesium 
Mg is an essential biological element which is predominantly
located in bones (approx. 52%), in muscle cells (28%), and
soft tissue (19%). Serum and red blood cells contain only
0.3% and 0.5%, respectively. In general, Mg is involved as an
important regulator in three main physiological processes; 1)
enzyme activation, e.g. during energy metabolism, 2) stabiliz-
ing membrane function and integrity, 3) cell signalling, e.g. as
a natural antagonist of intracellular calcium signals (263).
With respect to the function of the immune system Mg seems
to be involved in the following steps: cofactor for
immunoglobulin synthesis, immune cell adherence, antibody-
dependent cytolysis, activation of macrophages. Moreover,
Mg deficiency is associated with clinical signs of inflamma-
tion, such as immune cell activation and enhanced levels of
circulating inflammatory mediators (222).
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The concentration of total serum Mg is approximately 0.75-
1.1 mmol/l, which is, however, a rather poor indicator of the
body’s Mg status. Serum acts as a transit pathway between
electrolyte uptake and excretion, bone stores and actively
metabolising tissues. These processes are affected by a num-
ber of hormones such as parathyroid hormone, calcitonin,
vitamin D, insulin, glucagon, antidiuretic hormone, aldos-
terone and sex steroids.
Exercise-induced alterations of serum Mg seem to depend on
exercise intensity and duration. After short-term, high-intensi-
ty exercise the majority of studies indicated an increase of
extracellular Mg; however, after prolonged submaximal exer-
cise most studies reported a hypomagnesaemia (56). It seems
unlikely that sweat Mg losses and/or enhanced renal Mg
excretion alone account for this decrease in serum. Some
authors suggested therefore that, during prolonged exercise, a
shift of Mg into the cellular compartment occurs. Longitudi-
nal and cross-sectional studies demonstrated that intensive
training periods may be followed by Mg depletion and that
athletes are prone to Mg deficiency (348). 
Therefore it can be speculated that the exercise-associated
changes in immune function especially in the early post-exer-
cise period might be aggravated in Mg-deficient athletes
(222). In contrast, it has been demonstrated that Mg supple-
mentation did not prevent exercise-induced alterations of
immune parameters in athletes with balanced Mg status (262).
Therefore, Mg supplementation can be recommended only
after diagnosis of Mg deficiency which relies on both clinical
symptoms and laboratory diagnosis (serum Mg < 0.75 mmol/l
is considered to be a useful measurement for severe deficien-
cy). Important food sources of Mg are vegetables, fish, nuts,
and whole grains. Mg formulations include both inorganic
and organic compounds of which the latter seemed to have a
better bioavailability.
Iron
Fe is an essential nutrient which is primarily used as a cofac-
tor for enzymes in the mitochondrial respiratory chain, in the
citric acid cycle and during DNA synthesis, as well as being
the central molecule for binding and transport of oxygen by
haemoglobin and myoglobin (414).
For immunity, Fe is important for lymphocyte proliferation
and differentiation while it interferes with cell mediated
immune effector pathways and cytokine activities (356,414).
Furthermore, Fe exerts multiple effects on macrophage polar-
ization and functionality (269). 
Changes in Fe status can thus affect the immune response in
multiple ways, particularly in the context of infection (82).
The RDA is 18 and 8 mg for women and men respectively.
Sources of Fe are flesh foods, vegetables and grains. The
haem Fe, found in meat products, is best absorbed. In general,
male athletes tend to consume at least the RDA for Fe, but
female athletes tend to consume somewhat less (166). If this
under-supply is combined with heavy Fe loss by menstrua-
tion, haemolysis, gastrointestinal bleeding, inflammatory sta-
tus by heavy physical activity or loss by sweat, Fe balance
may be compromised (235,253). Accordingly, Fe deficiencies
have been reported mainly in women competing in running,
field hockey, cross country skiing, basketball and others
(253). In this case, the use of Fe fortified foods and Fe supple-
ments may be considered (51). Therefore, Fe supplementation
in combination with vitamin C should be recommended for
athletes with Fe deficiency anaemia and monitored carefully
for prophylaxis. During infection the supplementation of
some minerals like Fe is not recommended because it is sug-
gested that pathogenic microorganisms might benefit (107).
However, an immunological effect of Fe supplementation in
the context of exercise has not been shown so far.
Selenium and Manganese
Se status may affect the function of cells of both adaptive and
innate immunity. Currently, the recommended amounts for
adequate Se intake of adults range between 25 and 100
μg/day, with an average of 60 μg/day for men and 53 μg/day
for women (328,376). Neither Se deficiencies nor immuno-
logical effects of supplementation in athletes have been
described yet. For Mn, daily intake through dietary sources
provides the necessary amount required for several key physi-
ological processes, including antioxidant defence, energy
metabolism, immune function and others. During exercise,
Mn might play a role as an antioxidant since a superoxide dis-
mutase in the mitochondrial matrix functions with Mn. There
is no evidence for neither deficiency nor supplementation for
Se nor Mn in athletes, thus both minerals cannot be classified
as immunonutrition during exercise (81). An overview about
these minerals, their immune related functions, symptoms of
deficiency, deficiencies in sports and recommendations for
supplementation is given in Table 1.
Future directions
While there is evidence that regular exercise training of high
volume and intensity may be accompanied by deficiencies of
certain minerals such as Zn, Mg and Fe, the impact of these
alterations on the athlete’s immune function needs to be
demonstrated. In vitro experiments could demonstrate the
involvement of these ions in certain immune processes. But it
remains to be shown whether these deficiencies are able to
aggravate exercise-induced immune responses.
ANTIOXIDANTS 
Background
Free radicals are reactive molecules with unpaired electron(s)
(158). High levels of free radicals damage cellular compo-
nents. Antioxidants are chemical compounds and enzymes
that exist as a natural means of quenching free radical over-
production. However, moderate levels of radicals and other
oxidants are central to the control of gene expression, cell sig-
nalling pathway regulation, and physiological modulation of
skeletal muscle force production (318). In the context of
inflammation in health and disease, genomic, cellular, and
physiological outcomes are regulated by fluctuations between
free radical species and their antioxidant counterparts. In this
section, we outline oxidants (mainly ROS and reactive nitro-
gen species (RNS)) and antioxidants (with a focus on dietary
sources of antioxidants), their effects on exercise, and the
interface with the immune system (329).
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Relevant to immune system interactions, superoxide is one of
the strongest cellular oxidants, but it is quickly dismutated to
hydrogen peroxide by the enzyme superoxide dismutase.
Hydrogen peroxide is a more stable, non-free radical ROS
that is permeable to cellular membranes. Despite being a
weak oxidizing agent, high local concentrations of hydrogen
peroxide are cytotoxic. Toxicity is typically associated with
oxidizing chain reactions promoted by Fe (Fenton reaction)
centered molecules which produce hydroxyl radicals.
Hydroxyl radicals are strong oxidants, highly reactive and,
when concentrated, can be the most damaging ROS in biolog-
ical systems. Central to inflammation, hypochlorite is another
well-known ROS product (329). Hypochlorite is formed by
the action of the oxidative enzyme myeloperoxidase utilizing
hydrogen peroxide. Hypochlorite is produced by neutrophils
and macrophages (233,432) and, independent of pathogen
defence, can oxidize circulating cholesterol and other humoral
factors with deleterious consequences. Moreover, this oxidant
readily forms hypochlorous acid, subsequently crossing cell
membranes and damaging essentially all cellular constituents
with negative effects (71). 
Nitric oxide is held to be the main RNS in inflammatory
processes and is synthesized enzymatically (nitrogen oxide
synthase isoforms) from the amino acid L-arginine. Nitric
oxide is a weak reducing agent, but can react with superoxide
to produce peroxynitrite. As with ROS, RNS promote health
or disease within the context of a dose, duration and the local
biochemical environment. In certain scenarios peroxynitrite is
a strong oxidizing agent that depletes thiol groups, and dam-
ages DNA and proteins (234).
Consensus
Undeniably, participation in acute exercise is associated with
a transient production in the ROS/RNS (317). Moreover,
while the source of ROS/RNS production is largely thought to
be generated within the contracting skeletal muscle (331)
there is ample evidence that the immune system is also
responsible for exercise-generated radical species (325).
The involvement of the immune system in ROS and RNS
 production 
The rate of oxygen consumption by phagocytes (e.g., neu-
trophils, eosinophils and mononuclear phagocytes) increases
when exposed to certain stimuli (e.g., pathogens, pollutants,
etc.). When this occurs, the phagocytes produce high levels of
superoxide and collectively these events are known as the
"respiratory burst" (14). The purpose of this phenomenon is to
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Table 1: Overview about specific minerals, their immune related functions, symptoms of deficiency, deficiencies in sports and recommendations
for supplementation.  
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generate powerful microbiocidal agents by the internal
defence arm of the immune system. Specifically,
macrophages produce NO which plays a critical role in redox-
related functions of the immune response (422).
Interaction of exercise and antioxidant content (potential) of
the immune system
It is well established that prolonged, high intensity training
and competition can result in acute immune impairment in
athletes and usually manifests as an increased susceptibility to
minor illnesses, particularly URTI (see Section 12). Essential
to this understanding is the fact that acute high intensity exer-
cise is associated with upregulation of endogenous antioxi-
dant enzyme transcripts (129). This finding is important and
suggestive of the fact that, as with muscle level adaptations,
the immune system is resilient and ultimately adapts benefi-
cially to exercise. 
Controversies
Advocates of antioxidant supplementation argue that exer-
cise-induced oxidant production cannot be adequately
quenched without dietary intervention. While this logic may
seem reasonable at first, several arguments contradict the
notion that athletes and recreational exercisers require dietary
antioxidant supplementation. For example, dietary antioxidant
consumption has been proposed to reduce the risk of respira-
tory illness, but conclusive data to support or oppose this
statement are not available (121). Furthermore, links between
exercise-induced oxidative stress and immune dysfunction
(275), and the postulated benefits of dietary antioxidant sup-
plementation in preventing immune dysfunction during exer-
cise, are not substantiated empirically (276).
In addition, to counteract the proposed need for supplemental
antioxidants, there is no conclusive evidence that exercise-
induced ROS production is detrimental to human health. By
contrast, the fact that exercise elicits both oxidative stress and
numerous adaptive health and athletic performance benefits is
paradoxical to the idea that supplemental antioxidants are
needed. Moreover, regular exercise training promotes fortifi-
cation of endogenous enzymatic and non-enzymatic antioxi-
dants, a fact that extends to circulating immune cells from
exercised individuals (129). The adaptive increase in endoge-
nous antioxidants does not fully quench the ROS/RNS gener-
ated during the exercise, but is clearly sufficient to protect
against deleterious outcomes due to exercise-induced oxida-
tive stress (194).
According to scientific consensus, therefore, athletes who
consume an appropriate energy intake from nutrient-dense
foods do not need antioxidant supplementation. Moreover,
there is no evidence that exercise in extreme environments
necessitates antioxidant supplementation (324). In contrast,
one feasible circumstance in which supplemental dietary
antioxidants may be warranted is in individual cases of nutri-
ent deficiencies (e.g., antioxidant status below the normal
range for good health). This latter instance is a rare exception
to our broader understanding of exercise and oxidative stress:
nevertheless it has been questioned scientifically by investi-
gating the dietary practices of athletes (396). Importantly,
emerging evidence indicates that antioxidant supplementation
mitigates important exercise-induced adaptations which now
appear to extend to the immune system. 
Future directions
The debate for and against antioxidant supplementation in
athletes and regular exercisers appears likely to continue
despite comprehensive understanding of immunonutrition and
exercise-induced oxidative stress. Antioxidant supplementa-
tion practices are often driven by business models and con-
sumer biases that seek a convenient means to improve athletic
performance, health, and longevity. Accordingly, there is a
pressing need for additional research to demonstrate when,
and in what context, antioxidant supplementation may be effi-
cacious. Moreover, future work should be mindful of corpo-
rate biases and include points for consumer advocacy when-
ever possible. It is proposed that exercise and nutritional sci-
entists should join with practitioners to educate athletes about
the current scientific understanding regarding antioxidant sup-
plements and exercise-induced oxidative stress and inflamma-
tion. Education efforts should be strategic and ever mindful of
consumer demand for pill-based solutions to complex prob-
lems like performance enhancement, a point that is of particu-
lar importance to exercise and immunonutrition.
PLANT-DERIVED IMMUNOMODULATORS:
HERBAL SUPPLEMENTS
In this article “botanical supplements” (“herbal supplements”)
refers to single- or multi-organ plant extracts in tablet or liq-
uid form containing a diverse array of phytochemicals, in con-
trast to “botanicals” (“herbals”) which refers to isolated plant
compounds or compound groups. 
Background
Several plants are used by athletes as dietary/nutritional sup-
plements (Table 2). Quantifying global rates of use is logisti-
cally problematical because athletes and researchers differ in
their definition of “herbal supplement”, and multicomponent
preparations or foodstuffs may contain herbs unbeknownst to
athletes. Usage surveys sometimes neglect herbal supple-
ments or lump different supplements together as one group
(123,211,359). Thus, use is likely to be underestimated.
Athletes consume herbal supplements for both health and per-
formance reasons, and a given supplement often has more
than one presumed use. Many herbal supplements consumed
by athletes have purported immunomodulatory capacities
(Table 2). Presumed immunomodulatory herbal supplements
are diverse in terms of taxonomy, plant organs used, and
bioactive compounds.
Consensus
Empirical evidence for the immunomodulatory capacities of
herbal supplements is often incomplete, equivocal, and/or
weak, whether the studies used athletes/non-athletes or exer-
cise/non-exercise models. Ginseng and echinacea possibly
serve as the best models for examining immunomodulatory
herbal supplements in athletic contexts, because they have
been more robustly researched, and bioavailability studies
suggest these supplements’ bioactive molecules can pass
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through the gut into the bloodstream in physiologically rele-
vant quantities. 
Echinacea is primarily taken by athletes for prevention or
treatment of upper respiratory tract infections such as colds or
influenza. Recent reviews and meta-analyses from clinical tri-
als with the general population concur that echinacea supple-
mentation may lessen symptom severity or duration, but are
equivocal in their assessment of its prevention capabilities
(204,349). Results from athlete/exercise studies on echinacea
are similar (Table 3) (27,155,353). Though all three studies
used E. purpurea-based preparations, Table 3 epitomizes the
problems in forming conclusions
about echinacea supplements (or
most herbal supplements for that
matter; e.g., few studies, different
populations, measurements, exer-
cise interventions, and treatment
interventions). One recent review
that examined clinical studies, ex
vivo studies (where blood samples
were drawn pre- and post-exercise,
but lymphocytes were stimulated in
vitro), and in vitro studies conclud-
ed that echinacea supplements may
stimulate both innate and adaptive
immunity (the former more so) and
that alk(yl)amides and caffeic acid
derivatives are the likely bioactive
molecules (358). In terms of
ergogenic potential, echinacea sup-
plementation did not improve
endurance capacity or VO2max in
three studies (22,25,375) but did in
one (417). 
Ginseng is primarily taken by ath-
letes as an ergogenic or adaptogenic
aid, either as a standalone supple-
ment or in multicomponent “energy
drinks.” Recent reviews have dis-
counted its utility as an ergogenic
aid (15) and further suggest that any benefits seen in energy
drinks are likely attributable to caffeine or sugars and not gin-
seng (18). Ginsenosides are the presumed immunomodulatory
constituents. A review of the immunomodulatory effects of
ginseng supplements in athletes has been provided elsewhere
(Table 2 in (358)). Though there are more in vivo studies on
ginseng and its potential immunomodulatory effects than
echinacea, outcomes were worryingly inconsistent across
studies and often weak, likely owing to the diverse species,
extract types, and dosing used. The two studies investigating
IL-6 are a good example of this predicament. In one study
(202), trained males consumed heat-treated P. ginseng supple-
ments for seven days before two 45-
minute treadmill runs and demon-
strated reduced IL-6 compared to
controls a couple hours post-exer-
cise but not a day later. In a sepa-
rate study (225), untrained male
subjects consumed P. pseudogin-
seng for three days before 30 min-
utes of treadmill running at 60%
VO2max and demonstrated no dif-
ference in IL-6 levels post-exercise
compared to controls.
Owing to the sparse literature avail-
able, many athletics-associated
claims about herbal supplements
have yet to be scientifically
addressed and recommendations
need be cautious. As therapeutic
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Table 2: Herbal supplement use by 8424 athletes based on 27 published surveys.  Data used for
this table were gleaned from a subset of 27 athlete surveys identified by Knapik et al. (211) as con-
taining references to specific herbal supplements (references 9-12, 15, 19, 23, 35, 49, 58, 67, 68,
80, 101, 121, 123, 128, 131, 132, 141, 144, 149, 151-153, 159, and 198 in (211)), but were analyzed
differently here.   * = Many herbal supplements were quantified only once and were not tabulated:
alfalfa, chamomile, ciwujia, evening primrose, goldenseal, green tea, guarana, kava kava, kola nut,
peppermint, tea tree oil, and yohimbe.  Some surveys also noted “herbal supplements” (4 surveys;
0.9 ± 2.9%) or mixed herbal preparations (4 surveys; 3.5 ± 10.5%).  † = “Yes” indicates at least
some use among athletes as an immunomodulator, and “no” indicates the supplement is not con-
sumed as an immunomodulator; designations do not connote whether the plant is primarily taken
as an immunomodulator (e.g., echinacea) or only secondarily (e.g., ginseng), or efficacy.  ‡ Two
additional studies did not provide usage statistics.  § One additional study did not provide usage
statistics.
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Table 3. Representative studies concerning potential immunomodulatory effects of Echinacea
supplementation in athletes.  Abbreviations: RA = recreationally-active, TR = trained.
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immunomodulators for athletes, there is some evidence that
echinacea may be efficacious whereas the evidence for gin-
seng is murky. Scant literature exists on the potential
immunomodulatory effects of the other herbal supplements in
Table 2 among athletes or even in the general population, and
reviews may be found elsewhere (78). 
Controversies and Future Directions
For some herbal supplements, data are only available from
animal models or in vitro work with human or animal cells.
While valuable, such data may not directly translate to human
clinical outcomes because of bioavailability/pharmacokinetic
reasons or species differences. Potential immunomodulatory
effects of bystander molecules (such as endotoxin [LPS] from
bacteria growing on plant material or incorporated during the
extraction process) are concerns for in vitro studies and may
explain contradictory activities of plant extracts such as dual
cytokine-enhancing and -suppressing properties from a single
extract (387); some experiments proactively addressed such
concerns whereas others did not. Unaccounted “pre-clinical
factors” (especially those during plant growth, harvest, and
processing) and differences in experimental methods con-
found cross-study comparisons (357).
Muddying the waters are issues related to the products them-
selves: herbal supplement labels may not accurately represent
actual supplement contents; there can be lot-to-lot variation
from a single manufacturer; and stark differences can exist
across manufacturers for a single supplement. Supplements
may also inadvertently (or, some allege, covertly) contain
substances considered banned/”doping agents”
(92,135,214,297). Many herbal supplements are not regulated
by government agencies.
Thus, one should be cautious in concluding that any given
supplement is consistently efficacious, or that there is a signal
failure due to a lack of consiliency in the published research.
Rather, lack of consiliency represents the Byzantine nature of
herbal supplements in “real world” contexts due to the factors
just described. It also limits the guidance professionals can
provide to athletes concerning herbal supplement efficacy or
safety.
Aforementioned pitfalls can guide future work, which will
need to be transdisciplinary to account for all pre-clinical and
clinical factors that may influence immune outcomes. Few
human in vivo studies have focused on specific immune
parameters such as cell subpopulations or antibody or
cytokine profiles. Such work would help illumine mecha-
nisms and provide the additional benefit of linking clinical
outcomes with findings from ex vivo or in vitro studies. 
POLYPHENOLS
Introduction to Polyphenols
The plant kingdom uses nearly 50,000 secondary metabolites
for defence, attraction, and protection (163). These plant
metabolites include approximately 29,000 terpenes, 12,000
alkaloids, and 8,000 phenolics. The 8,000 phenolic com-
pounds or polyphenols are divided into four main classes:
flavonoids (~50% of all polyphenols), phenolic acids, lignans,
and stilbenes. Flavonoids are further classified into six simple
(flavan-3-ols, flavanones, flavones, isoflavones, flavonols,
anthocyanins) and two complex subgroups (condensed tan-
nins or proanthocyanidins, derived tannins) (17) (Table 4). In
foods, flavonoids, lignans, and stilbenes are usually found as
glycosides, and phenolic acids as esters with various polyols,
and structural variations influence absorption and bioavail-
ability (429).
Nutritional assessment of dietary polyphenol and flavonoid
intake has improved with the development of databases from
Phenol Explorer (www. http://phenol-explorer.eu/) and the
U.S. Department of Agriculture (http://www.ars.usda.gov/ser-
vices/docs.htm?docid=24953). Recommendations for dietary
polyphenol and flavonoid intake have not yet been established
but should be forthcoming as improvements in assessment
methods continue. In Europe, the average dietary polyphenol
intake has been estimated at 1,187 mg/day (ranging from
about 1,700 mg/day in Denmark to 660 mg/day in Greece),
with coffee, tea, fruits, and wine as the principal sources
(429). In Europe, only ~100 polyphenols are consumed at lev-
els exceeding 1 mg/day, and flavonoids represent 40% of the
total polyphenols ingested (429). Dietary flavonoid intake
from all foods and beverages among US adults is 251 mg/day,
with tea as the primary source (80% of total flavonoid intake)
(355). Only 29% consume tea on a given day, and when tea is
removed from the analysis, total flavonoid intake falls to
about 50 mg/day, reflecting the low intake of fruits and veg-
etables by US adults (~2 servings/day) (185,355).  
Many flavonoids exhibit strong anti-inflammatory, antioxi-
dant, anti-pathogenic, and immuno-regulatory properties
when studied using in vitro procedures (1,128,241,413). Most
flavonoids are poorly absorbed in the human small intestine
and undergo extensive biotransformation after ingestion.
Thus, in vitro data using the original food-based flavonoid
molecule has questionable relevance when evaluating bioac-
tive effects following ingestion. A large proportion of ingested
plant polyphenols reaches the colon, and microbial degrada-
tion transforms the extremely diverse population of dietary
polyphenols into a smaller number of metabolites, including
simple phenols and derivatives of benzoic acid, phenylacetic
acid, mandelic acid, phenylpropionic acid, and cinnamic acid
(116,119,120,345). The bacterial transformation of food
polyphenols in the colon varies widely depending on the
unique gut microbiota composition of the individual as influ-
enced by genotype, diet, lifestyle, and other factors (116). The
metabolites created from bacterial degradation can exert local
health benefits to colon endothelial cells, modulate the com-
position of the microbiota, and hence indirectly influence
their own metabolism and bioavailability (116). The gut-
derived phenolics can be reabsorbed into the portal vein,
undergo phase II biotransformation in the liver, enter the sys-
temic circulation and become a part of the so-called “food
metabolome”, exert a variety of bioactive effects, and then
finally be excreted in the urine (119,120,345) (see Figure 1).
Recent in vitro studies using biotransformed phenolics at
physiologically relevant concentrations indicate that degrada-
tion of flavonoids to simpler phenolics actually increases their
overall anti-inflammatory bioactivity (241,413). 
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Epidemiological studies support a strong linkage between
high versus low dietary polyphenol intake and reduced risk
for overall mortality (189) and a wide spectrum of health con-
ditions including neurodegenerative diseases (371), body
weight gain (29), systemic inflammation and oxidative stress
(11,72), diabetes (391), cardiovascular disease (409), and
hypertension (223). A higher intake of flavonoids predicts
increased odds of healthy aging (344). A systematic review
and meta-analysis showed that flavonoid supplementation
(range of 0.2 to 1.2 g/day in 14 selected studies) decreased
URTI incidence by 33% compared with control (372). Many
flavonoids exert anti-viral effects, modulate NK cell activities
and regulatory T (Treg) cell properties, and influence
macrophage inflammatory responses (209). High dietary
intake of flavonoids has been linked in the Framingham Heart
Study Offspring Cohort with decreased systemic inflamma-
tion using a cluster of biomarkers (72).  
Countermeasure Effects of Polyphenols to Exercise-Indu-
ced Physiological Stress
Taken together, cell culture and epidemiological data support
the recent focus of investigators on the use of polyphenols as
potential countermeasures to exercise-induced inflammation,
oxidative stress, immune changes, illness, and delayed onset
of muscle soreness (DOMS) (for reviews, see
(268,277,278,379)). Multiple dosing strategies have been
employed including single and combined purified polyphe-
nols (e.g., quercetin, resveratrol), plant extracts (e.g., green
tea, black currant, pomegranates), and increased fruit and veg-
etable food or juice intake (e.g., blueberries, bananas, tart
cherry juice). Most studies incorporate a one to three week
polyphenol loading period prior to an exercise stress interven-
tion. Few papers are available for any particular polyphenol or
plant extract, and research designs vary in regards to the sup-
plementation regimen, form of exercise stress, and outcome
measures (268,277,278,281,282,379). The data in general
support that polyphenol-rich plant extracts and unique
polyphenol-nutrient mixtures (e.g., quercetin with green tea
extract, vitamin C, and fish oil, or freeze-dried blueberry pow-
der with green tea extract) have small but significant effects in
increasing anti-oxidant capacity, with inconsistent, short-term
effects on mitigating exercise-induced oxidative stress,
inflammation, and immune dysfunction. High blueberry and
green tea flavonoid versus placebo intake for 17 days was
linked to reduced ex vivo viral replication in blood samples
collected from athletes after a 3-day overreaching, running
protocol (1). Large-dose intake of
single flavonoids (e.g., 500 to
1,000 mg quercetin) has been
linked to reduced URTI in athletes,
but has not proved to be a useful
alternative to ibuprofen in regards
to countering post-exercise pain,
inflammation, and soreness for the
athlete (277).
Future Directions
Future studies should focus on the
long-term relationship between
increased intake of polyphenols,
gut-derived phenolics, and sys-
temic and post-exercise inflamma-
tion, oxidative stress, anti-viral
defence, and immune function in
athletes using global and targeted
metabolomics (281,282). Intense
and prolonged exertion has been
related to an enhanced transloca-
tion of gut-derived phenolics into
the circulation during a 17-day
period of polyphenol supplementa-
tion (282) (Figure 1). Elevated
blood and tissue gut-derived phe-
nolics from chronic, high polyphe-
nol intake over several months may
result in subtle but important
bioactive effects that translate to
improved recovery and ability to
train intensively, with reduced rates
of illness (1,241,281,282). This is a
complex relationship that demands
a multi-omics, long-term approach.
Research is needed to define opti-
mal dosing regimens and whether
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Table 4. Polyphenol classes and subclasses, and food sources.
Immunonutrition and Exercise •   23
EIR 23 2017
increased intake of foods high in polyphenols such as berries,
tea, and coffee results in meaningful bioactive effects without
the need for high doses of unique flavonoid mixtures. In the
very least, long-term, high polyphenol intake from plants food
sources is important for the health of all humans, including
and more importantly, in relation to the present series, for ath-
letes.
PROBIOTICS – PREBIOTICS
Background
Probiotic-rich foods and supplements contain non-pathogenic
bacteria that colonise the gut purportedly yielding a variety of
health benefits that include reduced incidence of respiratory
and gastrointestinal illness. There are several possible ways
in which probiotics may reduce the risk of respiratory and
gastrointestinal illness symptoms. By their growth and
metabolism, probiotics help inhibit the growth of other bacte-
ria, antigens, toxins and carcinogens in the gut, and reduce
potentially harmful effects. Probiotics can also influence
immune function via interaction with immune cells associat-
ed with the gut. Prebiotics are non-digestible food ingredients
that promote the growth of beneficial microorganisms in the
intestines. Probiotics are found in several foods, particularly
dairy products such as milk, yoghurt and cheese (134),
although concentrations are relatively low. Consequently,
there is widespread interest in use of dietary supplements
containing probiotics in both the general and sporting com-
munities.
Figure 1 
 
Figure 1 - Cyanidin-3-glucoside (C3G) is a widely consumed dietary anthocyanin, and can be used as a sample polyphenol to show how the
body metabolizes flavonoids. After ingestion, the majority of C3G goes to the colon where bacteria degrade it to multiple, simple phenolics
including hydroxybenzoic acid. Next, hydroxybenzoic acid and other phenolics are absorbed through the colon to the liver via the superior
mesenteric and hepatic portal veins. Prolonged and intensive exercise accelerates the translocation of simple phenolics from the colon to the
liver. In the liver, phase II metabolism adds glycine to convert hydroxybenzoic acid to hippuric acid that is released into the circulation. Hippuric
acid has been linked to multiple bioactive effects, and is ultimately eliminated from the body through the urine. Many other polyphenols go
through a similar biotransformation pathway. 
SOURCES: Based on data from references (128) and (281). The contribution of Xiaowei Chen in designing this figure is acknowledged.
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Consensus
In clinical practice, probiotics have been used since the early
1900s to manage common gastrointestinal conditions includ-
ing stomach cramps, irregular bowel movements, excessive
flatulence, diarrhoea, and irritable bowel syndrome. In
research settings, the focus has been on verifying the clinical
benefits of probiotic ingestion and supplementation, and
underlying mechanisms of action. Many studies have been
conducted on the effects of probiotic use on gastrointestinal
problems and URTI in the general population. A recent sys-
tematic review (210) of twenty placebo-controlled trials con-
cluded that probiotic use resulted in lower numbers of illness
days, shorter illness episodes and fewer days absence from
day care/school/work. The most recent Cochrane systematic
review of probiotic benefits for URTI using data from ran-
domised controlled trials involving 3,720 non-athletes from
12 studies concluded that probiotics were better than placebo
in reducing URTI incidence by ~47%, and the average dura-
tion of an acute URTI episode by ~2 days (162).
The most important mechanisms of probiotic action are
thought to be via immunomodulation of local immunity (by
interaction with gut-associated lymphoid tissue and mainte-
nance of gut barrier function) and systemic immunity (by
enhancing some aspects of both innate and acquired immune
responses) (31,227). Probiotic intake can increase NK cell
cytolytic activity (330), enhance phagocytic activity and
microbicidal capacity of granulocytes and monocytes, modify
the production of cytokines and elevate levels of specific IgG,
IgA and IgM (162), with effects that can extend beyond the
gut to distal mucosal sites. Animal studies indicate that regu-
lar probiotic ingestion can influence responses in the respira-
tory tract and improve protection against bacterial and viral
pathogens via modulation of lung macrophage and T-cell
numbers and functions (131,227,245).
Controversies
To date there are few published studies of the effectiveness of
probiotic use in athletes and team sports; a recent comprehen-
sive review (323) identified 15 relevant experimental studies
that investigated immunomodulatory and/or clinical out-
comes. Of the eight studies that recorded self-reported URTI
incidence, five found reduced URTI frequency or fewer days
of illness (94,142,167,415,416), and three reported trivial or
no effects (141,206,386). A randomised, placebo-controlled
trial involving physically active individuals (415) reported
that fewer URTI episodes (relative risk ratio 0.73) were expe-
rienced in those who ingested daily a Bifidobacterium probi-
otic compared with placebo over a 150-day intervention peri-
od. However, a large study of 983 Finnish military recruits
failed to show significant clinical benefits for supplementa-
tion with a combination of Lactobacillus rhamnosus GG
(LGG) and Bifidobacterium animalis ssp. lactis BB12 for 150
days (203). Studies that examined immunomodulatory effects
of probiotics in athletes have reported increased interferon-γ
production in whole blood culture (83) and T-cells (94) and
better maintenance of secretory IgA during intensive training
(142,242). A recent study reported that URTI incidence was
unchanged despite reductions in cytomegalovirus (CMV) and
Epstein-Barr Virus (EBV) antibody titres after 20 weeks of
supplementation with Lactobacillus casei (144). 
Most studies have examined probiotic effects in small num-
bers (<50) of recreationally active individuals over periods
lasting <6 months. URTI has typically been established by
self-report questionnaires and not all studies have used a ran-
domised, placebo controlled design. However, there is now
sufficient understanding of the mechanism of action of certain
probiotic strains, and enough evidence from trials with ath-
letes and highly physically active people (in addition to 12
studies cited in The Cochrane review (162) on children and
adults) to signify that there are mostly positive effects. Similar
to other supplements for which health claims are made there is
concern of bias in the literature, with a stronger likelihood of
publication of studies with positive, as opposed to trivial,
equivocal or negative outcomes.
Other potential benefits of probiotics could be reduced risk of
gastrointestinal discomfort symptoms and diarrhoea (e.g. so-
called runner’s trots) during prolonged exercise, reduced
endotoxaemia during exercise in the heat, and reduced inci-
dence of gastrointestinal infections – a particular concern
when travelling abroad. Further large-scale studies are needed
to determine if these potential benefits are real, and to confirm
that taking probiotics can reduce the number of training days
lost to infection and which strains of probiotics are most
effective for athletes. The studies that have shown reduced
URTI incidence in athletes have been mostly limited to Lact-
obacillus and Bifidobacterium species and used daily doses of
~1010 live bacteria. These doses (~1010 live bacteria) showing
efficacy with athletes are comparable to those used in non-
athlete studies (range ~108-1010) although recommended
dosages can be strain-specific. Although probiotic supple-
ments contain similar bacterial species to dairy foods, there is
little consensus on the relative effectiveness of commonly
used species. As for prebiotics, or combinations of prebiotics
and probiotics, there are currently no published studies on
their efficacy in athletes for reducing respiratory or gastroin-
testinal illness symptoms.
Future Directions
Long-term tolerance of probiotic supplementation in highly-
trained athletes over several months to years or the benefits, if
any, of cycling on and off probiotics, are important questions
warranting investigation. The laboratory-based efficacy and
field effectiveness of multi-component formulations combin-
ing several different probiotics species, or probotics and pre-
biotics, need evidence-based studies. Pharmaceutical compa-
nies are already making a wide range of multi-component for-
mulations. No studies have systematically investigated how
the dosage regimens of probiotic supplementation might vary
as a function of sex, age, medical history, dietary practices,
fitness level and/or training background. Health care practi-
tioners are seeking this information to assist them in prescrib-
ing individualised probiotic/prebiotic supplementation pro-
grammes.
BOVINE COLOSTRUM
Background 
Bovine colostrum is the fluid produced by the mammary
glands for 24-72 hours following calving. While antibody
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transfer in a human takes place predominantly via the placen-
ta, calves rely on colostrum for the passive transfer of
immunoglobulins (Ig). As such, the concentration of Ig and
other immune factors, in combination with growth factors and
nutrients, is much greater in bovine than human colostrum.
For the calf, bovine colostrum is essential for immune system
establishment and gastrointestinal growth and differentiation.
This has led researchers to explore the potential of bovine
colostrum to modulate immune function in humans, particu-
larly in exercise where immune perturbations are common. 
Bovine colostrum is an incredibly complex fluid and under-
standing of its potential molecular function is improving with
advances in technology, such as proteomic analysis (8).
Bioactive components of bovine colostrum include IgG,
lactoferrin, lactoperoxidase, defensins, trypsin inhibitor,
micro RNAs, insulin-like growth factor-1 (IGF-1) and trans-
forming growth factor-β (190,343). Following ingestion,
many of these components have been shown to survive diges-
tion and exert effects at the level of the gut, or systemically. In
cell culture and animal models (porcine, rat and mice) bovine
colostrum exhibits anti-bacterial, anti-inflammatory and anti-
viral properties (425,427). However, the effectiveness of sta-
ble, standardised preparations of non-hyperimmunised bovine
colostrum to modulate the immune system in healthy, exercis-
ing humans is less clear. 
Consensus 
Exercise is associated with immune perturbations and upper
respiratory symptoms (URS) are commonly reported in elite
athletes (122). Several investigations have reported URS inci-
dence following a period of bovine colostrum supplementa-
tion, with all of them suggesting that bovine colostrum sup-
plementation is associated with a reduction (not always statis-
tically significant) in URS incidence in athletes. A retrospec-
tive analysis of training diaries from investigations with
healthy, active male participants (n=174) reported a signifi-
cantly lower incidence of URS with eight weeks of bovine
colostrum supplementation of 60 g/day (32%) compared to a
whey placebo (48%) [relative risk (RR) of 0.6](49). Similarly,
when compared to a whey or skim milk powder placebo, oth-
ers have reported a trend for a reduction in URS incidence
over 8-12 weeks of lower dose colostrum supplementation (10
to 25 g) in trained cyclists [RR 0.4 (362) and 0.3 (363)], elite
swimmers (weeks 5-10: RR 0.4) (95), active males (RR 0.6)
(198) and marathon runners (mean URS incidence of 0.8 in
colostrum group compared to 1.1 in placebo) (96). The ability
of bovine colostrum to shorten URS duration is less clear,
with some investigations reporting no change (49,198,362)
and some a reduction (95,96,363). While the ability of bovine
colostrum to shorten symptom duration is unclear, bovine
colostrum supplementation (10-60 g) for greater than four
weeks appears to reduce self-reported URS incidence by 30 to
60%. 
While changes in salivary SIgA have been related to URS
(137) the mechanism for a reduction in URS following a peri-
od of bovine colostrum supplementation does not appear to
relate specifically to increases in SIgA concentration
(101,199,363). One investigation reported a significant 79%
increase in SIgA concentration after 12 weeks of bovine
colostrum supplementation (26 g/day) (d=4.8) (96), although
the placebo group also reported a large increase over this
timeframe (d=3.0). While some of the increase in SIgA was
attributed to competing in a marathon, colostrum accounted
for 29% of the variation in SIgA (96). In contrast, studies of
similar duration and/or those providing higher doses of bovine
colostrum (~60 g/day) have not reported changes in SIgA
(198,256,362,363). Other proposed mechanisms for the
reduction in URS incidence may be related to minimising the
increase in winter salivary bacterial load (198) or a reduction
in the suppression of receptor-mediated stimulation of neu-
trophil oxidative burst (199). There is also evidence that
bovine colostrum may reduce the post-exercise decrease in
neutrophil function and salivary lysozyme (101), and reduce
immunodepression during a period of intensified training
(362) although these mechanisms are yet to be confirmed. It is
unlikely that bovine colostrum supplementation alters circu-
lating cytokine concentrations following short-term intense
exercise (68,362) in athletes who have not undertaken a peri-
od of intensified training overload.
Controversies 
The gastrointestinal tract is the largest immune organ in the
human body and in combination with its intestinal microbiota
it not only provides a physical barrier against commensal and
pathogenic bacteria, but plays a central role in innate and
adaptive immunity (364). In the calf, bovine colostrum is
essential for intestinal development, providing a rationale to
investigate the potential of bovine colostrum to influence gut
health in humans.   
Early work in healthy adults demonstrated that bovine
colostrum reduced gastrointestinal permeability when co-
ingested with non-steroidal anti-inflammatory drugs (314)
and reduced systemic endotoxin concentrations in abdominal
surgery patients (44), suggestive of maintenance of the intes-
tinal barrier preventing endotoxin translocation across the gut.
Only two human studies have investigated if bovine
colostrum reduces the increase in intestinal permeability asso-
ciated with exercise (240,264) and their findings are conflict-
ing, possibly attributable to study differences in markers of
intestinal permeability, exercise protocols, colostrum dose and
period of supplementation. While animal studies suggest a
beneficial effect (321), more controlled human studies are
required to determine the impact of bovine colostrum on exer-
cise associated gut permeability and endotoxin translocation. 
In combination with influencing gastrointestinal growth, IGF-
1 plays a role in immune and neuroendocrine regulation.
While only one study has reported autonomic alterations fol-
lowing a period of colostrum supplementation (363), contro-
versy exists as to the possibility of absorption of IGF-1 from
bovine colostrum. Only one laboratory has reported increases
in IGF-1 following bovine colostrum supplementation periods
of eight days and of two weeks (255,256) with others report-
ing no change (53,90,228), and athletes ingesting 60 g/day not
returning any positive doping test (for substances banned in
2002) (217). Mero determined that orally administered IGF-1
alone did not appear in the circulation and concluded that
IGF-1 is not absorbed from bovine colostrum (255) although
this is not necessarily correct as bovine colostrum contains
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numerous components that would keep IGF-1 intact during
gastrointestinal transit (315). The IGF-1 content in a 20 g dose
of bovine colostrum (343) is approximately equivalent to that
contained in three glasses of milk. Although not on the World
Anti-Doping Agency’s list of banned substances, this govern-
ing body does not recommend the ingestion of colostrum. 
Future Directions
While bovine colostrum appears to reduce the incidence of
URS, the specific mechanism/s for this require further investi-
gation and should include measures of salivary antimicrobial
proteins, in addition to SIgA. Well-designed investigations are
also necessary to elucidate the potential of bovine colostrum
to modulate intestinal permeability and inflammation in exer-
cising humans.
As more is discovered about the minor constituents of bovine
colostrum (8), there is the potential to discover novel bioac-
tive proteins, and enhance understanding of the efficacy of
already known components. Lactoferrin, isolated from bovine
colsotrum, shows particular promise as an immune modulat-
ing glycoprotein. The majority of orally administered bovine
lactoferrin survives gastric transit (392), exerting its effects
through the interaction with gut enterocytes and resident
immune cells. In neonatal animal models lactoferrin stimu-
lates crypt cell proliferation (333), increases serum IgG and
modulates cytokine secretion of stimulated mesenteric lymph
nodes and spleen immune cells (89). Animal and cell culture
models support the anti-viral, anti-bacterial immune modulat-
ing properties of lactoferrin (399) so it is suprising that there
is limited literature investigating the effects of bovine lacto-
ferrin supplementation in healthy humans (266), and no stud-
ies investigating potential effects on exercise-induced
immune modulation. Benefits of lactoferrin for Fe deficiency
anaemia associated with pregnancy (301), and a reported
increase in T cell activation in healthy males (unblinded
study) (266) support the exploration of bovine lactoferrin sup-
plementation to modulate exercise-induced immune perturba-
tions and/or enhance immune surveillance. 
VITAMIN D
Introduction 
From a sport and exercise science perspective, interest and
research into vitamin D over the last decade has witnessed a
remarkable resurgence (420). The reason for this is partly
attributable to the re-emergence of the entirely preventable
bone disorder rickets (298) but perhaps mainly due to the
emerging evidence to suggest a fundamental role of vitamin D
in many areas pertinent to the athlete. These include: skeletal
muscle function (84), body composition (172), inflammation
(421), muscle regeneration (299), and cardiac structure as
well as aspects of innate and acquired immunity (168).
Vitamin D is unique in that, unlike other vitamins, it is not pri-
marily obtained from dietary sources; rather it is synthesized
via UV irradiation of the skin’s dermis. Once in the circula-
tion, either from diet, supplements or UV irradiation, vitamin
D is transported to the liver bound to vitamin D binding pro-
tein where it is hydroxylated eventually leading to its activa-
tion. The hydroxylated compound 25-(OH) D is the major cir-
culating vitamin D metabolite and is therefore the assay of
choice when it comes to detecting vitamin D deficiencies. A
further hydroxylation step in the kidney (or some tissues
directly) is required to produce the active metabolite 1,25-
(OH)2 D and it is this active metabolite that is responsible for
the multiple biological effects via both genomic and non-
genomic mechanisms.
Defining terminology and why deficiencies occur 
Although the multiplicity of fundamental biological roles of
vitamin D is now appreciated, it is well documented that
many individuals, including elite athletes, exhibit vitamin D
deficiencies (Figure 2). These deficiencies are clear in athletes
who live in temperate (84) as well as sunny climates and train
predominantly in both indoor (424) and outdoor environments
(84). This worldwide phenomenon of vitamin D deficiencies
is partially attributable to poor dietary intakes, although the
major reason is more likely a direct consequence of modern
sun-shy lifestyles, including the use of appropriately applied
high-factor sunscreen creams (125), which significantly
restrict vitamin D synthesis. 
A major area of confusion in the vitamin D literature arises
from a lack of consensus as to what constitutes a genuine vita-
min D deficiency and, more recently, the concept of a poten-
tially “optimal” vitamin D concentration for health and athlet-
ic performance. It is beyond the scope of this article to explore
this debate and therefore an “adequate” concentration will be
classed here as >50 nmol/l as defined by the US Institute of
Medicine. Moreover, it has also been suggested that what may
be optimal for one tissue, such as bone or skeletal muscle,
may not be optimal for another, such as immune function. In
fact, from an exercise immunology perspective recent
research is beginning to indicate that aspects of the immune
system may require higher concentrations of vitamin D than
has previously been defined as “adequate” for bone health
(168). 
Vitamin D and the immune system 
Emerging research suggests that vitamin D plays a key role in
both innate and acquired immunity, most likely exerting its
function through gene expression modulation (168,183). In
this role 1,25-(OH)2 D functions as part of a heterodimer with
its vitamin D receptor (VDR) and the retinoid X receptor
modulating the expression of genes with specific vitamin D
response elements located in the regulatory region (168). In
fact it is estimated that close to 5% of the human genome is
modulated by vitamin D (430), which is required in sufficient
quantities to work effectively in gene expression modulation. 
Many cells of the immune system including monocytes,
macrophage, neutrophils and T and B lymphocytes contain
the VDR and also express the enzyme, 1-α hydroxylase,
which is responsible for hydroxylation of 25-(OH) D to its
active 1,25-(OH)2 D form. Activation in immune cells appears
to be regulated by circulating concentrations of 25-(OH) D
and induced by activation of the toll-like receptor cascade in
the presence of pathogenic microbiota (30). In the immune
system specifically, vitamin D up-regulates gene expression
of broad-spectrum anti-microbial peptides (AMP), important
regulators in innate immunity (231,408), and exerts an
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immunomodulatory effect on T and B lymphocytes in
acquired immunity (168,431). AMP, including cathelicidin,
are important proteins in the innate immune system (148) and
help defend against acute illness including tuberculosis,
influenza and the common cold (64,65,395). It is further sug-
gested that vitamin D maintains a balance between the inflam-
matory Th1/Th17 cells and the immunosuppressive Th2/Treg
cells to dampen inflammation and tissue damage (178) and to
modulate the acquired immune response. Additional studies
suggest that vitamin D enhances natural killer cell cytolytic
activity (4), and acts to trigger the oxidative burst in activated
macrophages (368). A single dose of vitamin D3 (100,000 IU)
has been shown to enhance the innate immune response and
restrict growth of mycobacteria in vitro (248). 
Variations in vitamin D concentrations have the potential to
influence immune response. A handful of studies in athletes
(93,168), military personnel (218) and the general population
(28,136,342) have reported negative associations between
vitamin D concentration and incidences of URTI. In one study
in college athletes, vitamin D concentrations over the winter
and spring were negatively associated with documented fre-
quency of acute URTI (157). The breakpoint for contracting
single illness appeared to occur at ~95 nmol/l such that all ath-
letes with circulating concentrations lower than this break-
point had one or more episodes of illness whereas those with
higher concentrations had one or fewer episodes. As has been
shown in Figure 2, many athletes present with vitamin D con-
centrations significantly below this proposed breakpoint. A
similar study in endurance athletes reported that a greater pro-
portion of athletes maintaining circulating 25-(OH) D concen-
tration <30 nmol/l presented with URS with the fewest symp-
toms reported in those with 25-(OH) D concentrations >120
nmol/l (171). Athletes with low vitamin D concentrations also
had more URS days and higher symptom-severity scores.
Randomly-assigned, placebo-controlled studies are needed in
athletic populations to confirm the effectiveness of correcting
low vitamin D concentrations on aspects of immune health
and the prevention of URTI. A recent study in university ath-
letes found evidence that 14-week supplementation with 5000
IU per day of vitamin D3 during winter training significance
increased salivary secretion rates of cathelicidin and SIgA
(171). 
Consensus 
It is now established that many athletes present with deficient
D concentrations, especially during the winter months, which
result in numerous deleterious consequences. The concept of
an “optimal” vitamin D concentration, however, is proving
difficult to establish with emerging evidence suggesting that
“optimal” vitamin D concentrations may in fact be tissue spe-
cific. Recent evidence is suggesting that athletes presenting
with “sufficient” vitamin D concentrations (>50 nmol/l) may
still be at an increased risk of contracting a URTI compared
with athletes presenting with >75 nmol/l (171). 
It must be stressed that there is a growing trend for mega dose
supplementation in athletes. This is of concern due to some
evidence which suggests an increase in all-cause mortality in
individuals with high (>140 nmol/l) vitamin D concentrations
(118), although cause and effect data to prove this are still
lacking. 
At present, perhaps the best advice for athletes is to monitor
their vitamin D concentration and, in terms of immune health,
aim for a target concentration >75 nmol/l. During the summer
months athletes should aim to obtain sensible sun exposure,
whilst ensuring that they do not suffer from sunburn, and con-
sider a supplement of up to 4000 IU vitamin D3 per day during
the winter months if concentrations drop below 75 nmol/l. 
Figure 2 – Vitamin D concentrations of a variety of athletes tested (at rest) internationally. Pink area represents deficiency (<30 nmol/l), yellow
area insufficiency (<50 nmol/l) and green area adequate (>50 nmol/l) as defined by the US National Institutes of Health Office of Dietary Supple-
ments. (Data redrawn from (84,157,226,421,424)).
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Future directions
Future studies now need to establish if there is in fact an opti-
mum concentration for an athlete’s immune health utilizing a
research design that will allow cause and effect to be estab-
lished rather than reliance on correlative data.
IMMUNONUTRITION AND EXERCISE IN
SPECIFIC POPULATIONS
Competitive athletes and military personnel
Background
A commonly asked question is, ‘do athletes and military per-
sonnel have special nutritional requirements to maintain
immunity; for example, do they need ‘immune-boosting’ sup-
plements?’ A somewhat simplistic answer is ‘no’; so long as
the diet meets the energy demands and provides sufficient
macro- and micro- nutrients to support the immune system
(140,405). The reasoning here is mostly based on the empiri-
cal evidence along with some sound logic: support for
‘immune-boosting’ nutritional supplements largely comes
from studies in those with compromised immunity, such as
the elderly and clinical patients; not, from young, otherwise
healthy, individuals whom, as logic would dictate, might have
little to gain from such supplements (229). To accept this
viewpoint ignores the proviso about matching energy intake
to expenditure and providing sufficient macro- and micro-
nutrients to maintain immunity. Indeed, there are various ath-
lete and military scenarios where energy, macro- and micro-
nutrient intake may be insufficient.
Consensus 
In the real world, athletes and warfighters either intentionally
or non-intentionally experience deficits in energy intake (e.g.
weight-loss diets, restricted rations) and macronutrient intake
(e.g. restricted carbohydrate). There is substantial evidence
showing that only a few days on restricted energy intake com-
promises immunity (221,295,401). There may be other times
when athletes or warfighters experience both a down-turn in
host defence and increased exposure to pathogens, e.g. for-
eign travel for training camps, competitions and military oper-
ations. As such, there are specific scenarios when these indi-
viduals might benefit from nutritional supplements to bolster
immunity (Table 5). Thus the current, more reasoned, answer
to the question, ‘do athletes and military personnel have spe-
cial nutritional requirements to maintain immunity?’ is ‘yes,
sometimes.’
Controversies and future directions 
Paradoxically, nutritional strategies currently adopted by
endurance athletes, including training with low carbohydrate
(Table 5), may benefit training adaptations and performance at
the expense of immunity; for example, carbohydrate restric-
tion may increase the immunosuppressive stress hormone
response to exercise (86,140,165). Consequently, the rather
modest benefits studies show in terms of training adaptations
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Table 5. Effects of nutritional supplements on the common cold and immunity in athlete and military scenarios
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and performance might, in the long term, be lost if the athlete
gets sick more often; viz. ‘the less sick the more the athlete
trains and the better they perform’ (246,380,407). Studies are
required to investigate whether the nutritional practices adopt-
ed by elite athletes impair immunity and increase infection;
and, whether purported ‘immune-boosting’ supplements bene-
fit immune health without blunting the desired training adap-
tations. Recent Cochrane reviews have noted the low quality
of many studies on nutritional supplements to support
immune health; specifically, small samples, poor controls and
unclear procedures for randomisation and blinding were com-
monplace (162). Clearly, there is a pressing need for random-
ized controlled trials in elite athletes and military personnel
with sufficient participant numbers; rigorous controls and pro-
cedures; appropriate supplementation regimens; and, clinical-
ly meaningful in vivo measures of immunity (see section on
biomarkers) 
Overweight and obese exercising humans  
Obesity, a state of malnutrition related to excessive intake of
energy has been related to immune dysfunction (175). High
body fat levels are accompanied by changes in white blood
cells, especially an increase in total leucocyte number, with
altered differential counts in neutrophils, monocytes and lym-
phocytes, finding increased values of lymphocytes and neu-
trophils in boys and girls, respectively. However, low T- and
B-cell mitogen-induced proliferation is shown in obesity
(247). Both cell-mediated and humoral immunity are affected
by obesity, with low antibody production after vaccination
(247,361). Moreover, obesity has been characterized as a state
of chronic low-grade inflammation, with an excessive amount
of adipose tissue as the main determinant of this process
(411).
Physical inactivity seems to be a prominent and modifiable
risk factor to develop excess weight and obesity. According to
epidemiological studies and clinical trials there is evidence
addressing the influence of physical activity and fitness on
low-grade inflammation in adulthood (160,302), athletes
(292,390) and, to a lesser extent, in children and adolescents
(412). Regular exercise seems to have proven anti-inflamma-
tory effects in normal subjects (412) but also in overweight
and obese individuals (175,411).
Regular training leads to a reduced TLR4 expression baseline,
accompanied by a lower percentage of circulating
CD14+CD16+ monocytes, which could result in an anti-
inflammatory effect (243,385). In the case of obese subjects,
macrophages are a potential source of inflammatory processes
where the microbiota is also involved leading to lower insulin
sensitivity in several tissues (liver, adipose tissue, hypothala-
mus, muscle) and a state of chronic low-grade inflammation
(393). Studies performed in mice fed a high fat diet showed
that exercise training reduces visceral adipose tissue followed
by a change of M1 macrophage phenotype to M2
macrophages (205).
Cytokines have been shown to play a particular role in the
regulation of the metabolism due to exercise, leading to
immunomodulation within the adaptation mechanisms
involved (272). However, it is important to highlight that the
cytokine response depends on the acute or chronic exercise as
well as its intensity, duration, the mass of muscle recruited,
endurance capacity and idiosyncracy of the person practising
exercise (411). The contracting skeletal muscle is a major
source of circulating IL-6 in response to acute exercise. Dur-
ing heavy exercise, such as a marathon, there can be up to a
120-fold increase in the IL-6 plasma levels with the duration
of the event explaining more than 50% of the variation. The
aforementioned plasma IL-6 increase supports the hypothesis
that post-exercise cytokine production is related to skeletal
muscle and duration of exercise. Nevertheless, IL-6 shows a
markedly lower response to acute exercise in trained subjects.
The health benefits of long-term regular exercise are ascribed
to the anti-inflammatory response elicited by an acute bout of
exercise, which is partly mediated by muscle-derived IL-6.
This IL-6 increase seems to induce an anti-inflammatory
cytokine cascade (IL-1ra and IL-10), and to inhibit the pro-
duction of pro-inflammatory cytokines, such as TNF-α
(305,308). Therefore, the anti-inflammatory effects of exer-
cise may offer protection against TNF-induced insulin resist-
ance.
IL-6 stimulates lipolysis as well as fat oxidation. The increase
of IL-6 after acute exercise is linked to increased CRP levels
(290). In response to regular physical activity, basal as well as
post-exercise plasma levels of IL-6 decrease  by mechanisms
that might include increased glycogen content, improved anti-
oxidative capacity and improved insulin sensitivity. The lower
levels of IL-6 in circulation will subsequently result in lower
CRP levels. In untrained subjects, basal plasma IL-6 and CRP
levels are elevated via mechanisms that may involve impaired
insulin sensitivity and/or increased oxidative stress (305,308).
The status of glycogen stores is also an important contributor
to IL-6 production with exercise: the lower the glycogen the
higher the IL-6 production. It is of particular importance in
overweight, obese and diabetic patients especially for those
with particular diets.
Adipose tissue is regarded as an active endocrine organ that
releases a large number of bioactive mediators (pro-inflam-
matory cytokines, leptin, adiponectin, peptide YY, among oth-
ers) modulating not only appetite and metabolism, but also the
immune system involving inflammatory processes (339). 
The EVASYON study aimed to develop a comprehensive
intervention including diet and physical activity and to evalu-
ate its efficacy in adolescents with excess weight and obesity.
Some beneficial changes were achieved due to an early reduc-
tion of immunological and metabolic markers including lep-
tin, IL-8 and TNF-α, delivered by adipose tissue and whose
high levels are considered to be linked to an inflammatory
state (339). 
In the AFINOS study performed in Spanish adolescents, car-
diorespiratory fitness and muscular fitness were shown to be
inversely associated with adiponectin and leptin levels. Vigor-
ous physical activity levels have also been inversely associat-
ed with leptin (249). 
Preliminary evidence from the AFINOS study seemed to indi-
cate that achievement of a healthy weight in this population
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group might be the most effective strategy to prevent chronic
low-grade inflammation and future cardiovascular and meta-
bolic diseases. Indeed, an active lifestyle and a desirable car-
diorespiratory fitness may attenuate these problems. 
Therefore, physical exercise has been shown to increase
weight management efficacy, being a potential therapeutic
approach to modulate low-grade inflammation. Particularly,
the encouragement of doing physical activity during adoles-
cence could have important implications for public health, as
a specific strategy to avoid high levels of the well-known
sedentary habits during this crucial life period. Likewise,
other types of physical activity related to muscular fitness
(that is, resistance training) might be taken into consideration
during adolescence because high levels of muscular fitness
have shown negative associations with inflammatory proteins.
Therefore, understanding the interrelationships between phys-
ical activity, fitness and fatness may be the main way to pre-
vent low-grade inflammation, particularly at these ages (250).
The exercising elderly 
It is well documented that aging is associated with a decline in
cell-mediated immune function, a phenomenon often called
immunosenescence, which contributes to the higher morbidity
and mortality from infectious diseases in older population. On
the other hand, mounting evidence suggests that aging is asso-
ciated with an increased inflammatory response
(212,347,398). Chronic, low-grade inflammation has been
implicated in the pathogenesis of many common degenerative
and metabolic diseases associated with aging. Several studies
have shown that acute and prolonged or vigorous bouts of
exercise cause immunodepression as well as the related
increase in incidence of URTI symptoms, and may also
induce increased inflammation and oxidative stress
(273,365,406). Therefore, extreme exercise may exacerbate
the age-associated dysregulation of the aging immune system
(286,366,394). However, regular moderate exercise in general
causes no such adverse effect, and might even enhance the
immune function (274), particularly in older individuals
(365,406). Studies showed that calisthenic exercise increased
NK activity and T cell function in elderly women (286); pri-
mary antibody and delayed-type hypersensitivity (DTH)
responses to the novel antigen keyhole limpet haemocyanin
(KLH) were lower in older than in young subjects, but these
in vivo measures of the immune function were improved by
exercise in older but not young subjects (150,370). A possible
reason behind this observation is that, relative to their young
counterparts, the older individuals have a less optimal
immune response which is restored by moderate exercise
(406).
Proper nutrition, i.e., adequate and well balanced intake of
nutrients, is important for normal function of the immune sys-
tem. Currently no information is available as to whether exer-
cising older persons have unique nutritional needs compared
to their young adult counterparts. However, a significant per-
centage of older adults have low consumption of several
micronutrients including the B vitamins, vitamin E and Zn, all
of which are needed for the normal function of the immune
system (239,300). At the same time, both inflammation and
oxidative stress increases with aging suggesting that the older
exercising adults might require higher level of nutrients and
foods with antioxidant and anti-inflammatory properties. In
addition, when conducting the same type of exercise, the older
persons are known to more easily suffer from muscle damage
and require a longer period to recover from it (127). The exer-
cise-induced muscle damage can initiate an inflammatory
response, which could further exacerbate the chronic low-
grade inflammation observed in older adults, further suggest-
ing that exercising older adults might require higher level of
nutrients and other dietary components with immune enhanc-
ing and/or anti-inflammatory properties than non-exercising
older adults or their young counterparts. However, previous
studies which mainly involve younger adults have indicated
that consuming antioxidant supplements, with the possible
exception of quercetin, does not help in terms of improving
exercise-induced immunodepression, inflammatory response,
and URTI (see the antioxidants and polyphenols sections –
both in this series). In support of this, studies thus far suggest
that antioxidant micronutrient supplementation may not
afford protection against muscle damage but, rather, it may
interfere with cellular signalling functions of ROS and inter-
rupt training-induced adaptations (50,192). Further studies are
needed to determine whether exercising older adults would
respond in a different manner from young adults, given the
observation that older adults may have higher requirements
for nutrients and food components that possess antioxidant
and anti-inflammatory properties.
Another nutritional consideration for older adults is the
amount of total energy. Since the intensity and duration of
exercise are usually less in older persons compared to young
adults, the total calorie intake should be adjusted accordingly
to avoid conversion of excess calories to body fat. Additional-
ly, the general recommendation to increase calorie intake
from carbohydrates should be exercised with caution for older
persons, due to the fact that glucose tolerance and insulin sen-
sitivity are decreased with aging. 
In summary, information on nutritional needs of exercising
older adults whether micro or macro-nutrients is scarce. The
age-associated dysregulation of the immune response (sup-
pression of cell-mediated immunity and increased inflamma-
tion), together with other age associated changes, and low
consumption of nutrient rich foods strongly supports the
necessity of further research in this area so that specific rec-
ommendations can be made.
BIOMARKERS IN IMMUNONUTRITION 
Introduction
In this section the strengths and weaknesses of various bio-
markers used in studies by nutritional immunologists are eval-
uated (Table 6). An important consideration is that exercise
immunologists often perform investigative work in the field,
away from the rigorously controlled laboratory environment.
Consequently, the studies are often limited by a lack of exper-
imental control and the choice of measurement tool(s) is often
dictated by convenience, practicality and cost. With this in
mind, areas of uncertainty, gaps in knowledge and opportuni-
ties for continued research development on immune biomark-
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ers are highlighted, particularly research targeted towards the
development of technologies applicable in the field. These
opportunities include rapid, non-invasive measurements of
immunity by portable devices at single time points and even
continuous monitoring by wearable technology (e.g. smart
contact lenses) may be possible in the not too distant future. 
Classification of upper respiratory tract illness
Arguably the most illuminating studies on factors influencing
common cold incidence (e.g. psychological stress, sleep) have
quarantined individuals before and for up to 7 days after intra-
nasal inoculation with live common cold viruses (rhinovirus,
respiratory syncytial virus or coronavirus) and assessed the
development of clinical colds (Table 6) (87,88). Although this
represents a strong experimental model to identify the effects
of nutritional interventions on common cold incidence, there
are obvious limitations that have prohibited its adoption by
exercise immunologists. These include ethical considerations,
as well as cost, requirement for medical facilities and support,
together with the fact that athletes are unlikely to participate
in a study where ~40% of individuals develop a common cold
(191). Another limitation is that studies using the common
cold challenge model have not identified whether the
increased development of common cold in those under psy-
chological stress (88) or sleep stress (87) is due to a systemic
immunodepression or local effects at the nasal mucosa. For
these reasons exercise immunologists have relied heavily on
subjective self-report of common cold symptoms using either
unstandardised health logs, standardised symptom question-
naires (e.g. Jackson) or physician assessment of common cold
symptoms (Table 6). In 1958 Jackson et al. reported clinical
features of the common cold after infecting >1,000 individu-
als by nasal instillation of nasal common cold secretions col-
lected from donors (191). In the ~40% of individuals who
developed symptoms of a common cold in the 6-day monitor-
ing period, 8 clinical symptoms were incorporated into the
questionnaire. Symptoms included headache, sneezing, chilli-
ness and sore throat that appeared in the first 48 h and nasal
discharge, nasal obstruction, cough and malaise that appeared
later. The 8 clinical symptoms were scored on a 4-point scale
from 0 (no symptom) to 3 (severe symptom): Jackson’s crite-
ria for a common cold included a total symptom score of ≥14
and a “yes” answer to the dichotomous question, ‘do you
think that you are suffering from a common cold?’ during the
6-day monitoring period (191). 
The Wisconsin upper respiratory symptom survey (WURSS;
(20)) has also been used widely by exercise immunologists
(149,283,374), including nutritional intervention studies
(149), as it considers the impact of common cold symptoms
on quality of life measures (Table 6). Studies have raised
questions about the validity of the physician-verified common
cold, highlighting that neither self-reported nor physician-ver-
ified common colds should ubiquitously be referred to as
infectious (93,374). Notwithstanding these limitations, studies
highlight the negative impact of self-reported common cold
symptoms on training volume (246) and medal-winning
prospects in elite athletes (322,380). 
Three key recommendations include: 1) standardising the
recording of common cold symptoms in athletes (e.g. incorpo-
rating the Jackson common cold scale or the WURSS into a
training log); 2) recording the impact of common cold symp-
toms on training and performance (e.g. discontinued or
reduced training); and 3) where possible, incorporating identi-
fication of infections from pathological analysis of swabs
(Table 6 see next page). Common cold challenge studies show
that only ~40% of those inoculated develop symptoms associ-
ated with the common cold yet >80% are typically infected
(positive virology/specific antibody response) (87,88,191).
Thus, an important research question for exercise immunolo-
gists is, ‘why do less than half of those infected develop
symptoms of the common cold? Adopting these recommenda-
tions will allow the exercise immunologist to understand more
fully the influence of exercise training and nutritional inter-
ventions on the development of common cold symptoms and
their impact on training and performance in those with and
without confirmed infectious aetiology.
In vivo immunity 
Where feasible, exercise immunologists are encouraged to use
in vivo methods for assessing immune responses (3,405,406).
By initiating an integrated and highly coordinated immune
response in the normal tissue environment, in vivo immune
methods provide more clinically relevant information that
extends beyond in vitro assays (Table 6) (87). A weakness of
many in vitro assays is the requirement to separate immune
cells from their normal environment and incubate in artificial
culture. Examples of in vivo immune methods include assess-
ing: the circulating antibody response to influenza vaccination
and hepatitis B vaccination (55); the local skin response to
intradermal antigens using delayed type hypersensitivity
(DTH) (52) and to topically applied antigens using contact
hypersensitivity (CHS) (164). Studies demonstrate that both
acute and chronic exercise can increase influenza vaccination
success (circulating antibody titre) in those with sub-optimal
immunity (e.g. elderly) or where antigen immunogenicity is
low; but little is known about the influence of high-level train-
ing and nutritional interventions on the success of influenza
vaccination in young, healthy athletes. A distinct advantage of
the vaccine model (e.g. influenza) is that athletes may be keen
to participate in a study where the clinical protection afforded
by the vaccine is directly beneficial to them (147,406). Recog-
nised limitations with the vaccine model include that the ex
vivo T cell response to influenza vaccination has been more
strongly related to vaccine protection than the circulating anti-
body titre that is typically measured (304). Also, the incorpo-
ration of repeat antigens in the influenza vaccine elicits a mix-
ture of primary and secondary antibody responses; thus pro-
viding limited mechanistic insight (55,406). Using a novel
antigen in the DTH method (e.g. keyhole limpet haemo-
cyanin) (369); or CHS method (e.g. diphenylcyclopropenone
(DPCP))(109,164) presents the opportunity to assess the
influence of exercise as a stressor, and nutritional interven-
tions on both the primary and secondary immune response.
The DTH and CHS methods (Table 6) also overcome some
other limitations with the vaccine method including: variable
immunogenicity (e.g. hepatitis B (177)); annual changes in
vaccine composition (e.g. influenza (55)); and, difficulty
when comparing the circulating antibody results from differ-
ent studies using in-house enzyme-linked immunosorbent
assays (ELISA) or other technologies (55). Nevertheless,
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Table 6. Classification and ratings of biomarkers used in immunonutrition and exercise experiments
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determining the clinical significance of DTH and CHS
responses, with specific regard to infection, is an important
avenue for future research. It is possible that the strength of
the cutaneous recall response e.g. to DPCP (109) could be
generalised beyond skin immunity to indicate the immune
system’s general ability to respond to an infectious challenge.
Available evidence from clinical studies supports this notion
as cutaneous immune measures are impaired in individuals
with acute infectious illness (26); they also track immune sta-
tus and predict mortality in critically ill human immunodefi-
ciency virus (HIV)-infected patients (113). 
Mucosal immunity
Assessing immune markers in saliva and tears is of interest to
exercise immunologists, particularly those working in the
field environment. This is because collection of these fluids is
non-invasive, convenient, practical and low cost (Table 6) but
also because as many as 95% of all infections are thought to
be initiated at the mucosal surfaces (46). This highlights the
important role mucosal immunity plays in defence against
opportunistic infections such as the common cold (46). SIgA
production is the major effector function of the mucosal
immune system providing a ‘first line of defence’. SIgA is
known to exhibit broad-spectrum antimicrobial activity
against a range of viral and bacterial pathogens, through inhi-
bition of pathogen adherence and penetration of the mucosal
epithelia and by neutralising viruses within the epithelial cells
during transcytosis (48).
Exercise and nutritional interventions might conceivably alter
mucosal immunity at the level of local B cell antibody synthe-
sis (e.g. via altered autonomic nervous system (ANS) activity
or altered nutrient availability) (291) and/or by altering the
transport of IgA (e.g. via altered ANS activity or availability
of polymeric Ig receptor (69,320)). On this premise, there has
been widespread attention and optimism that salivary SIgA
may serve as a non-invasive biomarker of mucosal immunity
and common cold risk. Research demonstrates that salivary
SIgA has some utility for a monitoring application, whereby
an individual’s normal, healthy reference range is determined
under standardised conditions and atypically low values can
indicate an increased likelihood of common cold (145,271).
The availability of a point-of-care tool for measuring salivary
SIgA has made its monitoring in athletes possible (85), high-
lighting an avenue for continued research efforts. Perhaps not
surprisingly, given the large individual variability, research
has not convincingly demonstrated the utility of salivary SIgA
as a predictive biomarker for the common cold by identifying
atypically low values for an on-the-spot application (against
the population reference range). Studies have shown a
decrease in salivary SIgA lasting for an hour or more after
prolonged exercise (146); this is in line with the ‘open win-
dow hypothesis’ (389,402). However, studies have also shown
no change (32) or even an increase in salivary SIgA after pro-
longed exercise (40). Low levels of saliva SIgA during fluid
and energy deficits (295) and in those deficient for vitamin D
(171) were countered by additional energy intake in one study
in military personnel (110) and by vitamin D supplementation
in another study in athletes (170). Nevertheless, there are
examples of conflicting evidence for mucosal immune
responses to nutritional supplementation. Twelve weeks of
bovine colostrum supplementation increased salivary SIgA
~80% in athletes in one study (96) but had no effect in another
(198). The levels of salivary SIgA and other saliva antimicro-
bial proteins (AMP) (e.g. lysozyme) reported in the literature
are highly variable: key considerations include that multiple
glands contribute to saliva composition, and likely to its vari-
able composition. There are also various potential con-
founders (e.g. diurnal variation (111); psychological stress
(193); nutritional status (295) and gender (169)). Those wish-
ing to measure salivary SIgA (and other AMP) in their studies
should: standardise the saliva collection method (e.g. 5 min
passive drool); standardise the reporting of salivary SIgA
(report both SIgA concentration and secretion rate) (40,404);
and control potential confounders. With the search for viable
alternatives in mind, a recent study demonstrated that tear
SIgA (tear is secreted only by the lacrimal gland) has potential
as a non-invasive biomarker of mucosal immunity and com-
mon cold risk (161). Decreased levels of tear sIgA but no
change in salivary SIgA were observed during pathology-con-
firmed common cold and the week before individuals reported
common cold symptoms. The risk of common cold symptoms
the following week increased nine-fold in those with low tear
SIgA. Further advances in nanotechnology and microfluidics
might, in the near future, afford the possibility for on-the-spot
tear fluid measurement devices and even continuous bio-mon-
itoring by contact lenses.
Ex vivo/in vitro immunity
To assess if a nutritional intervention is effective in modulat-
ing immune response, it is necessary to use appropriate mark-
ers as measurable outcomes. A variety of markers has been
identified as suitable for assessing different aspects of
immune system status and functionality, and different tech-
niques are developed to measure these markers with varied
sensitivity, accuracy, feasibility, and relevance for the intend-
ed purpose. Investigators can select appropriate markers
based on the specific objectives of their studies. These mark-
ers, along with the studies for which they are adopted, are usu-
ally classified as in vivo, ex vivo, and in vitro markers/studies.
In the in vivo setting, both nutritional intervention and the
assessment of the immune response are conducted using a liv-
ing subject (human or animal). This approach best reflects the
physiological response to the intervention. In the ex vivo set-
ting, the intervention is administered to a living subject but
the immune function analysis is conducted outside of the body
using accessible biological materials. For example, assessing
the ability of the immune cells isolated from the blood of
study participants to respond to a stimulus which mimics
pathogenic or non-pathogenic agents to which the immune
cells might be exposed. The incubation is performed in the
presence of a synthetic media enriched in serum that can be
from an animal, typically foetal calf serum, or from a human
subject. This approach, particularly when performed in the
presence of a subject’s serum, can provide very useful infor-
mation about how the immune cells might respond when chal-
lenged in vivo. The in vitro setting for both the intervention
and assessment are conducted outside of the body using either
cells from the participant or cell lines. Thus the key difference
between the ex vivo and in vitro studies is whether the inter-
vention is administered to humans/animals or added to the cell
culture. In vitro experiments alone have limited value, but
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they are usually used as a screening tool to search for candi-
dates of interest for animal or human studies, or for further
investigation of the cellular and molecular mechanisms of an
intervention that has shown functional efficacy in vivo. A brief
description is provided below to introduce the most common-
ly used ex vivo and in vitro indices for assessing immune
function in exercise and nutrition research (Table 6). 
In these assays, immune cells are separated from the body (or
from stock as cell lines) and maintained in culture medium.
Various stimuli, e.g. mitogens, are used to activate cells to
make them proliferate, synthesize and release soluble factors,
directly attack target cells, or engulf the added foreign parti-
cles (microorganisms or inert substances). 
Phagocytosis
Phagocytosis is a process by which specialized phagocytic
cells (neutrophils and monocytes/macrophages) engulf and
internalize solid matter. Phagocytosis is a key mechanism of
the innate immune system to contain and kill invading
pathogens, or to process them for antigen presentation to T
cells, and activating the adaptive immunity. The substrates
used for phagocytosis assay include bacteria, yeast, red blood
cells, and inert particles. One popular method is to incubate
one of these substrates labelled with fluorescence with phago-
cytic cells and then determine the cellular uptake of these sub-
strates using a flow cytometer. This assay can be coupled to
evaluation of oxidative burst and bacterial killing, as
described below. 
Oxidative (respiratory) burst
This reaction is triggered by phagocytosis or exposure to cer-
tain inflammatory mediators causing a dramatic increase in
oxidative metabolism which will result in the rapid generation
and release of reactive oxygen species by neutrophils and
monocytes. These released toxic compounds are used to kill
bacteria after phagocytosis. Oxidative burst is commonly
measured either using cytochrome C reduction with a pho-
tometry method, the chemiluminescence conversion method
is used by most people now, or based on changes in fluores-
cence properties of appropriate substrate compounds, which
can be assessed by flow cytometry.  The bactericidal assay
adds live bacteria to a culture of phagocytes, subsequently
measuring phagocytosis and the destruction of pathogens.
Cytotoxicity assay
Activity of both cytotoxic T lymphocytes (CTL) and NK cells
can be assessed by a cytotoxicity assay. CTL recognizes cells
on the basis of their cell-specific surface antigens. NK cells, a
special type of lymphocyte, directly lyse tumour cells or viral-
ly infected cells. In the CTL activity assay, target cells can be
lymphoblasts, cultured tissue cells, or tumour cells. In NK
activity assay, tumour cells serve as target cells. In both
assays, target cells are labelled with 51Cr and then incubated
with effector cells (e.g. human peripheral blood mononucleo-
cytes (PBMC), or animal spleen cells as a source of NK cells)
at different ratios. The percentage of 51Cr released is calculat-
ed to represent lysis of target cells which reflects the cytotoxi-
city of effector cells. Flow cytometry methods are now used
as a favourable non-isotope alternative to the classical 51Cr
method. 
Lymphocyte proliferation
The proliferative response of lymphocytes is frequently used
to assess cell-mediated immune response. Cell proliferation
can be quantified by measuring incorporation of [3H]-thymi-
dine into DNA, or non-radioactive methods such as bromod-
eoxyuridine incorporation, and fluorescence dye dilution
assays. Common agents used to simulate lymphocyte prolifer-
ation are the T-cell mitogens concanavalin A (Con A), phyto-
haemagglutinin (PHA), and anti-CD3 Ab, all of which stimu-
late T-cell proliferation. LPS stimulates B-cell proliferation,
and pokeweed mitogen (PWM) stimulates proliferation of
both T- and B-cells. 
Cytokine production
Immune cells produce an array of protein mediators called
cytokines, which serve as messengers to regulate immune cell
activities or directly exert effector function. Cytokine quan-
tification is helpful for assessing both general state and partic-
ular functions of immune system. Agents used to stimulate
lymphocyte proliferation as mentioned above as well as some
cytokines and growth factors can induce high levels of
cytokine production in culture medium which can be conve-
niently quantified by ELISA. In addition, intracellular
cytokine levels in specific cells can be assessed in a mixed
cell population (without the need for purification specific cell
types) using flow cytometer and a combination of stains for
cell surface markers and antibodies (Ab) against the cytokine
of interest. 
One difficulty in interpreting data obtained from cytokine
analysis is that many of them are, at times, redundant and at
other times oppose function. This makes it difficult to gain
insight into the “real change” in function of the immune sys-
tem based on the impact of an intervention on relatively few
cytokines measured. Assay costs can constrain the numbers of
samples measured. Fortunately, in recent years, the emerging
“omics” technologies (genomics, proteomics, and
metabolomics) have provided the opportunity to obtain a
more holistic and integrated view of the basal and stimulated
potential for cytokine production using small aliquot of sam-
ple and more sophisticated data analysis approaches. Com-
bined with the conventional assays, these newer approaches
will provide a more comprehensive and insightful understand-
ing of whether and how nutritional intervention impacts
cytokine production and the function of the immune system in
general. Furthermore, these approaches will help address and
reduce the well-known intra-individual variation observed in
response to exercise and nutritional interventions. The
“omics” information comes from genomic and epigenetic reg-
ulations (alleles, single nucleotide polymorphism, methyla-
tion), post-transcriptional regulation (microRNA), and pro-
teomics screening for isomeric forms of protein and post-
translational modification. These can be used as tools to iden-
tify the intrinsic inter-personal differences and to design per-
sonalized interventions to achieve optimal results.
Leucocyte trafficking 
Leucocytes or white blood cells, including granulocytes (neu-
trophils, eosinophils, and basophils), monocytes, and lympho-
cytes (T-cells, B-cells, NK-cells), have essential roles in host
defence. Leucocyte counts have long been used as a simple
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clinical marker of inflammation and/or immune function but,
because there is a variety of mechanisms which also influence
each other, careful consideration is necessary to understand
the implication of the observed changes in the leucocyte
counts in association with exercise and training. 
Acute alteration of leucocyte counts by a single bout of 
exercise 
A single bout of exercise results in changes in the circulating
numbers of leucocytes. The direction of change depends on
the duration and intensity of the exercise. Short-term exhaus-
tive exercise of less than one hour induces leucocytosis main-
ly due to increases in the circulating numbers of neutrophils
and lymphocytes including NK cells, whereas prolonged exer-
cise beyond one hour induces a marked neutrophilia. After
strenuous or prolonged exercise, circulating T-cell and NK
cell counts usually go down transiently below baseline within
about 30 minutes after exercise (39,310). All these changes
may be attenuated by carbohydrate ingestion. Leucocytosis
after high intensity running in marathon runners or long dis-
tance running (18-20 km) was attenuated by carbohydrate
supplementation (188,280).  
Leucocyte count in persons with different level of aerobic
 fitness or with obesity
As a long term effect of exercise training, recent studies
demonstrated the association between fitness measurements
and leucocyte counts. Maximal metabolic equivalents (METs)
achieved during a treadmill exercise test were inversely asso-
ciated with total leucocytes, neutrophil and basophil counts
after adjustment for age, whereas body mass index (BMI) was
positively associated with total leucocyte, neutrophil, lympho-
cyte, monocyte, and basophil counts in a cross sectional sur-
vey of non-smoking healthy men (195). The Dose-Response
to Exercise in Women Aged 45–75 yr (DREW) study demon-
strated an exercise-volume dependent decrease in total leuco-
cyte and neutrophil counts after 6-month moderate intensity
exercise intervention for 390 sedentary obese post-
menopausal women randomly assigned to different doses of
exercise (196). The decrease in the waist circumference, but
not the decrease in BMI, correlated with the reduction of leu-
cocyte and neutrophil counts in this study. During a study
with a mean follow-up period of 45.6 months, obesity was
associated with leucocytosis with low grade elevation of
serum acute phase CRP without any recognized cause of leu-
cocytosis other than being obese (176).
Mechanism of alterations in leucocyte trafficking
Haematopoiesis, retention, release and clearance of leuco-
cytes need to be considered to understand leucocyte traffick-
ing. They are known to be differentially regulated across dif-
ferent subsets of leucocytes. Myeloid cells are constantly pro-
duced in the bone marrow under the regulation of the local
microenvironment, in which stromal cells play the central
role. Upon conventional inflammatory response initiated by
bacterial infection, monocyte or dendritic cell derived granu-
locyte macrophage colony-stimulating factor and granulocyte
colony-stimulating factor accelerate proliferation of myeloid
progenitors as well as their maturation. CXC chemokines,
such as IL-8, produced at the site of inflammation or infec-
tion, recruit neutrophils from the bone marrow (377). Malnu-
trition has long been recognized as a factor that suppresses
haematopoiesis leading to anaemia and pan-leucopaenia.
Recently, protein malnutrition was found to promote adi-
pogenic differentiation of bone marrow stromal cells, which
affects haematopoiesis (98). 
Chemokine receptor CXCR4 and the corresponding ligand
CXCL12 are essential for retention and homing as well as for
the clearance of leucocytes. CXCL12 is abundantly expressed
in the stromal cells of bone marrow as well as in the endovas-
culature in various organs such as spleen, liver and lung.
CXCL12 expression on bone marrow stromal cells was
recently shown to be decreased by noradrenaline released
from the sympathetic terminal in the bone marrow via the β
adrenergic receptor. Circadian fluctuation of noradrenaline
release in the bone marrow is suggested to be the major cause
of circadian fluctuation of leucocyte counts, especially neu-
trophils (352). On the other hand, the corresponding receptor
CXCR4 on lymphocyte is known to be under the control of
glucocorticoid. Strenuous or exhausting exercise that induces
hypothalamic pituitary adrenal axis activation is considered as
the major cause of post exercise lymphopaenia (294). Interest-
ingly, senescent neutrophils expressing CXCR4 are rede-
ployed into the bone marrow, where they are subjected to
phagocytic elimination (378). Stressful exercise, such as pro-
longed, exhaustive or high intensity strenuous exercise, may
therefore lead to post exercise lymphopaenia.
NK cells (CD56 dim cytotoxic NK subset) and CD8 positive T
cells, γ-δ T cells are major cytotoxic leucocytes in the circula-
tion. These cytotoxic effector leucocyte subsets comprise the
marginal pool by an adhesion molecule CD11a/ fractalkine
CX3CR1-mediated attachment to the endothelium. Adrenaline
rapidly attenuates this attachment without affecting the expres-
sion of the adhesion molecule to allow demargination and
release of these leucocytes into circulation to induce adrener-
gic leucocytosis through β2 adrenergic stimuli (112). Adrener-
gic stimulus is not only delivered through bone marrow sym-
pathetic nerve terminal, but also through catecholamines
released from either sympathetic nerve terminals in various
organs and adrenal medulla. 
In summary, during a single bout of exercise with either
peripheral sympathetic nerve activation or systemic adrena-
line response during prolonged exercise when extensive lipol-
ysis is required, neutrophils and monocytes of myeloid origin
will be released from bone marrow by CXCL12 downregula-
tion. Catecholamines would also attenuate CD11a/CXCR1
mediated attachment of marginated cytotoxic leucocytes
including NK cells resulting in marked leucocytosis. Neu-
trophils are known to have a blood half-life of 6.5 hours, and
the majority of aged neutrophils would express CXCR4 sever-
al hours after the release from bone marrow and will return to
bone marrow for clearance by phagocytes. In conditions of
exercise with a glucocorticoid response, lymphocytes will be
redeployed to secondary lymphoid tissues by enhanced
CXCR4 expression and may lead to transient lymphopaenia. 
Enhanced sympathetic activity in obese individuals seems to
play a central role in the observed leukocytosis similar to the
observed elevated blood pressure. The obesity-associated
chronic inflammation, through increased leptin production,
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enhances sympathetic activity and therefore leukocytosis
(156). Therefore, attenuation of obesity-related leucocytosis
after sessions of exercise training may either be the result of
decreased sympathetic activity through weight reduction or
because of anti-inflammatory effect of exercise leading to
reduced leptin release or both.
Clinical implication and limitations
Impaired adhesion or excess retention of leucocytes both
compromise self-defence as demonstrated in primary
immuno-deficiency patients with leucocyte adhesion-defi-
ciency (LAD) syndrome (293). LAD is caused by the muta-
tions of the gene encoding for the β-2 integrin CD18, which is
required for firm adhesion of leucocytes to endothelium
before transmigration. LAD patients demonstrate marked leu-
cocytosis with high incidence of gingivitis, periodontitis,
cutaneous infections without pus formation, life-threatening
bacterial infections and delayed wound healing.
The clinical implication of altered leucocyte trafficking by
exercise is that, during sympathetic activation, even though
the circulating leucocyte number is high, it is possible that
immune or inflammatory reaction through leucocytes may be
blunted because of attenuation of adhesion through β adren-
ergic stimuli. This may avoid both systemic and local
immune responses and inflammation that affects “fight or
flight” actions. However, a similar situation may happen
when metabolic demand is high and after prolonged exercise
or in obesity with sympathetic activation. Therefore, leucocy-
tosis in such situations may be considered as a new “open
window”. Previously the term “open window” referred to the
occurrence of lymphopaenia or decreased NK cells after
strenuous exercise due to retention in secondary lymphoid
organs and marginal pool. However, a mild and transient
retention to their site of action may not confer impaired
immunity. This might be explained by the fact that NK cells
have a limited spectrum of cytotoxicity, which is strictly
determined by the expression of variant MHC-I (major histo-
compatibility antigen 1) or loss of MHC-1 due to either viral
infection such as CMV or herpes simplex virus or in some
tumour cells (70).
Carbohydrate ingestion known to attenuate leucocytosis is
likely to be mediated by attenuation of sympathetic drive by
reducing the energy demand, which may be an effective way
to close the open window, as previously recognized. On the
other hand, reduced energy intake as often observed in female
athletes’ triad or relative energy deficiency in sports, may
affect haematopoiesis in starvation or malnutrition (265).
Although there is insufficient clinical information related to
leucocyte trafficking, it is likely that serious cases may pres-
ent leucopaenia as well as anaemia, leading to impaired
immunity when haematopoiesis is limited. At the earlier phase
of reduced energy intake, sympathetic driven lipolysis may
attenuate leucocyte adhesion, and this may compromise neu-
trophil defence as mentioned above. 
Conflict of Interest
F. Mooren has received grants from Verla Pharm and Hermes
Arzneimittel, Germany. 
M. Gleeson has received grants for research projects from
GlaxoSmithKline, Nestle, Pepsico and Yakult Honsha.
The other authors have declared no conflict of interests in
regard to this article.
REFERENCES
1. Ahmed M, Henson DA, Sanderson MC, Nieman DC, Gillitt
ND and Lila MA. The protective effects of a polyphenol-
enriched protein powder on exercise-induced susceptibility to
virus infection. Phytother Res PTR 28: 1829–1836, 2014.
2. Albers R, Antoine J-M, Bourdet-Sicard R, Calder PC, Gleeson M,
Lesourd B, Samartín S, Sanderson IR, Van Loo J, Vas Dias FW
and Watzl B. Markers to measure immunomodulation in human
nutrition intervention studies. Br J Nutr 94: 452–481, 2005.
3. Albers R, Bourdet-Sicard R, Braun D, Calder PC, Herz U,
Lambert C, Lenoir-Wijnkoop I, Méheust A, Ouwehand A,
Phothirath P, Sako T, Salminen S, Siemensma A, van Loveren
H and Sack U. Monitoring immune modulation by nutrition in
the general population: identifying and substantiating effects
on human health. Br J Nutr 110 Suppl 2: S1-30, 2013.
4. Al-Jaderi Z and Maghazachi AA. Effects of vitamin D3, cal-
cipotriol and FTY720 on the expression of surface molecules
and cytolytic activities of human natural killer cells and den-
dritic cells. Toxins 5: 1932–1947, 2013.
5. Allaire J, Couture P, Leclerc M, Charest A, Marin J, Lépine M-
C, Talbot D, Tchernof A and Lamarche B. A randomized,
crossover, head-to-head comparison of eicosapentaenoic acid
and docosahexaenoic acid supplementation to reduce inflam-
mation markers in men and women: the Comparing EPA to
DHA (ComparED) Study. Am J Clin Nutr 104: 280–287, 2016.
6. Allan GM and Arroll B. Prevention and treatment of the com-
mon cold: making sense of the evidence. Can Med Assoc J
186: 190–199, 2014.
7. Allegra S, Deleine C, Michael-Jubely R, Gryson C, Boirie Y,
Kantakamalakul W and Vasson M-P. Implementation of the
EGFP-K562 flow cytometric NK test: determination of NK
cytotoxic activity in healthy elderly volunteers before and after
feeding. Cytometry A 69: 992–998, 2006.
8. Altomare A, Fasoli E, Colzani M, Parra XMP, Ferrari M, Cil-
urzo F, Rumio C, Cannizzaro L, Carini M, Righetti PG and
Aldini G. An in depth proteomic analysis based on ProteoMin-
er, affinity chromatography and nano-HPLC-MS/MS to
explain the potential health benefits of bovine colostrum. J
Pharm Biomed Anal 121: 297–306, 2016.
9. Amulic B, Cazalet C, Hayes GL, Metzler KD and Zychlinsky
A. Neutrophil function: from mechanisms to disease. Annu
Rev Immunol 30: 459–489, 2012.
10. Andrade PMM, Ribeiro BG, Bozza MT, Costa Rosa LFB and
Tavares do Carmo MG. Effects of the fish-oil supplementation
on the immune and inflammatory responses in elite swimmers.
Prostaglandins Leukot Essent Fatty Acids 77: 139–145, 2007.
11. Annuzzi G, Bozzetto L, Costabile G, Giacco R, Mangione A,
Anniballi G, Vitale M, Vetrani C, Cipriano P, Della Corte G,
Pasanisi F, Riccardi G and Rivellese AA. Diets naturally rich
in polyphenols improve fasting and postprandial dyslipidemia
and reduce oxidative stress: a randomized controlled trial. Am
J Clin Nutr 99: 463–471, 2014.
12. Ardawi MS. Glutamine and glucose metabolism in human
peripheral lymphocytes. Metabolism 37: 99–103, 1988.
38 •   Immunonutrition and Exercise
EIR 23 2017
13. Ardawi MS and Newsholme EA. Metabolism in lymphocytes
and its importance in the immune response. Essays Biochem
21: 1–44, 1985.
14. Babior BM. The respiratory burst of phagocytes. J Clin Invest
73: 599–601, 1984.
15. Bahrke MS, Morgan WP and Stegner A. Is ginseng an
ergogenic aid? Int J Sport Nutr Exerc Metab 19: 298–322,
2009.
16. Bailey DM, Castell LM, Newsholme EA and Davies B. Con-
tinuous and intermittent exposure to the hypoxia of altitude:
implications for glutamine metabolism and exercise perform-
ance. Br J Sports Med 34: 210–212, 2000.
17. Balentine DA, Dwyer JT, Erdman JW, Ferruzzi MG, Gaine
PC, Harnly JM and Kwik-Uribe CL. Recommendations on
reporting requirements for flavonoids in research. Am J Clin
Nutr 101: 1113–1125, 2015.
18. Ballard SL, Wellborn-Kim JJ and Clauson KA. Effects of
commercial energy drink consumption on athletic performance
and body composition. Phys Sportsmed 38: 107–117, 2010.
19. Bannenberg G and Serhan CN. Specialized pro-resolving lipid
mediators in the inflammatory response: An update. Biochim
Biophys Acta 1801: 1260–1273, 2010.
20. Barrett B, Locken K, Maberry R, Schwamman J, Brown R,
Bobula J and Stauffacher EA. The Wisconsin Upper Respira-
tory Symptom Survey (WURSS): a new research instrument
for assessing the common cold. J Fam Pract 51: 265, 2002.
21. Bassit RA, Sawada LA, Bacurau RF, Navarro F and Costa
Rosa LF. The effect of BCAA supplementation upon the
immune response of triathletes. Med Sci Sports Exerc 32:
1214–1219, 2000.
22. Baumann CW, Bond KL, Rupp JC, Ingalls CP and Doyle JA.
Echinacea purpurea supplementation does not enhance
VO2max in distance runners. J Strength Cond Res Natl
Strength Cond Assoc 28: 1367–1372, 2014.
23. de Beaux FRCS AC, O’Riordain MD MG, Ross PhD JA,
Jodozi PhD L, Carter MD DC and Fearon MD KCH. Gluta-
mine-supplemented total parenteral nutrition reduces blood
mononuclear cell interleukin-8 release in severe acute pancre-
atitis. Nutrition 14: 261–265, 1998.
24. Beier-Holgersen R and Brandstrup B. Influence of postopera-
tive enteral nutrition on cellular immunity. A random double-
blinded placebo controlled clinical trial. Int J Colorectal Dis
27: 513–520, 2012.
25. Bellar D, Moody KM, Richard NS and Judge LW. Efficacy of
a botanical supplement with concentrated Echinacea purpurea
for increasing aerobic capacity. ISRN Nutr 2014: 149549,
2014.
26. Bennett BK, Hickie IB, Vollmer-Conna US, Quigley B, Bren-
nan CM, Wakefield D, Douglas MP, Hansen GR, Tahmindjis
AJ and Lloyd AR. The relationship between fatigue, psycho-
logical and immunological variables in acute infectious illness.
Aust N Z J Psychiatry 32: 180–186, 1998.
27. Berg A, Northoff H, Konig D, Weinstock C, Grathwohl D,
Parnham M, Stuhlfauth I and Keul J. Influence of Echinacin
(EC31) treatment on the exercise-induced immune response in
athletes. J Clin Res 1: 367–380, 1998.
28. Berry DJ, Hesketh K, Power C and Hyppönen E. Vitamin D
status has a linear association with seasonal infections and
lung function in British adults. Br J Nutr 106: 1433–1440,
2011.
29. Bertoia ML, Rimm EB, Mukamal KJ, Hu FB, Willett WC and
Cassidy A. Dietary flavonoid intake and weight maintenance:
three prospective cohorts of 124,086 US men and women fol-
lowed for up to 24 years. Brit Med J 352: i17, 2016.
30. Bikle DD. Vitamin D and immune function: understanding
common pathways. Curr Osteoporos Rep 7: 58–63, 2009.
31. Binnendijk KH and Rijkers GT. What is a health benefit? An
evaluation of EFSA opinions on health benefits with reference
to probiotics. Benef Microbes 4: 223–230, 2013.
32. Bishop NC, Blannin AK, Armstrong E, Rickman M and Glee-
son M. Carbohydrate and fluid intake affect the saliva flow
rate and IgA response to cycling. Med Sci Sports Exerc 32:
2046–2051, 2000.
33. Bishop NC, Blannin AK, Walsh NP and Gleeson M. Carbohy-
drate beverage ingestion and neutrophil degranulation
responses following cycling to fatigue at 75% VO2 max. Int J
Sports Med 22: 226–231, 2001.
34. Bishop NC, Walker GJ, Bowley LA, Evans KF, Molyneux K,
Wallace FA and Smith AC. Lymphocyte responses to influenza
and tetanus toxoid in vitro following intensive exercise and
carbohydrate ingestion on consecutive days. J Appl Physiol
99: 1327–1335, 2005.
35. Bishop NC, Walker GJ, Gleeson M, Wallace FA and Hewitt
CRA. Human T lymphocyte migration towards the super-
natants of human rhinovirus infected airway epithelial cells:
influence of exercise and carbohydrate intake. Exerc Immunol
Rev 15: 127–144, 2009.
36. Bishop NC, Walsh NP, Haines DL, Richards EE and Gleeson
M. Pre-exercise carbohydrate status and immune responses to
prolonged cycling: I. Effect on neutrophil degranulation. Int J
Sport Nutr Exerc Metab 11: 490–502, 2001.
37. Bishop NC, Walsh NP, Haines DL, Richards EE and Gleeson
M. Pre-exercise carbohydrate status and immune responses to
prolonged cycling: II. Effect on plasma cytokine concentra-
tion. Int J Sport Nutr Exerc Metab 11: 503–512, 2001.
38. Bishop NC, Walsh NP and Scanlon GA. Effect of prolonged
exercise and carbohydrate on total neutrophil elastase content.
Med Sci Sports Exerc 35: 1326–1332, 2003.
39. Blannin A. Acute exercise and innate immune function. In:
Immune function in sport and exercise. Gleeson M, ed.
Churchill Livingstone, 2006.
40. Blannin AK, Robson PJ, Walsh NP, Clark AM, Glennon L and
Gleeson M. The effect of exercising to exhaustion at different
intensities on saliva immunoglobulin A, protein and electrolyte
secretion. Int J Sports Med 19: 547–552, 1998.
41. Blomstrand E, Celsing F and Newsholme EA. Changes in
plasma concentrations of aromatic and branched-chain amino
acids during sustained exercise in man and their possible role
in fatigue. Acta Physiol Scand 133: 115–121, 1988.
42. Blomstrand E and Saltin B. BCAA intake affects protein
metabolism in muscle after but not during exercise in humans.
Am J Physiol Endocrinol Metab 281: E365-374, 2001.
43. Bloomer RJ, Larson DE, Fisher-Wellman KH, Galpin AJ and
Schilling BK. Effect of eicosapentaenoic and docosahexaenoic
acid on resting and exercise-induced inflammatory and oxida-
tive stress biomarkers: a randomized, placebo controlled,
cross-over study. Lipids Health Dis 8: 36, 2009.
44. Bölke E, Jehle PM, Hausmann F, Däubler A, Wiedeck H,
Steinbach G, Storck M and Orth K. Preoperative oral applica-
tion of immunoglobulin-enriched colostrum milk and mediator
response during abdominal surgery. Shock 17: 9–12, 2002.
Immunonutrition and Exercise •   39
EIR 23 2017
45. Booth CK, Coad RA, Forbes-Ewan CH, Thomson GF and
Niro PJ. The physiological and psychological effects of com-
bat ration feeding during a 12-day training exercise in the trop-
ics. Mil Med 168: 63–70, 2003.
46. Bosch JA, Ring C, de Geus EJC, Veerman ECI and Ameron-
gen AVN. Stress and secretory immunity. Int Rev Neurobiol
52: 213–253, 2002.
47. Bozbay M and Uyarel H. Neutrophil-to-lymphocyte ratio: A
novel and simple prognostic marker for infective endocarditis.
J Crit Care 30: 822, 2015.
48. Brandtzaeg P. Secretory immunity with special reference to the
oral cavity. J Oral Microbiol 5, 2013.
49. Brinkworth GD and Buckley JD. Concentrated bovine
colostrum protein supplementation reduces the incidence of
self-reported symptoms of upper respiratory tract infection in
adult males. Eur J Nutr 42: 228–232, 2003.
50. Brisswalter J and Louis J. Vitamin supplementation benefits in
master athletes. Sports Med 44: 311–318, 2014.
51. Brutsaert TD, Hernandez-Cordero S, Rivera J, Viola T, Hugh-
es G and Haas JD. Iron supplementation improves progressive
fatigue resistance during dynamic knee extensor exercise in
iron-depleted, nonanemic women. Am J Clin Nutr 77: 441–
448, 2003.
52. Bruunsgaard H, Hartkopp A, Mohr T, Konradsen H, Heron I,
Mordhorst CH and Pedersen BK. In vivo cell-mediated immu-
nity and vaccination response following prolonged, intense
exercise. Med Sci Sports Exerc 29: 1176–1181, 1997.
53. Buckley JD, Brinkworth GD and Abbott MJ. Effect of bovine
colostrum on anaerobic exercise performance and plasma
insulin-like growth factor I. J Sports Sci 21: 577–588, 2003.
54. Burdge GC and Calder PC. Introduction to fatty acids and
lipids. World Rev Nutr Diet 112: 1–16, 2015.
55. Burns VE. Using vaccinations to assess in vivo immune func-
tion in psychoneuroimmunology. Methods Mol Biol 934: 371–
381, 2012.
56. Calbet JA, Mooren FC, Burke LM, Stear SJ and Castell LM.
A-Z of nutritional supplements: dietary supplements, sports
nutrition foods and ergogenic aids for health and performance:
part 24. Br J Sports Med 45: 1005–1007, 2011.
57. Calder PC. Branched-chain amino acids and immunity. J Nutr
136: 288S–293S, 2006.
58. Calder PC. n-3 polyunsaturated fatty acids, inflammation, and
inflammatory diseases. Am J Clin Nutr 83: 1505S–1519S,
2006.
59. Calder PC. The relationship between the fatty acid composi-
tion of immune cells and their function. Prostaglandins Leukot
Essent Fatty Acids 79: 101–108, 2008.
60. Calder PC. Very long chain omega-3 (n-3) fatty acids and
human health. Eur J Lipid Sci Technol 116: 1280–1300, 2014.
61. Calder PC. Marine omega-3 fatty acids and inflammatory
processes: Effects, mechanisms and clinical relevance.
Biochim Biophys Acta 1851: 469–484, 2015.
62. Calder PC. Functional roles of fatty acids and their effects on
human health. JPEN J Parenter Enteral Nutr 39: 18S–32S,
2015.
63. Calder PC and Jackson AA. Undernutrition, infection and
immune function. Nutr Res Rev 13: 3–29, 2000.
64. Cannell JJ and Hollis BW. Use of vitamin D in clinical prac-
tice. Altern Med Rev J Clin Ther 13: 6–20, 2008.
65. Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB,
Madronich S, Garland CF and Giovannucci E. Epidemic
influenza and vitamin D. Epidemiol Infect 134: 1129–1140,
2006.
66. Capó X, Martorell M, Llompart I, Sureda A, Tur JA and Pons
A. Docosahexanoic acid diet supplementation attenuates the
peripheral mononuclear cell inflammatory response to exer-
cise following LPS activation. Cytokine 69: 155–164, 2014.
67. Caris AV, Lira FS, de Mello MT, Oyama LM and dos Santos
RVT. Carbohydrate and glutamine supplementation modulates
the Th1/Th2 balance after exercise performed at a simulated
altitude of 4500 m. Nutrition 30: 1331–1336, 2014.
68. Carol A, Witkamp RF, Wichers HJ and Mensink M. Bovine
colostrum supplementation’s lack of effect on immune vari-
ables during short-term intense exercise in well-trained ath-
letes. Int J Sport Nutr Exerc Metab 21: 135–145, 2011.
69. Carpenter GH, Proctor GB, Ebersole LE and Garrett JR.
Secretion of IgA by rat parotid and submandibular cells in
response to autonomimetic stimulation in vitro. Int
Immunopharmacol 4: 1005–1014, 2004.
70. Carrillo-Bustamante P, Kesmir C and de Boer RJ. Can selec-
tive MHC downregulation explain the specificity and genetic
diversity of NK cell receptors? Front Immunol 6: 311, 2015.
71. Carroll L, Davies MJ and Pattison DI. Reaction of low-molec-
ular-mass organoselenium compounds (and their sulphur ana-
logues) with inflammation-associated oxidants. Free Radic
Res 49: 750–767, 2015.
72. Cassidy A, Rogers G, Peterson JJ, Dwyer JT, Lin H and
Jacques PF. Higher dietary anthocyanin and flavonol intakes
are associated with anti-inflammatory effects in a population
of US adults. Am J Clin Nutr 102: 172–181, 2015.
73. Castell L. Glutamine supplementation in vitro and in vivo, in
exercise and in immunodepression. Sports Med 33: 323–345,
2003.
74. Castell L, Vance C, Abbott R, Marquez J and Eggleton P.
Granule localization of glutaminase in human neutrophils and
the consequence of glutamine utilization for neutrophil activi-
ty. J Biol Chem 279: 13305–13310, 2004.
75. Castell LM and Newsholme EA. The effects of oral glutamine
supplementation on athletes after prolonged, exhaustive exer-
cise. Nutrition 13: 738–742, 1997.
76. Castell LM, Poortmans JR, Leclercq R, Brasseur M,
Duchateau J and Newsholme EA. Some aspects of the acute
phase response after a marathon race, and the effects of gluta-
mine supplementation. Eur J Appl Physiol 75: 47–53, 1997.
77. Castell LM, Poortmans JR and Newsholme EA. Does gluta-
mine have a role in reducing infections in athletes? Eur J Appl
Physiol 73: 488–490, 1996.
78. Castell LM, Stear SJ and Burke LM. Nutritional supplements
in sport, exercise, and health: An A-Z guide. Abingdon, Oxon,
UK: Routledge, 2015.
79. Castell LM, Thake CD and Ensign W. Biochemical markers of
possible immunodepression in military training in harsh envi-
ronments. Mil Med 175: 158–165, 2010.
80. Ceriello A. Postprandial hyperglycemia and diabetes compli-
cations: is it time to treat? Diabetes 54: 1–7, 2005.
81. Chen P, Chakraborty S, Mukhopadhyay S, Lee E, Paoliello
MMB, Bowman AB and Aschner M. Manganese homeostasis
in the nervous system. J Neurochem 134: 601–610, 2015.
40 •   Immunonutrition and Exercise
EIR 23 2017
82. Cherayil BJ. Iron and immunity: immunological consequences
of iron deficiency and overload. Arch Immunol Ther Exp
(Warsz) 58: 407–415, 2010.
83. Clancy RL, Gleeson M, Cox A, Callister R, Dorrington M,
D’Este C, Pang G, Pyne D, Fricker P and Henriksson A.
Reversal in fatigued athletes of a defect in interferon gamma
secretion after administration of Lactobacillus acidophilus. Br
J Sports Med 40: 351–354, 2006.
84. Close GL, Russell J, Cobley JN, Owens DJ, Wilson G, Gregson
W, Fraser WD and Morton JP. Assessment of vitamin D concen-
tration in non-supplemented professional athletes and healthy
adults during the winter months in the UK: implications for
skeletal muscle function. J Sports Sci 31: 344–353, 2013.
85. Coad S, Gray B, Wehbe G and McLellan C. Physical demands
and salivary immunoglobulin A responses of elite Australian
rules football athletes to match play. Int J Sports Physiol Per-
form 10: 613–617, 2015.
86. Cochran AJ, Myslik F, MacInnis MJ, Percival ME, Bishop D,
Tarnopolsky MA and Gibala MJ. Manipulating carbohydrate
availability between twice-daily sessions of high-intensity
interval training over 2 weeks improves time-trial perform-
ance. Int J Sport Nutr Exerc Metab 25: 463–470, 2015.
87. Cohen S, Doyle WJ, Alper CM, Janicki-Deverts D and Turner
RB. Sleep habits and susceptibility to the common cold. Arch
Intern Med 169: 62–67, 2009.
88. Cohen S, Tyrrell DA and Smith AP. Psychological stress and
susceptibility to the common cold. N Engl J Med 325: 606–
612, 1991.
89. Comstock SS, Reznikov EA, Contractor N and Donovan SM.
Dietary bovine lactoferrin alters mucosal and systemic immune
cell responses in neonatal piglets. J Nutr 144: 525–532, 2014.
90. Coombes JS, Conacher M, Austen SK and Marshall PA. Dose
effects of oral bovine colostrum on physical work capacity in
cyclists. Med Sci Sports Exerc 34: 1184–1188, 2002.
91. Corder KE, Newsham KR, McDaniel JL, Ezekiel UR and
Weiss EP. Effects of short-term docosahexaenoic acid supple-
mentation on markers of inflammation after eccentric strength
exercise in women. J Sports Sci Med 15: 176–183, 2016.
92. Coutinho Moraes DF, Still DW, Lum MR and Hirsch AM.
DNA-Based authentication of botanicals and plant-derived
dietary supplements: where have we been and where are we
going? Planta Med 81: 687–695, 2015.
93. Cox AJ, Gleeson M, Pyne DB, Callister R, Hopkins WG and
Fricker PA. Clinical and laboratory evaluation of upper respi-
ratory symptoms in elite athletes. Clin J Sport Med 18: 438–
445, 2008.
94. Cox AJ, Pyne DB, Saunders PU and Fricker PA. Oral adminis-
tration of the probiotic Lactobacillus fermentum VRI-003 and
mucosal immunity in endurance athletes. Br J Sports Med 44:
222–226, 2010.
95. Crooks C, Cross ML, Wall C and Ali A. Effect of bovine
colostrum supplementation on respiratory tract mucosal
defenses in swimmers. Int J Sport Nutr Exerc Metab 20: 224–
235, 2010.
96. Crooks CV, Wall CR, Cross ML and Rutherfurd-Markwick KJ.
The effect of bovine colostrum supplementation on salivary
IgA in distance runners. Int J Sport Nutr Exerc Metab 16: 47–
64, 2006.
97. Cruzat VF, Krause M and Newsholme P. Amino acid supple-
mentation and impact on immune function in the context of
exercise. J Int Soc Sports Nutr 11: 61, 2014.
98. Cunha MCR, Lima F da S, Vinolo MAR, Hastreiter A, Curi R,
Borelli P and Fock RA. Protein malnutrition induces bone
marrow mesenchymal stem cells commitment to adipogenic
differentiation leading to hematopoietic failure. PloS One 8:
e58872, 2013.
99. Da Boit M, Mastalurova I, Brazaite G, McGovern N, Thomp-
son K and Gray SR. The effect of krill oil supplementation on
exercise performance and markers of immune function. PloS
One 10: e0139174, 2015.
100. Dai Z-L, Li X-L, Xi P-B, Zhang J, Wu G and Zhu W-Y. L-Glu-
tamine regulates amino acid utilization by intestinal bacteria.
Amino Acids 45: 501–512, 2013.
101. Davison G and Diment BC. Bovine colostrum supplementa-
tion attenuates the decrease of salivary lysozyme and enhances
the recovery of neutrophil function after prolonged exercise.
Br J Nutr 103: 1425–1432, 2010.
102. Davison G, Kehaya C, Diment BC and Walsh NP. Carbohy-
drate supplementation does not blunt the prolonged exercise-
induced reduction of in vivo immunity. Eur J Nutr 55: 1583–
1593, 2016.
103. Davison HM. Nutrition and allergy. J Am Acad Appl Nutr 1:
75, 1947.
104. Décombaz J, Reinhardt P, Anantharaman K, von Glutz G and
Poortmans JR. Biochemical changes in a 100 km run: free
amino acids, urea, and creatinine. Eur J Appl Physiol 41: 61–
72, 1979.
105. Delfan M, Ebrahim K, Baesi F, Mirakhori Z, Ghalamfarsa G,
Bakhshaei P, Saboor-Yaraghi AA, Razavi A, Setayesh M,
Yousefi M and Jadidi-Niaragh F. The immunomodulatory
effects of fish-oil supplementation in elite paddlers: A pilot
randomized double blind placebo-controlled trial.
Prostaglandins Leukot Essent Fatty Acids 99: 35–40, 2015.
106. Dennis EA and Norris PC. Eicosanoid storm in infection and
inflammation. Nat Rev Immunol 15: 511–523, 2015.
107. Diaz-Ochoa VE, Jellbauer S, Klaus S and Raffatellu M. Tran-
sition metal ions at the crossroads of mucosal immunity and
microbial pathogenesis. Front Cell Infect Microbiol 4: 2, 2014.
108. DiLorenzo FM, Drager CJ and Rankin JW. Docosahexaenoic
acid affects markers of inflammation and muscle damage after
eccentric exercise. J Strength Cond Res 28: 2768–2774, 2014.
109. Diment BC, Fortes MB, Edwards JP, Hanstock HG, Ward MD,
Dunstall HM, Friedmann PS and Walsh NP. Exercise intensity
and duration effects on in vivo immunity. Med Sci Sports
Exerc 47: 1390–1398, 2015.
110. Diment BC, Fortes MB, Greeves JP, Casey A, Costa RJS, Wal-
ters R and Walsh NP. Effect of daily mixed nutritional supple-
mentation on immune indices in soldiers undertaking an 8-
week arduous training programme. Eur J Appl Physiol 112:
1411–1418, 2012.
111. Dimitriou L, Sharp NCC and Doherty M. Circadian effects on
the acute responses of salivary cortisol and IgA in well trained
swimmers. Br J Sports Med 36: 260–264, 2002.
112. Dimitrov S, Lange T and Born J. Selective mobilization of
cytotoxic leukocytes by epinephrine. J Immunol 184: 503–
511, 2010.
113. Dolan MJ, Clerici M, Blatt SP, Hendrix CW, Melcher GP,
Boswell RN, Freeman TM, Ward W, Hensley R and Shearer
GM. In vitro T cell function, delayed-type hypersensitivity
skin testing, and CD4+ T cell subset phenotyping independent-
ly predict survival time in patients infected with human
immunodeficiency virus. J Infect Dis 172: 79–87, 1995.
Immunonutrition and Exercise •   41
EIR 23 2017
114. Douglas RM, Hemilä H, Chalker E and Treacy B. Vitamin C
for preventing and treating the common cold. Cochrane Data-
base Syst Rev CD000980, 2007.
115. Draganidis D, Karagounis LG, Athanailidis I, Chatzinikolaou
A, Jamurtas AZ and Fatouros IG. Inflammaging and skeletal
muscle: can protein intake make a difference? J Nutr 146:
1940–1952, 2016.
116. Duda-Chodak A, Tarko T, Satora P and Sroka P. Interaction of
dietary compounds, especially polyphenols, with the intestinal
microbiota: a review. Eur J Nutr 54: 325–341, 2015.
117. Duramad P, McMahon CW, Hubbard A, Eskenazi B and Hol-
land NT. Flow cytometric detection of intracellular TH1/TH2
cytokines using whole blood: validation of immunologic bio-
marker for use in epidemiologic studies. Cancer Epidemiol
Biomarkers Prev 13: 1452–1458, 2004.
118. Durup D, Jørgensen HL, Christensen J, Schwarz P, Heegaard
AM and Lind B. A reverse J-shaped association of all-cause
mortality with serum 25-hydroxyvitamin D in general prac-
tice: the CopD study. J Clin Endocrinol Metab 97: 2644–2652,
2012.
119. van Duynhoven J, Vaughan EE, Jacobs DM, Kemperman RA,
van Velzen EJJ, Gross G, Roger LC, Possemiers S, Smilde
AK, Doré J, Westerhuis JA and Van de Wiele T. Metabolic fate
of polyphenols in the human superorganism. Proc Natl Acad
Sci USA 108 Suppl 1: 4531–4538, 2011.
120. Edmands WM, Ferrari P, Rothwell JA, Rinaldi S, Slimani N,
Barupal DK, Biessy C, Jenab M, Clavel-Chapelon F, Fagher-
azzi G, Boutron-Ruault M-C, Katzke VA, Kühn T, Boeing H,
Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Grioni S
et al. Polyphenol metabolome in human urine and its associa-
tion with intake of polyphenol-rich foods across European
countries. Am J Clin Nutr 102: 905–913, 2015.
121. Elkington LJ, Gleeson M, Pyne DB, Callister R and Wood LG.
Inflammation and immune function: can antioxidants help the
endurance athlete? In: Antioxidants in Sport Nutrition. Lam-
precht M, ed. . Boca Raton (FL): CRC Press/Taylor & Francis,
2015.
122. Engebretsen L, Steffen K, Alonso JM, Aubry M, Dvorak J,
Junge A, Meeuwisse W, Mountjoy M, Renström P and Wilkin-
son M. Sports injuries and illnesses during the Winter Olympic
Games 2010. Br J Sports Med 44: 772–780, 2010.
123. Erdman KA, Fung TS and Reimer RA. Influence of perform-
ance level on dietary supplementation in elite Canadian ath-
letes. Med Sci Sports Exerc 38: 349–356, 2006.
124. Fardet A. New hypotheses for the health-protective mecha-
nisms of whole-grain cereals: what is beyond fibre? Nutr Res
Rev 23: 65–134, 2010.
125. Faurschou A, Beyer DM, Schmedes A, Bogh MK, Philipsen
PA and Wulf HC. The relation between sunscreen layer thick-
ness and vitamin D production after ultraviolet B exposure: a
randomized clinical trial. Br J Dermatol 167: 391–395, 2012.
126. Fehrenbach E and Niess AM. Role of heat shock proteins in
the exercise response. Exerc Immunol Rev 5: 57–77, 1999.
127. Fell J and Williams D. The effect of aging on skeletal-muscle
recovery from exercise: possible implications for aging ath-
letes. J Aging Phys Act 16: 97–115, 2008.
128. de Ferrars RM, Czank C, Zhang Q, Botting NP, Kroon PA,
Cassidy A and Kay CD. The pharmacokinetics of anthocyanins
and their metabolites in humans. Br J Pharmacol 171: 3268–
3282, 2014.
129. Fisher G, Schwartz DD, Quindry J, Barberio MD, Foster EB,
Jones KW and Pascoe DD. Lymphocyte enzymatic antioxidant
responses to oxidative stress following high-intensity interval
exercise. J Appl Physiol 110: 730–77, 2011.
130. Flannagan RS, Jaumouillé V and Grinstein S. The cell biology
of phagocytosis. Annu Rev Pathol 7: 61–98, 2012.
131. Forsythe P. Probiotics and lung immune responses. Ann Am
Thorac Soc 11 Suppl 1: S33-37, 2014.
132. Fortes MB, Diment BC, Greeves JP, Casey A, Izard R and
Walsh NP. Effects of a daily mixed nutritional supplement on
physical performance, body composition, and circulating ana-
bolic hormones during 8 weeks of arduous military training.
Appl Physiol Nutr Metab 36: 967–975, 2011.
133. Franceschi C, Bonafè M, Valensin S, Olivieri F, De Luca M,
Ottaviani E and De Benedictis G. Inflamm-aging. An evolu-
tionary perspective on immunosenescence. Ann N Y Acad Sci
908: 244–254, 2000.
134. Getz L. A healthful dose of bacteria — yogurt is the best probi-
otic source, but clients do have other options. Today’s Dietitian
13: 46, 2011.
135. Gilroy CM, Steiner JF, Byers T, Shapiro H and Georgian W.
Echinacea and truth in labeling. Arch Intern Med 163: 699–
704, 2003.
136. Ginde AA, Mansbach JM and Camargo CA. Association
between serum 25-hydroxyvitamin D level and upper respira-
tory tract infection in the Third National Health and Nutrition
Examination Survey. Arch Intern Med 169: 384–390, 2009.
137. Gleeson M. Mucosal immune responses and risk of respiratory
illness in elite athletes. Exerc Immunol Rev 6: 5–42, 2000.
138. Gleeson M. Can nutrition limit exercise-induced immunode-
pression? Nutr Rev 64: 119–131, 2006.
139. Gleeson M. Dosing and efficacy of glutamine supplementation
in human exercise and sport training. J Nutr 138: 2045S–
2049S, 2008.
140. Gleeson M. Immunological aspects of sport nutrition.
Immunol Cell Biol 94: 117–123, 2016.
141. Gleeson M, Bishop NC, Oliveira M, McCauley T, Tauler P and
Lawrence C. Effects of a Lactobacillus salivarius probiotic
intervention on infection, cold symptom duration and severity,
and mucosal immunity in endurance athletes. Int J Sport Nutr
Exerc Metab 22: 235–242, 2012.
142. Gleeson M, Bishop NC, Oliveira M and Tauler P. Daily probi-
otic’s (Lactobacillus casei Shirota) reduction of infection inci-
dence in athletes. Int J Sport Nutr Exerc Metab 21: 55–64,
2011.
143. Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS
and Nimmo MA. The anti-inflammatory effects of exercise:
mechanisms and implications for the prevention and treatment
of disease. Nat Rev Immunol 11: 607–615, 2011.
144. Gleeson M, Bishop NC and Struszczak L. Effects of Lacto-
bacillus casei Shirota ingestion on common cold infection and
herpes virus antibodies in endurance athletes: a placebo-con-
trolled, randomized trial. Eur J Appl Physiol 116: 1555–1563,
2016.
145. Gleeson M, McDonald WA, Pyne DB, Cripps AW, Francis JL,
Fricker PA and Clancy RL. Salivary IgA levels and infection
risk in elite swimmers. Med Sci Sports Exerc 31: 67–73, 1999.
146. Gleeson M and Pyne DB. Respiratory inflammation and infec-
tions in high-performance athletes. Immunol Cell Biol 94:
124–131, 2016.
42 •   Immunonutrition and Exercise
EIR 23 2017
147. Gleeson M, Pyne DB, McDonald WA, Clancy RL, Cripps AW,
Horn PL and Fricker PA. Pneumococcal antibody responses in
elite swimmers. Clin Exp Immunol 105: 238–244, 1996.
148. Gombart AF, Borregaard N and Koeffler HP. Human catheli-
cidin antimicrobial peptide (CAMP) gene is a direct target of
the vitamin D receptor and is strongly up-regulated in myeloid
cells by 1,25-dihydroxyvitamin D3. FASEB J 19: 1067–1077,
2005.
149. Grabs V, Nieman DC, Haller B, Halle M and Scherr J. The
effects of oral hydrolytic enzymes and flavonoids on inflam-
matory markers and coagulation after marathon running: study
protocol for a randomized, double-blind, placebo-controlled
trial. BMC Sports Sci Med Rehabil 6: 8, 2014.
150. Grant RW, Mariani RA, Vieira VJ, Fleshner M, Smith TP,
Keylock KT, Lowder TW, McAuley E, Hu L, Chapman-
Novakofski K and Woods JA. Cardiovascular exercise inter-
vention improves the primary antibody response to keyhole
limpet hemocyanin (KLH) in previously sedentary older
adults. Brain Behav Immun 22: 923–932, 2008.
151. Gray P, Chappell A, Jenkinson AM, Thies F and Gray SR. Fish
oil supplementation reduces markers of oxidative stress but
not muscle soreness after eccentric exercise. Int J Sport Nutr
Exerc Metab 24: 206–214, 2014.
152. Gray P, Gabriel B, Thies F and Gray SR. Fish oil supplementa-
tion augments post-exercise immune function in young males.
Brain Behav Immun 26: 1265–1272, 2012.
153. Green KJ, Croaker SJ and Rowbottom DG. Carbohydrate sup-
plementation and exercise-induced changes in T-lymphocyte
function. J Appl Physiol 95: 1216–1223, 2003.
154. van Hall G, MacLean DA, Saltin B and Wagenmakers AJ.
Mechanisms of activation of muscle branched-chain alpha-
keto acid dehydrogenase during exercise in man. J Physiol
494: 899–905, 1996.
155. Hall H, Fahlman MM and Engels HJ. Echinacea purpurea and
mucosal immunity. Int J Sports Med 28: 792–797, 2007.
156. Hall JE, da Silva AA, do Carmo JM, Dubinion J, Hamza S,
Munusamy S, Smith G and Stec DE. Obesity-induced hyper-
tension: role of sympathetic nervous system, leptin, and
melanocortins. J Biol Chem 285: 17271–17276, 2010.
157. Halliday TM, Peterson NJ, Thomas JJ, Kleppinger K, Hollis
BW and Larson-Meyer DE. Vitamin D status relative to diet,
lifestyle, injury, and illness in college athletes. Med Sci Sports
Exerc 43: 335–343, 2011.
158. Halliwell B and Gutteridge J. Free radicals in biology and
medicine. Oxford, UK: Oxford University Press, 2007.
159. Hamer DH, Sempértegui F, Estrella B, Tucker KL, Rodríguez
A, Egas J, Dallal GE, Selhub J, Griffiths JK and Meydani SN.
Micronutrient deficiencies are associated with impaired
immune response and higher burden of respiratory infections
in elderly Ecuadorians. J Nutr 139: 113–119, 2009.
160. Hamer M. The relative influences of fitness and fatness on
inflammatory factors. Prev Med 44: 3–11, 2007.
161. Hanstock HG, Walsh NP, Edwards JP, Fortes MB, Cosby SL,
Nugent A, Curran T, Coyle PV, Ward MD and Yong XHA.
Tear fluid SIgA as a noninvasive biomarker of mucosal immu-
nity and common cold risk. Med Sci Sports Exerc 48: 569–
577, 2016.
162. Hao Q, Dong BR and Wu T. Probiotics for preventing acute
upper respiratory tract infections. Cochrane Database Syst Rev
CD006895, 2015.
163. Harnly J. Importance of accurate measurements in nutrition
research: dietary flavonoids as a case study. Adv Nutr 7: 375–
382, 2016.
164. Harper Smith AD, Coakley SL, Ward MD, Macfarlane AW,
Friedmann PS and Walsh NP. Exercise-induced stress inhibits
both the induction and elicitation phases of in vivo T-cell-
mediated immune responses in humans. Brain Behav Immun
25: 1136–1142, 2011.
165. Hawley JA and Morton JP. Ramping up the signal: promoting
endurance training adaptation in skeletal muscle by nutritional
manipulation. Clin Exp Pharmacol Physiol 41: 608–613, 2014.
166. Haymes E. Trace minerals and exercise. In: Nutrition in Exer-
cise and Sport.CRC Press, 1998.
167. Haywood BA, Black KE, Baker D, McGarvey J, Healey P and
Brown RC. Probiotic supplementation reduces the duration
and incidence of infections but not severity in elite rugby
union players. J Sci Med Sport 17: 356–360, 2014.
168. He C-S, Aw Yong XH, Walsh NP and Gleeson M. Is there an
optimal vitamin D status for immunity in athletes and military
personnel? Exerc Immunol Rev 22: 42–64, 2016.
169. He C-S, Bishop NC, Handzlik MK, Muhamad AS and Gleeson
M. Sex differences in upper respiratory symptoms prevalence
and oral-respiratory mucosal immunity in endurance athletes.
Exerc Immunol Rev 20: 8–22, 2014.
170. He C-S, Fraser WD, Tang J, Brown K, Renwick S, Rudland-
Thomas J, Teah J, Tanqueray E and Gleeson M. The effect of
14 weeks of vitamin D3 supplementation on antimicrobial
peptides and proteins in athletes. J Sports Sci 34: 67–74, 2016.
171. He C-S, Handzlik M, Fraser WD, Muhamad A, Preston H,
Richardson A and Gleeson M. Influence of vitamin D status on
respiratory infection incidence and immune function during 4
months of winter training in endurance sport athletes. Exerc
Immunol Rev 19: 86–101, 2013.
172. Heller JE, Thomas JJ, Hollis BW and Larson-Meyer DE. Rela-
tion between vitamin D status and body composition in colle-
giate athletes. Int J Sport Nutr Exerc Metab 25: 128–135,
2015.
173. Hemilä H and Chalker E. Vitamin C for preventing and treat-
ing the common cold. Cochrane Database Syst Rev
CD000980, 2013.
174. Henson DA, Nieman DC, Parker JC, Rainwater MK, Butter-
worth DE, Warren BJ, Utter A, Davis JM, Fagoaga OR and
Nehlsen-Cannarella SL. Carbohydrate supplementation and
the lymphocyte proliferative response to long endurance run-
ning. Int J Sports Med 19: 574–580, 1998.
175. de Heredia FP, Gómez-Martínez S and Marcos A. Obesity,
inflammation and the immune system. Proc Nutr Soc 71: 332–
8, 2012.
176. Herishanu Y, Rogowski O, Polliack A and Marilus R. Leuko-
cytosis in obese individuals: possible link in patients with
unexplained persistent neutrophilia. Eur J Haematol 76: 516–
520, 2006.
177. Hernández-Bernal F, Aguilar-Betancourt A, Aljovin V, Arias
G, Valenzuela C, de Alejo KP, Hernández K, Oquendo O,
Figueredo N, Figueroa N, Musacchio A, Véliz G, García E,
Mollineda AD, Juvier AI, Trujillo J, Delahanty A, Ortega D,
Cinza Z et al. Comparison of four recombinant hepatitis B
vaccines applied on an accelerated schedule in healthy adults.
Hum Vaccin 7: 1026–1036, 2011.
178. Hewison M. An update on vitamin D and human immunity.
Clin Endocrinol 76: 315–325, 2012.
Immunonutrition and Exercise •   43
EIR 23 2017
179. Hinchado MD, Giraldo E and Ortega E. Adrenoreceptors are
involved in the stimulation of neutrophils by exercise-induced
circulating concentrations of Hsp72: cAMP as a potential
“intracellular danger signal.” J Cell Physiol 227: 604–608,
2012.
180. Hiscock N, Morgan R, Davidson G, Garcia J, Grace F, Bois-
seau N, Castell LM, Mackinnon LT, Davies B and Bailey DM.
Peripheral blood mononuclear cell glutamine concentration
and in vitro proliferation in response to an acute, exercise-
induced decrease in plasma glutamine concentration in man.
In: Proc Phys Soc 539P, 54P, 2002.
181. Hiscock N, Petersen EW, Krzywkowski K, Boza J, Halkjaer-
Kristensen J and Pedersen BK. Glutamine supplementation
further enhances exercise-induced plasma IL-6. J Appl Physiol
95: 145–148, 2003.
182. Honda T, Uehara T, Matsumoto G, Arai S and Sugano M. Neu-
trophil left shift and white blood cell count as markers of bac-
terial infection. Clin Chim Acta 457: 46–53, 2016.
183. Hossein-nezhad A and Holick MF. Vitamin D for health: a
global perspective. Mayo Clin Proc 88: 720–755, 2013.
184. Hou TY, McMurray DN and Chapkin RS. Omega-3 fatty
acids, lipid rafts, and T cell signaling. Eur J Pharmacol 785: 2–
9, 2016.
185. Hoy MK, Goldman JD and Sebastian RS. Fruit and vegetable
intake of US adults estimated by two methods: What we eat in
America, National Health and Nutrition Examination Survey
2009-2012. Public Health Nutr 19: 2508–2512, 2016.
186. Hulisz D. Efficacy of zinc against common cold viruses: an
overview. J Am Pharm Assoc JAPhA 44: 594–603, 2004.
187. Ibs K-H and Rink L. Zinc-altered immune function. J Nutr
133: 1452S–1456S, 2003.
188. Ihalainen JK, Vuorimaa T, Puurtinen R, Hämäläinen I and
Mero AA. Effects of carbohydrate ingestion on acute leuko-
cyte, cortisol, and interleukin-6 response in high-intensity
long-distance running. J Strength Cond Res 28: 2786–2792,
2014.
189. Ivey KL, Hodgson JM, Croft KD, Lewis JR and Prince RL.
Flavonoid intake and all-cause mortality. Am J Clin Nutr 101:
1012–1020, 2015.
190. Izumi H, Kosaka N, Shimizu T, Sekine K, Ochiya T and
Takase M. Bovine milk contains microRNA and messenger
RNA that are stable under degradative conditions. J Dairy Sci
95: 4831–4841, 2012.
191. Jackson GG, Dowling HF, Spiesman IG and Boand AV. Trans-
mission of the common cold to volunteers under controlled
conditions. I. The common cold as a clinical entity. AMA Arch
Intern Med 101: 267–278, 1958.
192. Jackson MJ. Free radicals generated by contracting muscle:
by-products of metabolism or key regulators of muscle func-
tion? Free Radic Biol Med 44: 132–141, 2008.
193. Jemmott JB, Borysenko JZ, Borysenko M, McClelland DC,
Chapman R, Meyer D and Benson H. Academic stress, power
motivation, and decrease in secretion rate of salivary secretory
immunoglobulin A. Lancet 1: 1400–1402, 1983.
194. Ji LL, Kang C and Zhang Y. Exercise-induced hormesis and
skeletal muscle health. Free Radic Biol Med 98: 113–122,
2016.
195. Johannsen NM, Priest EL, Dixit VD, Earnest CP, Blair SN and
Church TS. Association of white blood cell subfraction con-
centration with fitness and fatness. Br J Sports Med 44: 588–
93, 2010.
196. Johannsen NM, Swift DL, Johnson WD, Dixit VD, Earnest
CP, Blair SN and Church TS. Effect of different doses of aero-
bic exercise on total white blood cell (WBC) and WBC sub-
fraction number in postmenopausal women: results from
DREW. PloS One 7: e31319, 2012.
197. Johnson GH and Fritsche K. Effect of dietary linoleic acid on
markers of inflammation in healthy persons: a systematic
review of randomized controlled trials. J Acad Nutr Diet 112:
1029–41, 2012.
198. Jones AW, Cameron SJS, Thatcher R, Beecroft MS, Mur LAJ
and Davison G. Effects of bovine colostrum supplementation
on upper respiratory illness in active males. Brain Behav
Immun 39: 194–203, 2014.
199. Jones AW, Thatcher R, March DS and Davison G. Influence of
4 weeks of bovine colostrum supplementation on neutrophil
and mucosal immune responses to prolonged cycling. Scand J
Med Sci Sports 25: 788–796, 2015.
200. Jordan I, Balaguer M, Esteban ME, Cambra FJ, Felipe A,
Hernández L, Alsina L, Molero M, Villaronga M and Esteban
E. Glutamine effects on heat shock protein 70 and inter-
leukines 6 and 10: Randomized trial of glutamine supplemen-
tation versus standard parenteral nutrition in critically ill chil-
dren. Clin Nutr 35: 34–40, 2016.
201. Jouris KB, McDaniel JL and Weiss EP. The Effect of Omega-3
Fatty Acid Supplementation on the Inflammatory Response to
eccentric strength exercise. J Sports Sci Med 10: 432–438,
2011.
202. Jung HL, Kwak HE, Kim SS, Kim YC, Lee CD, Byurn HK
and Kang HY. Effects of Panax ginseng supplementation on
muscle damage and inflammation after uphill treadmill run-
ning in humans. Am J Chin Med 39: 441–450, 2011.
203. Kalima K, Lehtoranta L, He L, Pitkäniemi J, Lundell R,
Julkunen I, Roivainen M, Närkiö M, Mäkelä MJ, Siitonen S,
Korpela R and Pitkäranta A. Probiotics and respiratory and
gastrointestinal tract infections in Finnish military conscripts -
a randomised placebo-controlled double-blinded study. Benef
Microbes 7: 463–471, 2016.
204. Karsch-Völk M, Barrett B and Linde K. Echinacea for pre-
venting and treating the common cold. JAMA 313: 618–619,
2015.
205. Kawanishi N, Yano H, Yokogawa Y and Suzuki K. Exercise
training inhibits inflammation in adipose tissue via both sup-
pression of macrophage infiltration and acceleration of pheno-
typic switching from M1 to M2 macrophages in high-fat-diet-
induced obese mice. Exerc Immunol Rev 16: 105–118, 2010.
206. Kekkonen RA, Vasankari TJ, Vuorimaa T, Haahtela T,
Julkunen I and Korpela R. The effect of probiotics on respira-
tory infections and gastrointestinal symptoms during training
in marathon runners. Int J Sport Nutr Exerc Metab 17: 352–
363, 2007.
207. Kephart WC, Wachs TD, Mac Thompson R, Brooks Mobley C,
Fox CD, McDonald JR, Ferguson BS, Young KC, Nie B, Mar-
tin JS, Company JM, Pascoe DD, Arnold RD, Moon JR and
Roberts MD. Ten weeks of branched-chain amino acid supple-
mentation improves select performance and immunological
variables in trained cyclists. Amino Acids 48: 779–789, 2016.
208. Khansari DN, Murgo AJ and Faith RE. Effects of stress on the
immune system. Immunol Today 11: 170–175, 1990.
209. Kim YS, Sayers TJ, Colburn NH, Milner JA and Young HA.
Impact of dietary components on NK and Treg cell function
for cancer prevention. Mol Carcinog 54: 669–678, 2015.
44 •   Immunonutrition and Exercise
EIR 23 2017
210. King S, Glanville J, Sanders ME, Fitzgerald A and Varley D.
Effectiveness of probiotics on the duration of illness in healthy
children and adults who develop common acute respiratory
infectious conditions: a systematic review and meta-analysis.
Br J Nutr 112: 41–54, 2014.
211. Knapik JJ, Steelman RA, Hoedebecke SS, Austin KG, Farina
EK and Lieberman HR. Prevalence of Dietary Supplement
Use by Athletes: Systematic Review and Meta-Analysis.
Sports Med 46: 103–123, 2016.
212. Krabbe KS, Pedersen M and Bruunsgaard H. Inflammatory
mediators in the elderly. Exp Gerontol 39: 687–699, 2004.
213. Krebs H. Glutamine metabolism in the animal body. In: Gluta-
mine: Metabolism, Enzymology, and Regulation. Mora J,
Palacios R, eds. . New York: Academic Press, 1980.
214. Krochmal R, Hardy M, Bowerman S, Lu Q-Y, Wang H-J,
Elashoff R and Heber D. Phytochemical assays of commercial
botanical dietary supplements. Evid Based Complement Alter-
nat Med 1: 305–313, 2004.
215. Krzywkowski K, Petersen EW, Ostrowski K, Kristensen JH,
Boza J and Pedersen BK. Effect of glutamine supplementation
on exercise-induced changes in lymphocyte function. Am J
Physiol Cell Physiol 281: C1259-1265, 2001.
216. Krzywkowski K, Petersen EW, Ostrowski K, Link-Amster H,
Boza J, Halkjaer-Kristensen J and Pedersen BK. Effect of glu-
tamine and protein supplementation on exercise-induced
decreases in salivary IgA. J Appl Physiol 91: 832–838, 2001.
217. Kuipers H, van Breda E, Verlaan G and Smeets R. Effects of
oral bovine colostrum supplementation on serum insulin-like
growth factor-I levels. Nutrition 18: 566–567, 2002.
218. Laaksi I, Ruohola J-P, Tuohimaa P, Auvinen A, Haataja R, Pih-
lajamäki H and Ylikomi T. An association of serum vitamin D
concentrations < 40 nmol/L with acute respiratory tract infec-
tion in young Finnish men. Am J Clin Nutr 86: 714–717, 2007.
219. de Labra C, Guimaraes-Pinheiro C, Maseda A, Lorenzo T and
Millán-Calenti JC. Effects of physical exercise interventions in
frail older adults: a systematic review of randomized con-
trolled trials. BMC Geriatr 15: 154, 2015.
220. Lacey JM and Wilmore DW. Is glutamine a conditionally
essential amino acid? Nutr Rev 48: 297–309, 1990.
221. Laing SJ, Oliver SJ, Wilson S, Walters R, Bilzon JLJ and
Walsh NP. Neutrophil-degranulation and lymphocyte-subset
response after 48 hr of fluid and/or energy restriction. Int J
Sport Nutr Exerc Metab 18: 443–456, 2008.
222. Laires MJ and Monteiro C. Exercise, magnesium and immune
function. Magnes Res 21: 92–96, 2008.
223. Lajous M, Rossignol E, Fagherazzi G, Perquier F, Scalbert A,
Clavel-Chapelon F and Boutron-Ruault M-C. Flavonoid intake
and incident hypertension in women. Am J Clin Nutr 103:
1091–1098, 2016.
224. Lancaster GI, Khan Q, Drysdale PT, Wallace F, Jeukendrup
AE, Drayson MT and Gleeson M. Effect of prolonged exercise
and carbohydrate ingestion on type 1 and type 2 T lymphocyte
distribution and intracellular cytokine production in humans. J
Appl Physiol 98: 565–571, 2005.
225. Lau W, Liang M, Sokmen B, Spalding T, Quezada L and
Chuang W. Effect of Panax notoginseng (Chinese ginseng) and
cycling exercise on IL-6 and cortisol in untrained non-diabetic
men. Med Sci Sports Exerc 43: S432, 2011.
226. Lehtonen-Veromaa MKM, Möttönen TT, Nuotio IO, Irjala
KMA, Leino AE and Viikari JSA. Vitamin D and attainment of
peak bone mass among peripubertal Finnish girls: a 3-y
prospective study. Am J Clin Nutr 76: 1446–14453, 2002.
227. Lehtoranta L, Pitkäranta A and Korpela R. Probiotics in respi-
ratory virus infections. Eur J Clin Microbiol Infect Dis 33:
1289–1302, 2014.
228. Leppäluoto J, Rasi S, Martikkala V and Puukka M. Bovine
colostrum supplementation enhances physical performance on
maximal exercise tests. In: International Congress on Sport
Science 2000.
229. Lesourd BM. Nutrition and immunity in the elderly: modifica-
tion of immune responses with nutritional treatments. Am J
Clin Nutr 66: 478S–484S, 1997.
230. Li P, Yin Y-L, Li D, Kim SW and Wu G. Amino acids and
immune function. Br J Nutr 98: 237–252, 2007.
231. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR,
Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagn-
er M, Bals R, Steinmeyer A, Zügel U, Gallo RL, Eisenberg D,
Hewison M, Hollis BW et al. Toll-like receptor triggering of a
vitamin D-mediated human antimicrobial response. Science
311: 1770–1773, 2006.
232. Lomax AR and Calder PC. Probiotics, immune function,
infection and inflammation: a review of the evidence from
studies conducted in humans. Curr Pharm Des 15: 1428–518,
2009.
233. Love DT, Barrett TJ, White MY, Cordwell SJ, Davies MJ and
Hawkins CL. Cellular targets of the myeloperoxidase-derived
oxidant hypothiocyanous acid (HOSCN) and its role in the
inhibition of glycolysis in macrophages. Free Radic Biol Med
94: 88–98, 2016.
234. Luiking YC, Ten Have GAM, Wolfe RR and Deutz NEP. Argi-
nine de novo and nitric oxide production in disease states. Am
J Physiol Endocrinol Metab 303: E1177-1189, 2012.
235. Lukaski HC. Vitamin and mineral status: effects on physical
performance. Nutrition 20: 632–644, 2004.
236. MacLean DA, Graham TE and Saltin B. Branched-chain
amino acids augment ammonia metabolism while attenuating
protein breakdown during exercise. Am J Physiol 267: E1010-
1022, 1994.
237. MacLean DA, Graham TE and Saltin B. Stimulation of muscle
ammonia production during exercise following branched-
chain amino acid supplementation in humans. J Physiol 493:
909–922, 1996.
238. Maecker HT, McCoy JP and Nussenblatt R. Standardizing
immunophenotyping for the Human Immunology Project. Nat
Rev Immunol 12: 191–200, 2012.
239. Maijó M, Clements SJ, Ivory K, Nicoletti C and Carding SR.
Nutrition, diet and immunosenescence. Mech Ageing Dev
136–137: 116–128, 2014.
240. Marchbank T, Davison G, Oakes JR, Ghatei MA, Patterson M,
Moyer MP and Playford RJ. The nutriceutical bovine
colostrum truncates the increase in gut permeability caused by
heavy exercise in athletes. Am J Physiol Gastrointest Liver
Physiol 300: G477-484, 2011.
241. Marín L, Miguélez EM, Villar CJ and Lombó F. Bioavailabili-
ty of dietary polyphenols and gut microbiota metabolism:
antimicrobial properties. BioMed Res Int 2015: 905215, 2015.
242. Marinkovic DM, Kostic-Vucicevic MM, Vukasinovic-Vesic
MD, Stojmenovic TB, Dikic NV, Andjelkovic MS, Djordjevic
BI, Tanaskovic BP and Minic RD. L. helveticus Lafti® L10
supplementation modulates mucosal and humoral immunity in
elite athletes: a randomized double-blinded placebo-controlled
trial. J Strength Cond Res , 2016. Epub
Immunonutrition and Exercise •   45
EIR 23 2017
243. Markofski MM, Flynn MG, Carrillo AE, Armstrong CLH,
Campbell WW and Sedlock DA. Resistance exercise training-
induced decrease in circulating inflammatory CD14+CD16+
monocyte percentage without weight loss in older adults. Eur J
Appl Physiol 114: 1737–1748, 2014.
244. Marques CG, Santos VC, Levada-Pires AC, Jacintho TM, Gor-
jão R, Pithon-Curi TC and Cury-Boaventura MF. Effects of
DHA-rich fish oil supplementation on the lipid profile, mark-
ers of muscle damage, and neutrophil function in wheelchair
basketball athletes before and after acute exercise. Appl Physi-
ol Nutr Metab 40: 596–604, 2015.
245. Marranzino G, Villena J, Salva S and Alvarez S. Stimulation of
macrophages by immunobiotic Lactobacillus strains: influence
beyond the intestinal tract. Microbiol Immunol 56: 771–781,
2012.
246. Mårtensson S, Nordebo K and Malm C. High training volumes
are associated with a low number of self-reported sick days in
elite endurance athletes. J Sports Sci Med 13: 929–933, 2014.
247. Martí A, Marcos A and Martínez JA. Obesity and immune
function relationships. Obes Rev 2: 131–140, 2001.
248. Martineau AR, Wilkinson RJ, Wilkinson KA, Newton SM,
Kampmann B, Hall BM, Packe GE, Davidson RN, Eldridge
SM, Maunsell ZJ, Rainbow SJ, Berry JL and Griffiths CJ. A
single dose of vitamin D enhances immunity to mycobacteria.
Am J Respir Crit Care Med 176: 208–213, 2007.
249. Martinez-Gomez D, Eisenmann JC, Gomez-Martinez S, Veses
A, Romeo J, Veiga OL, Marcos A and AFINOS Study Group.
Associations of physical activity and fitness with adipocy-
tokines in adolescents: the AFINOS Study. Nutr Metab Car-
diovasc Dis 22: 252–259, 2012.
250. Martinez-Gomez D, Eisenmann JC, Wärnberg J, Gomez-Mar-
tinez S, Veses A, Veiga OL, Marcos A and AFINOS Study
Group. Associations of physical activity, cardiorespiratory fit-
ness and fatness with low-grade inflammation in adolescents:
the AFINOS Study. Int J Obes 34: 1501–1507, 2010.
251. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D,
Schilter HC, Rolph MS, Mackay F, Artis D, Xavier RJ, Teix-
eira MM and Mackay CR. Regulation of inflammatory
responses by gut microbiota and chemoattractant receptor
GPR43. Nature 461: 1282–1286, 2009.
252. McAnulty LS, Nieman DC, Dumke CL, Shooter LA, Henson
DA, Utter AC, Milne G and McAnulty SR. Effect of blueberry
ingestion on natural killer cell counts, oxidative stress, and
inflammation prior to and after 2.5 h of running. Appl Physiol
Nutr Metab 36: 976–984, 2011.
253. McClung JP, Gaffney-Stomberg E and Lee JJ. Female athletes:
a population at risk of vitamin and mineral deficiencies affect-
ing health and performance. J Trace Elem Med Biol 28: 388–
392, 2014.
254. McFarlin BK, Flynn MG, Stewart LK and Timmerman KL.
Carbohydrate intake during endurance exercise increases natu-
ral killer cell responsiveness to IL-2. J Appl Physiol 96: 271–
275, 2004.
255. Mero A, Kähkönen J, Nykänen T, Parviainen T, Jokinen I,
Takala T, Nikula T, Rasi S and Leppäluoto J. IGF-I, IgA, and
IgG responses to bovine colostrum supplementation during
training. J Appl Physiol 93: 732–739, 2002.
256. Mero A, Miikkulainen H, Riski J, Pakkanen R, Aalto J and
Takala T. Effects of bovine colostrum supplementation on
serum IGF-I, IgG, hormone, and saliva IgA during training. J
Appl Physiol 83: 1144–1151, 1997.
257. Micheletti A, Rossi R and Rufini S. Zinc status in athletes:
relation to diet and exercise. Sports Med 31: 577–582, 2001.
258. Miller BF, Olesen JL, Hansen M, Døssing S, Crameri RM,
Welling RJ, Langberg H, Flyvbjerg A, Kjaer M, Babraj JA,
Smith K and Rennie MJ. Coordinated collagen and muscle
protein synthesis in human patella tendon and quadriceps mus-
cle after exercise. J Physiol 567: 1021–1033, 2005.
259. Mitchell JB, Pizza FX, Paquet A, Davis BJ, Forrest MB and
Braun WA. Influence of carbohydrate status on immune
responses before and after endurance exercise. J Appl Physiol
84: 1917–1925, 1998.
260. Moberg M, Apró W, Ekblom B, van Hall G, Holmberg H-C
and Blomstrand E. Activation of mTORC1 by leucine is poten-
tiated by branched-chain amino acids and even more so by
essential amino acids following resistance exercise. Am J
Physiol Cell Physiol 310: C874-884, 2016.
261. Mondello S, Italiano D, Giacobbe MS, Mondello P, Trimarchi
G, Aloisi C, Bramanti P and Spina E. Glutamine-supplemented
total parenteral nutrition improves immunological status in
anorectic patients. Nutrition 26: 677–681, 2010.
262. Mooren FC, Golf SW and Völker K. Effect of magnesium on
granulocyte function and on the exercise induced inflammato-
ry response. Magnes Res 16: 49–58, 2003.
263. Mooren FC, Krüger K, Völker K, Golf SW, Wadepuhl M and
Kraus A. Oral magnesium supplementation reduces insulin
resistance in non-diabetic subjects - a double-blind, placebo-
controlled, randomized trial. Diabetes Obes Metab 13: 281–
284, 2011.
264. Morrison SA, Cheung SS and Cotter JD. Bovine colostrum,
training status, and gastrointestinal permeability during exer-
cise in the heat: a placebo-controlled double-blind study. Appl
Physiol Nutr Metab 39: 1070–1082, 2014.
265. Mountjoy M, Sundgot-Borgen J, Burke L, Carter S, Constanti-
ni N, Lebrun C, Meyer N, Sherman R, Steffen K, Budgett R
and Ljungqvist A. The IOC consensus statement: beyond the
female athlete triad--Relative Energy Deficiency in Sport
(RED-S). Br J Sports Med 48: 491–497, 2014.
266. Mulder AM, Connellan PA, Oliver CJ, Morris CA and Steven-
son LM. Bovine lactoferrin supplementation supports immune
and antioxidant status in healthy human males. Nutr Res 28:
583–589, 2008.
267. Murphy WJ, Parham P and Miller JS. NK cells--from bench to
clinic. Biol Blood Marrow Transplant 18: S2-7, 2012.
268. Myburgh KH. Polyphenol supplementation: benefits for exer-
cise performance or oxidative stress? Sports Med 44 Suppl 1:
S57-70, 2014.
269. Nairz M, Schroll A, Demetz E, Tancevski I, Theurl I and Weiss
G. “Ride on the ferrous wheel”--the cycle of iron in
macrophages in health and disease. Immunobiology 220: 280–
294, 2015.
270. Nehlsen-Cannarella SL, Fagoaga OR, Nieman DC, Henson
DA, Butterworth DE, Schmitt RL, Bailey EM, Warren BJ,
Utter A and Davis JM. Carbohydrate and the cytokine
response to 2.5 h of running. J Appl Physiol 82: 1662–1667,
1997.
271. Neville V, Gleeson M and Folland JP. Salivary IgA as a risk
factor for upper respiratory infections in elite professional ath-
letes. Med Sci Sports Exerc 40: 1228–1236, 2008.
272. Nielsen AR and Pedersen BK. The biological roles of exercise-
induced cytokines: IL-6, IL-8, and IL-15. Appl Physiol Nutr
Metab 32: 833–839, 2007.
46 •   Immunonutrition and Exercise
EIR 23 2017
273. Nieman DC. Exercise, upper respiratory tract infection, and
the immune system. Med Sci Sports Exerc 26: 128–139, 1994.
274. Nieman DC. Exercise, infection, and immunity. Int J Sports
Med 15 Suppl 3: S131-141, 1994.
275. Nieman DC. Exercise immunology: nutritional countermea-
sures. Can J Appl Physiol 26: S45-55, 2001.
276. Nieman DC. Immunonutrition support for athletes. Nutr Rev
66: 310–320, 2008.
277. Nieman DC. Quercetin’s bioactive effects in human athletes.
Curr Top Nutraceut Res 33–44, 2010.
278. Nieman DC. Flavonoids. In: Nutritional Supplements in Sport,
Exercise, and Health, An A-Z Guide. Castell LM, Stear SJ,
Burke LM, eds. . Oxford, UK: Routledge, 2015.
279. Nieman DC, Davis JM, Brown VA, Henson DA, Dumke CL,
Utter AC, Vinci DM, Downs MF, Smith JC, Carson J, Brown
A, McAnulty SR and McAnulty LS. Influence of carbohydrate
ingestion on immune changes after 2 h of intensive resistance
training. J Appl Physiol 96: 1292–8, 2004.
280. Nieman DC, Fagoaga OR, Butterworth DE, Warren BJ, Utter
A, Davis JM, Henson DA and Nehlsen-Cannarella SL. Carbo-
hydrate supplementation affects blood granulocyte and mono-
cyte trafficking but not function after 2.5 h or running. Am J
Clin Nutr 66: 153–159, 1997.
281. Nieman DC, Gillitt ND, Knab AM, Shanely RA, Pappan KL,
Jin F and Lila MA. Influence of a polyphenol-enriched protein
powder on exercise-induced inflammation and oxidative stress
in athletes: a randomized trial using a metabolomics approach.
PloS One 8: e72215, 2013.
282. Nieman DC, Gillitt ND, Sha W, Meaney MP, John C, Pappan
KL and Kinchen JM. Metabolomics-based analysis of banana
and pear ingestion on exercise performance and recovery. J
Proteome Res 14: 5367–5377, 2015.
283. Nieman DC, Henson DA, Austin MD and Sha W. Upper respi-
ratory tract infection is reduced in physically fit and active
adults. Br J Sports Med 45: 987–992, 2011.
284. Nieman DC, Henson DA, Fagoaga OR, Utter AC, Vinci DM,
Davis JM and Nehlsen-Cannarella SL. Change in salivary IgA
following a competitive marathon race. Int J Sports Med 23:
69–75, 2002.
285. Nieman DC, Henson DA, Garner EB, Butterworth DE, Warren
BJ, Utter A, Davis JM, Fagoaga OR and Nehlsen-Cannarella
SL. Carbohydrate affects natural killer cell redistribution but
not activity after running. Med Sci Sports Exerc 29: 1318–
1324, 1997.
286. Nieman DC, Henson DA, Gusewitch G, Warren BJ, Dotson
RC, Butterworth DE and Nehlsen-Cannarella SL. Physical
activity and immune function in elderly women. Med Sci
Sports Exerc 25: 823–831, 1993.
287. Nieman DC, Henson DA, McAnulty SR, Jin F and Maxwell
KR. n-3 polyunsaturated fatty acids do not alter immune and
inflammation measures in endurance athletes. Int J Sport Nutr
Exerc Metab 19: 536–546, 2009.
288. Nieman DC, Nehlsen-Cannarella SL, Fagoaga OR, Henson
DA, Shannon M, Davis JM, Austin MD, Hisey CL, Holbeck
JC, Hjertman JM, Bolton MR and Schilling BK. Immune
response to two hours of rowing in elite female rowers. Int J
Sports Med 20: 476–481, 1999.
289. Nieman DC, Nehlsen-Cannarella SL, Fagoaga OR, Henson
DA, Utter A, Davis JM, Williams F and Butterworth DE.
Effects of mode and carbohydrate on the granulocyte and
monocyte response to intensive, prolonged exercise. J Appl
Physiol 84: 1252–1259, 1998.
290. Niemelä M, Kangastupa P, Niemelä O, Bloigu R and Juvonen
T. Acute changes in inflammatory biomarker levels in recre-
ational runners participating in a marathon or half-marathon.
Sports Med - Open 2: 21, 2016.
291. Norderhaug IN, Johansen FE, Schjerven H and Brandtzaeg P.
Regulation of the formation and external transport of secretory
immunoglobulins. Crit Rev Immunol 19: 481–508, 1999.
292. Northoff H, Weinstock C and Berg A. The cytokine response
to strenuous exercise. Int J Sports Med 15 Suppl 3: S167-171,
1994.
293. Notarangelo LD and Badolato R. Leukocyte trafficking in pri-
mary immunodeficiencies. J Leukoc Biol 85: 335–343, 2009.
294. Okutsu M, Ishii K, Niu KJ and Nagatomi R. Cortisol-induced
CXCR4 augmentation mobilizes T lymphocytes after acute
physical stress. Am J Physiol Regul Integr Comp Physiol 288:
R591-599, 2005.
295. Oliver SJ, Laing SJ, Wilson S, Bilzon JLJ, Walters R and
Walsh NP. Salivary immunoglobulin A response at rest and
after exercise following a 48 h period of fluid and/or energy
restriction. Br J Nutr 97: 1109–16, 2007.
296. Ortega E, Giraldo E, Hinchado MD, Martínez M, Ibáñez S,
Cidoncha A, Collazos ME and García JJ. Role of Hsp72 and
norepinephrine in the moderate exercise-induced stimulation
of neutrophils’ microbicide capacity. Eur J Appl Physiol 98:
250–5, 2006.
297. Outram S and Stewart B. Doping through supplement use: a
review of the available empirical data. Int J Sport Nutr Exerc
Metab 25: 54–9, 2015.
298. Owens DJ, Fraser WD and Close GL. Vitamin D and the ath-
lete: emerging insights. Eur J Sport Sci 15: 73–84, 2015.
299. Owens DJ, Sharples AP, Polydorou I, Alwan N, Donovan T,
Tang J, Fraser WD, Cooper RG, Morton JP, Stewart C and
Close GL. A systems-based investigation into vitamin D and
skeletal muscle repair, regeneration, and hypertrophy. Am J
Physiol Endocrinol Metab 309: E1019-1031, 2015.
300. Pae M, Meydani SN and Wu D. The role of nutrition in
enhancing immunity in aging. Aging Dis 3: 91–129, 2012.
301. Paesano R, Pacifici E, Benedetti S, Berlutti F, Frioni A, Poli-
meni A and Valenti P. Safety and efficacy of lactoferrin versus
ferrous sulphate in curing iron deficiency and iron deficiency
anaemia in hereditary thrombophilia pregnant women: an
interventional study. Biometals 27: 999–1006, 2014.
302. Panagiotakos DB, Kokkinos P, Manios Y and Pitsavos C.
Physical activity and markers of inflammation and thrombosis
related to coronary heart disease. Prev Cardiol 7: 190–194,
2004.
303. Parry-Billings M, Evans J, Calder PC and Newsholme EA.
Does glutamine contribute to immunosuppression after major
burns? Lancet 336: 523–525, 1990.
304. Pascoe AR, Fiatarone Singh MA and Edwards KM. The effects
of exercise on vaccination responses: a review of chronic and
acute exercise interventions in humans. Brain Behav Immun
39: 33–41, 2014.
305. Pedersen BK. The anti-inflammatory effect of exercise: its role
in diabetes and cardiovascular disease control. Essays
Biochem 42: 105–117, 2006.
306. Pedersen BK and Bruunsgaard H. How physical exercise
influences the establishment of infections. Sports Med 19:
393–400, 1995.
307. Pedersen BK and Saltin B. Evidence for prescribing exercise
as therapy in chronic disease. Scand J Med Sci Sports 16
Suppl 1: 3–63, 2006.
Immunonutrition and Exercise •   47
EIR 23 2017
308. Pedersen BK, Steensberg A, Fischer C, Keller C, Keller P,
Plomgaard P, Febbraio M and Saltin B. Searching for the exer-
cise factor: is IL-6 a candidate? J Muscle Res Cell Motil 24:
113–119, 2003.
309. Pedersen BK, Steensberg A and Schjerling P. Muscle-derived
interleukin-6: possible biological effects. J Physiol 536: 329–
337, 2001.
310. Pedersen BK and Toft AD. Effects of exercise on lymphocytes
and cytokines. Br J Sports Med 34: 246–251, 2000.
311. Petersen AMW and Pedersen BK. The role of IL-6 in mediat-
ing the anti-inflammatory effects of exercise. J Physiol Phar-
macol 57 Suppl 10: 43–51, 2006.
312. Phillips SM, Tipton KD, Aarsland A, Wolf SE and Wolfe RR.
Mixed muscle protein synthesis and breakdown after resist-
ance exercise in humans. Am J Physiol 273: E99-107, 1997.
313. Phillips SM and Van Loon LJC. Dietary protein for athletes:
from requirements to optimum adaptation. J Sports Sci 29
Suppl 1: S29-38, 2011.
314. Playford RJ, MacDonald CE, Calnan DP, Floyd DN, Podas T,
Johnson W, Wicks AC, Bashir O and Marchbank T. Co-admin-
istration of the health food supplement, bovine colostrum,
reduces the acute non-steroidal anti-inflammatory drug-
induced increase in intestinal permeability. Clin Sci 100: 627–
633, 2001.
315. Playford RJ, Woodman AC, Clark P, Watanapa P, Vesey D,
Deprez PH, Williamson RC and Calam J. Effect of luminal
growth factor preservation on intestinal growth. Lancet 341:
843–848, 1993.
316. Poortmans JR, Siest G, Galteau MM and Houot O. Distribu-
tion of plasma amino acids in humans during submaximal pro-
longed exercise. Eur J Appl Physiol 32: 143–147, 1974.
317. Powers SK, Duarte J, Kavazis AN and Talbert EE. Reactive
oxygen species are signalling molecules for skeletal muscle
adaptation. Exp Physiol 95: 1–9, 2010.
318. Powers SK, Ji LL, Kavazis AN and Jackson MJ. Reactive oxy-
gen species: impact on skeletal muscle. Compr Physiol 1:
941–969, 2011.
319. Prasad AS. Discovery of human zinc deficiency: its impact on
human health and disease. Adv Nutr 4: 176–90, 2013.
320. Proctor GB, Garrett JR, Carpenter GH and Ebersole LE. Sali-
vary secretion of immunoglobulin A by submandibular glands
in response to autonomimetic infusions in anaesthetised rats. J
Neuroimmunol 136: 17–24, 2003.
321. Prosser C, Stelwagen K, Cummins R, Guerin P, Gill N and
Milne C. Reduction in heat-induced gastrointestinal hyperper-
meability in rats by bovine colostrum and goat milk powders. J
Appl Physiol 96: 650–654, 2004.
322. Pyne DB, Hopkins WG, Batterham AM, Gleeson M and Frick-
er PA. Characterising the individual performance responses to
mild illness in international swimmers. Br J Sports Med 39:
752–756, 2005.
323. Pyne DB, West NP, Cox AJ and Cripps AW. Probiotics supple-
mentation for athletes - clinical and physiological effects. Eur
J Sport Sci 15: 63–72, 2015.
324. Quindry J, Dumke C, Slivka D and Ruby B. Impact of extreme
exercise at high altitude on oxidative stress in humans. J Phys-
iol 594: 5093–5104, 2016.
325. Quindry JC, Stone WL, King J and Broeder CE. The effects of
acute exercise on neutrophils and plasma oxidative stress. Med
Sci Sports Exerc 35: 1139–1145, 2003.
326. Radak Z, Suzuki K, Higuchi M, Balogh L, Boldogh I and
Koltai E. Physical exercise, reactive oxygen species and neu-
roprotection. Free Radic Biol Med 98: 187–96, 2016.
327. Raizel R, Leite JSM, Hypólito TM, Coqueiro AY, Newsholme
P, Cruzat VF and Tirapegui J. Determination of the anti-
inflammatory and cytoprotective effects of l-glutamine and l-
alanine, or dipeptide, supplementation in rats submitted to
resistance exercise. Br J Nutr 116: 470–9, 2016.
328. Rayman MP. Selenium and human health. Lancet 379: 1256–
1268, 2012.
329. Rayner BS, Love DT and Hawkins CL. Comparative reactivity
of myeloperoxidase-derived oxidants with mammalian cells.
Free Radic Biol Med 71: 240–255, 2014.
330. Reale M, Boscolo P, Bellante V, Tarantelli C, Di Nicola M,
Forcella L, Li Q, Morimoto K and Muraro R. Daily intake of
Lactobacillus casei Shirota increases natural killer cell activity
in smokers. Br J Nutr 108: 308–314, 2012.
331. Reid MB and Durham WJ. Generation of reactive oxygen and
nitrogen species in contracting skeletal muscle: potential
impact on aging. Ann N Y Acad Sci 959: 108–116, 2002.
332. Rennie MJ, Edwards RH, Krywawych S, Davies CT, Halliday
D, Waterlow JC and Millward DJ. Effect of exercise on protein
turnover in man. Clin Sci 61: 627–639, 1981.
333. Reznikov EA, Comstock SS, Yi C, Contractor N and Donovan
SM. Dietary bovine lactoferrin increases intestinal cell prolif-
eration in neonatal piglets. J Nutr 144: 1401–1408, 2014.
334. Rocha DM, Caldas AP, Oliveira LL, Bressan J and Hermsdorff
HH. Saturated fatty acids trigger TLR4-mediated inflammato-
ry response. Atherosclerosis 244: 211–215, 2016.
335. Rohde T, Asp S, MacLean DA and Pedersen BK. Competitive
sustained exercise in humans, lymphokine activated killer cell
activity, and glutamine--an intervention study. Eur J Appl
Physiol 78: 448–453, 1998.
336. Rohde T, MacLean DA, Hartkopp A and Pedersen BK. The
immune system and serum glutamine during a triathlon. Eur J
Appl Physiol 74: 428–434, 1996.
337. Rohde T, MacLean DA and Pedersen BK. Effect of glutamine
supplementation on changes in the immune system induced by
repeated exercise. Med Sci Sports Exerc 30: 856–862, 1998.
338. Romagnani S. Lymphokine production by human T cells in
disease states. Annu Rev Immunol 12: 227–257, 1994.       
339. Romeo J, Martinez-Gomez D, Diaz LE, Gómez-Martinez S,
Marti A, Martin-Matillas M, Puertollano MA, Veiga OL, Mar-
tinez JA, Wärnberg J, Zapatera B, Garagorri JM, Morandé G,
Campoy C, Moreno LA, Marcos A and EVASYON Study
Group. Changes in cardiometabolic risk factors, appetite-con-
trolling hormones and cytokines after a treatment program in
overweight adolescents: preliminary findings from the
EVASYON study. Pediatr Diabetes 12: 372–380, 2011.
340. Rose W. The nutritive significance of the amino acids. Physiol
Rev 109–136, 1938.
341. Roth E, Funovics J, Mühlbacher F, Schemper M, Mauritz W,
Sporn P and Fritsch A. Metabolic disorders in severe abdomi-
nal sepsis: glutamine deficiency in skeletal muscle. Clin Nutr
1: 25–41, 1982.
342. Sabetta JR, DePetrillo P, Cipriani RJ, Smardin J, Burns LA and
Landry ML. Serum 25-hydroxyvitamin d and the incidence of
acute viral respiratory tract infections in healthy adults. PloS
One 5: e11088, 2010.
48 •   Immunonutrition and Exercise
EIR 23 2017
343. Sacerdote P, Mussano F, Franchi S, Panerai AE, Bussolati G,
Carossa S, Bartorelli A and Bussolati B. Biological compo-
nents in a standardized derivative of bovine colostrum. J Dairy
Sci 96: 1745–1754, 2013.
344. Samieri C, Sun Q, Townsend MK, Rimm EB and Grodstein F.
Dietary flavonoid intake at midlife and healthy aging in
women. Am J Clin Nutr 100: 1489–1497, 2014.
345. Sánchez-Patán F, Monagas M, Moreno-Arribas MV and Bar-
tolomé B. Determination of microbial phenolic acids in human
faeces by UPLC-ESI-TQ MS. J Agric Food Chem 59: 2241–
2247, 2011.
346. Santos VC, Levada-Pires AC, Alves SR, Pithon-Curi TC, Curi R
and Cury-Boaventura MF. Effects of DHA-rich fish oil supple-
mentation on lymphocyte function before and after a marathon
race. Int J Sport Nutr Exerc Metab 23: 161–169, 2013.
347. Sarkar D and Fisher PB. Molecular mechanisms of aging-asso-
ciated inflammation. Cancer Lett 236: 13–23, 2006.
348. Saur P, Joneleit M, Tölke H, Pudel V, Niedmann P and Kettler.
Evaluation of the magnesium status in athletes. 53:72-78,
2002. German J Sports Med 53: 72–78, 2002.
349. Schapowal A, Klein P and Johnston SL. Echinacea reduces the
risk of recurrent respiratory tract infections and complications:
a meta-analysis of randomized controlled trials. Adv Ther 32:
187–200, 2015.
350. Scharhag J, Meyer T, Auracher M, Gabriel HH and Kinder-
mann W. Effects of graded carbohydrate supplementation on
the immune response in cycling. Med Sci Sports Exerc 38:
286–292, 2006.
351. Scharhag J, Meyer T, Gabriel HHW, Auracher M and Kinder-
mann W. Mobilization and oxidative burst of neutrophils are
influenced by carbohydrate supplementation during prolonged
cycling in humans. Eur J Appl Physiol 87: 584–587, 2002.
352. Scheiermann C, Kunisaki Y, Lucas D, Chow A, Jang J-E,
Zhang D, Hashimoto D, Merad M and Frenette PS. Adrenergic
nerves govern circadian leukocyte recruitment to tissues.
Immunity 37: 290–301, 2012.
353. Schoop R, Büechi S and Suter A. Open, multicenter study to
evaluate the tolerability and efficacy of Echinaforce Forte
tablets in athletes. Adv Ther 23: 823–833, 2006.
354. Science M, Johnstone J, Roth DE, Guyatt G and Loeb M. Zinc
for the treatment of the common cold: a systematic review and
meta-analysis of randomized controlled trials. Can Med Assoc
J 184: E551-561, 2012.
355. Sebastian RS, Wilkinson Enns C, Goldman JD, Martin CL,
Steinfeldt LC, Murayi T and Moshfegh AJ. A new database
facilitates characterization of flavonoid intake, sources, and
positive associations with diet quality among US adults. J Nutr
145: 1239–1248, 2015.
356. Seligman PA, Kovar J and Gelfand EW. Lymphocyte prolifera-
tion is controlled by both iron availability and regulation of
iron uptake pathways. Pathobiology 60: 19–26, 1992.
357. Senchina DS. Athletics and herbal supplements. Am Sci 101:
134–141, 2013.
358. Senchina DS, Hallam JE and Cheney DJ. Multidisciplinary
perspectives on mechanisms of activity of popular immune-
enhancing herbal supplements used by athletes. Front Biol 8:
78–100, 2013.
359. Senchina DS, Shah NB, Doty DM, Sanderson CR and Hallam
JE. Herbal supplements and athlete immune function--what’s
proven, disproven, and unproven? Exerc Immunol Rev 15:
66–106, 2009.
360. Sergeant S, Rahbar E and Chilton FH. Gamma-linolenic acid,
dihommo-gamma linolenic, eicosanoids and inflammatory
processes. Eur J Pharmacol 785: 77–86, 2016.
361. Sheridan PA, Paich HA, Handy J, Karlsson EA, Hudgens MG,
Sammon AB, Holland LA, Weir S, Noah TL and Beck MA.
Obesity is associated with impaired immune response to
influenza vaccination in humans. Int J Obes 2005 36: 1072–
1077, 2012.
362. Shing CM, Peake J, Suzuki K, Okutsu M, Pereira R, Steven-
son L, Jenkins DG and Coombes JS. Effects of bovine
colostrum supplementation on immune variables in highly
trained cyclists. J Appl Physiol 102: 1113–1122, 2007.
363. Shing CM, Peake JM, Suzuki K, Jenkins DG and Coombes JS.
A pilot study: bovine colostrum supplementation and hormon-
al and autonomic responses to competitive cycling. J Sports
Med Phys Fitness 53: 490–501, 2013.
364. Shulzhenko N, Morgun A, Hsiao W, Battle M, Yao M,
Gavrilova O, Orandle M, Mayer L, Macpherson AJ, McCoy
KD, Fraser-Liggett C and Matzinger P. Crosstalk between B
lymphocytes, microbiota and the intestinal epithelium governs
immunity versus metabolism in the gut. Nat Med 17: 1585–
1593, 2011.
365. Simpson RJ, Kunz H, Agha N and Graff R. Exercise and the
regulation of immune functions. Prog Mol Biol Transl Sci 135:
355–380, 2015.
366. Simpson RJ, Lowder TW, Spielmann G, Bigley AB, LaVoy
EC and Kunz H. Exercise and the aging immune system. Age-
ing Res Rev 11: 404–420, 2012.
367. Singh M and Das RR. Zinc for the common cold. Cochrane
Database Syst Rev CD001364, 2013.
368. Sly LM, Lopez M, Nauseef WM and Reiner NE. 1alpha,25-
Dihydroxyvitamin D3-induced monocyte antimycobacterial
activity is regulated by phosphatidylinositol 3-kinase and
mediated by the NADPH-dependent phagocyte oxidase. J Biol
Chem 276: 35482–93, 2001.
369. Smith AJ, Vollmer-Conna U, Bennett B, Hickie IB and Lloyd
AR. Influences of distress and alcohol consumption on the
development of a delayed-type hypersensitivity skin test
response. Psychosom Med 66: 614–619, 2004.
370. Smith TP, Kennedy SL and Fleshner M. Influence of age and
physical activity on the primary in vivo antibody and T cell-
mediated responses in men. J Appl Physiol 97: 491–498, 2004.
371. Solanki I, Parihar P, Mansuri ML and Parihar MS. Flavonoid-
based therapies in the early management of neurodegenerative
diseases. Adv Nutr 6: 64–72, 2015.
372. Somerville VS, Braakhuis AJ and Hopkins WG. Effect of
flavonoids on upper respiratory tract infections and immune
function: A systematic review and meta-analysis. Adv Nutr 7:
488–497, 2016.
373. Song Q-H, Xu R-M, Zhang Q-H, Shen G-Q, Ma M, Zhao X-P,
Guo Y-H and Wang Y. Glutamine supplementation and
immune function during heavy load training. Int J Clin Phar-
macol Ther 53: 372–376, 2015.
374. Spence L, Brown WJ, Pyne DB, Nissen MD, Sloots TP,
McCormack JG, Locke AS and Fricker PA. Incidence, etiolo-
gy, and symptomatology of upper respiratory illness in elite
athletes. Med Sci Sports Exerc 39: 577–586, 2007.
375. Stevenson JL, Krishnan S, Inigo MM, Stamatikos AD, Gonza-
les JU and Cooper JA. Echinacea-based dietary supplement
does not increase maximal aerobic capacity in endurance-
trained men and women. J Diet Suppl 13: 324–338, 2016.
Immunonutrition and Exercise •   49
EIR 23 2017
376. Stoffaneller R and Morse NL. A review of dietary selenium
intake and selenium status in Europe and the Middle East.
Nutrients 7: 1494–1537, 2015.
377. Strydom N and Rankin SM. Regulation of circulating neu-
trophil numbers under homeostasis and in disease. J Innate
Immun 5: 304–314, 2013.
378. Suratt BT, Petty JM, Young SK, Malcolm KC, Lieber JG, Nick
JA, Gonzalo J-A, Henson PM and Worthen GS. Role of the
CXCR4/SDF-1 chemokine axis in circulating neutrophil
homeostasis. Blood 104: 565–571, 2004.
379. Sureda A, Tejada S, Bibiloni M del M, Tur JA and Pons A.
Polyphenols: well beyond the antioxidant capacity: polyphe-
nol supplementation and exercise-induced oxidative stress and
inflammation. Curr Pharm Biotechnol 15: 373–379, 2014.
380. Svendsen IS, Taylor IM, Tønnessen E, Bahr R and Gleeson M.
Training-related and competition-related risk factors for respi-
ratory tract and gastrointestinal infections in elite cross-coun-
try skiers. Br J Sports Med 50: 809–815, 2016.
381. Takele Y, Adem E, Getahun M, Tajebe F, Kiflie A, Hailu A,
Raynes J, Mengesha B, Ayele TA, Shkedy Z, Lemma M, Diro
E, Toulza F, Modolell M, Munder M, Müller I and Kropf P.
Malnutrition in healthy individuals results in increased mixed
cytokine profiles, altered neutrophil subsets and function. PloS
One 11: e0157919, 2016.
382. Tartibian B, Maleki BH and Abbasi A. The effects of ingestion
of omega-3 fatty acids on perceived pain and external symp-
toms of delayed onset muscle soreness in untrained men. Clin
J Sport Med 19: 115–119, 2009.
383. Tartibian B, Maleki BH and Abbasi A. Omega-3 fatty acids
supplementation attenuates inflammatory markers after eccen-
tric exercise in untrained men. Clin J Sport Med 21: 131–137,
2011.
384. Thomas DT, Erdman KA and Burke LM. Position of the Acad-
emy of nutrition and dietetics, dietitians of Canada, and the
American college of sports medicine: nutrition and athletic
performance. J Acad Nutr Diet 116: 501–528, 2016.
385. Timmerman KL, Flynn MG, Coen PM, Markofski MM and
Pence BD. Exercise training-induced lowering of inflammato-
ry (CD14+CD16+) monocytes: a role in the anti-inflammatory
influence of exercise? J Leukoc Biol 84: 1271–1278, 2008.
386. Tiollier E, Chennaoui M, Gomez-Merino D, Drogou C, Filaire
E and Guezennec CY. Effect of a probiotics supplementation
on respiratory infections and immune and hormonal parame-
ters during intense military training. Mil Med 172: 1006–1011,
2007.
387. Todd DA, Gulledge TV, Britton ER, Oberhofer M, Leyte-Lugo
M, Moody AN, Shymanovich T, Grubbs LF, Juzumaite M,
Graf TN, Oberlies NH, Faeth SH, Laster SM and Cech NB.
Ethanolic echinacea purpurea extracts contain a mixture of
cytokine-suppressive and cytokine-inducing compounds,
including some that originate from endophytic bacteria. PloS
One 10: e0124276, 2015.
388. Toft AD, Thorn M, Ostrowski K, Asp S, Moller K, Iversen S,
Hermann C, Sondergaard SR and Pedersen BK. N-3 polyun-
saturated fatty acids do not affect cytokine response to strenu-
ous exercise. J Appl Physiol 89: 2401–2406, 2000.
389. Tomasi TB, Trudeau FB, Czerwinski D and Erredge S.
Immune parameters in athletes before and after strenuous
exercise. J Clin Immunol 2: 173–178, 1982.
390. Tomaszewski M, Charchar FJ, Przybycin M, Crawford L, Wal-
lace AM, Gosek K, Lowe GD, Zukowska-Szczechowska E,
Grzeszczak W, Sattar N and Dominiczak AF. Strikingly low
circulating CRP concentrations in ultramarathon runners inde-
pendent of markers of adiposity: how low can you go? Arte-
rioscler Thromb Vasc Biol 23: 1640–1644, 2003.
391. Tresserra-Rimbau A, Guasch-Ferré M, Salas-Salvadó J, Tole-
do E, Corella D, Castañer O, Guo X, Gómez-Gracia E, Lapetra
J, Arós F, Fiol M, Ros E, Serra-Majem L, Pintó X, Fitó M,
Babio N, Martínez-González MA, Sorli JV, López-Sabater
MC et al. Intake of total polyphenols and some classes of
polyphenols is inversely associated with diabetes in elderly
people at high cardiovascular disease risk. J Nutr 146: 767–
777, 2016.
392. Troost FJ, Steijns J, Saris WH and Brummer RJ. Gastric diges-
tion of bovine lactoferrin in vivo in adults. J Nutr 131: 2101–
2104, 2001.
393. Tsukumo DM, Carvalho BM, Carvalho Filho MA and Saad
MJA. Translational research into gut microbiota: new horizons
on obesity treatment: updated 2014. Arch Endocrinol Metab
59: 154–160, 2015.
394. Turner JE. Is immunosenescence influenced by our lifetime
“dose” of exercise? Biogerontology 17: 581–602, 2016.
395. Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y and
Ida H. Randomized trial of vitamin D supplementation to pre-
vent seasonal influenza A in schoolchildren. Am J Clin Nutr
91: 1255–1260, 2010.
396. Urso ML and Clarkson PM. Oxidative stress, exercise, and
antioxidant supplementation. Toxicology 189: 41–54, 2003.
397. Van Hall G, MacLean DA, Saltin B and Wagenmakers AJ.
Muscle protein degradation and amino acid metabolism during
prolonged knee-extensor exercise in humans. Clin Sci 97:
557–567, 1999.
398. Vasto S, Candore G, Balistreri CR, Caruso M, Colonna-
Romano G, Grimaldi MP, Listi F, Nuzzo D, Lio D and Caruso
C. Inflammatory networks in ageing, age-related diseases and
longevity. Mech Ageing Dev 128: 83–91, 2007.
399. Vogel HJ. Lactoferrin, a bird’s eye view. Biochem Cell Biol
90: 233–244, 2012.
400. Wagenmakers AJ, Brouns F, Saris WH and Halliday D. Oxida-
tion rates of orally ingested carbohydrates during prolonged
exercise in men. J Appl Physiol 75: 2774–2780, 1993.
401. Walrand S, Moreau K, Caldefie F, Tridon A, Chassagne J,
Portefaix G, Cynober L, Beaufrère B, Vasson MP and Boirie Y.
Specific and nonspecific immune responses to fasting and
refeeding differ in healthy young adult and elderly persons.
Am J Clin Nutr 74: 670–678, 2001.
402. Walsh NP, Bishop NC, Blackwell J, Wierzbicki SG and Mon-
tague JC. Salivary IgA response to prolonged exercise in a
cold environment in trained cyclists. Med Sci Sports Exerc 34:
1632–1637, 2002.
403. Walsh NP, Blannin AK, Bishop NC, Robson PJ and Gleeson
M. Effect of oral glutamine supplementation on human neu-
trophil lipopolysaccharide-stimulated degranulation following
prolonged exercise. Int J Sport Nutr Exerc Metab 10: 39–50,
2000.
404. Walsh NP, Blannin AK, Clark AM, Cook L, Robson PJ and
Gleeson M. The effects of high-intensity intermittent exercise
on saliva IgA, total protein and alpha-amylase. J Sports Sci 17:
129–134, 1999.
50 •   Immunonutrition and Exercise
EIR 23 2017
405. Walsh NP, Gleeson M, Pyne DB, Nieman DC, Dhabhar FS,
Shephard RJ, Oliver SJ, Bermon S and Kajeniene A. Position
statement. Part two: Maintaining immune health. Exerc
Immunol Rev 17: 64–103, 2011.
406. Walsh NP, Gleeson M, Shephard RJ, Gleeson M, Woods JA,
Bishop NC, Fleshner M, Green C, Pedersen BK, Hoffman-
Goetz L, Rogers CJ, Northoff H, Abbasi A and Simon P. Posi-
tion statement. Part one: Immune function and exercise. Exerc
Immunol Rev 17: 6–63, 2011.
407. Walsh NP and Oliver SJ. Exercise, immune function and respi-
ratory infection: An update on the influence of training and
environmental stress. Immunol Cell Biol 94: 132–139, 2016.
408. Wang T-T, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J,
Tavera-Mendoza L, Lin R, Hanrahan JW, Mader S, White JH
and Hanrahan JH. Cutting edge: 1,25-dihydroxyvitamin D3 is
a direct inducer of antimicrobial peptide gene expression. J
Immunol 173: 2909–2912, 2004.
409. Wang X, Ouyang YY, Liu J and Zhao G. Flavonoid intake and
risk of CVD: a systematic review and meta-analysis of
prospective cohort studies. Br J Nutr 111: 1–11, 2014.
410. Wang X, Pierre JF, Heneghan AF, Busch RA and Kudsk KA.
Glutamine improves innate immunity and prevents bacterial
enteroinvasion during parenteral nutrition. J Parenter Enter
Nutr 39: 688–697, 2015.
411. Wärnberg J, Cunningham K, Romeo J and Marcos A. Physical
activity, exercise and low-grade systemic inflammation. Proc
Nutr Soc 69: 400–406, 2010.
412. Wärnberg J, Nova E, Romeo J, Moreno LA, Sjöström M and
Marcos A. Lifestyle-related determinants of inflammation in
adolescence. Br J Nutr 98 Suppl 1: S116-120, 2007.
413. Warner EF, Zhang Q, Raheem KS, O’Hagan D, O’Connell MA
and Kay CD. Common phenolic metabolites of flavonoids, but
not their unmetabolized precursors, reduce the secretion of
vascular cellular adhesion molecules by human endothelial
cells. J Nutr 146: 465–473, 2016.
414. Weiss G. Iron and immunity: a double-edged sword. Eur J Clin
Invest 32 Suppl 1: 70–78, 2002.
415. West NP, Horn PL, Pyne DB, Gebski VJ, Lahtinen SJ, Fricker
PA and Cripps AW. Probiotic supplementation for respiratory
and gastrointestinal illness symptoms in healthy physically
active individuals. Clin Nutr 33: 581–587, 2014.
416. West NP, Pyne DB, Cripps AW, Hopkins WG, Eskesen DC,
Jairath A, Christophersen CT, Conlon MA and Fricker PA.
Lactobacillus fermentum (PCC®) supplementation and gas-
trointestinal and respiratory-tract illness symptoms: a ran-
domised control trial in athletes. Nutr J 10: 30, 2011.
417. Whitehead MT, Martin TD, Scheett TP and Webster MJ. Run-
ning economy and maximal oxygen consumption after 4
weeks of oral Echinacea supplementation. J Strength Cond
Res 26: 1928–1933, 2012.
418. Whiteside TL. Measurement of cytotoxic activity of NK/LAK
cells. Curr Protoc Immunol Ed John E Coligan Al Chapter 7:
Unit 7.18, 2001.
419. Wikby A, Maxson P, Olsson J, Johansson B and Ferguson FG.
Changes in CD8 and CD4 lymphocyte subsets, T cell prolifer-
ation responses and non-survival in the very old: the Swedish
longitudinal OCTO-immune study. Mech Ageing Dev 102:
187–198, 1998.
420. Willis KS, Peterson NJ and Larson-Meyer DE. Should we be
concerned about the vitamin D status of athletes? Int J Sport
Nutr Exerc Metab 18: 204–224, 2008.
421. Willis KS, Smith DT, Broughton KS and Larson-Meyer DE.
Vitamin D status and biomarkers of inflammation in runners.
Open Access J Sports Med 3: 35–42, 2012.
422. Wink DA, Hines HB, Cheng RYS, Switzer CH, Flores-San-
tana W, Vitek MP, Ridnour LA and Colton CA. Nitric oxide
and redox mechanisms in the immune response. J Leukoc Biol
89: 873–891, 2011.
423. Wischmeyer PE, Musch MW, Madonna MB, Thisted R and
Chang EB. Glutamine protects intestinal epithelial cells: role
of inducible HSP70. Am J Physiol 272: G879-884, 1997.
424. Wolman R, Wyon MA, Koutedakis Y, Nevill AM, Eastell R
and Allen N. Vitamin D status in professional ballet dancers:
winter vs. summer. J Sci Med Sport 16: 388–391, 2013.
425. Xu ML, Kim HJ, Wi GR and Kim H-J. The effect of dietary
bovine colostrum on respiratory syncytial virus infection and
immune responses following the infection in the mouse. J
Microbiol Seoul Korea 53: 661–666, 2015.
426. Xue H, Sufit AJD and Wischmeyer PE. Glutamine therapy
improves outcome of in vitro and in vivo experimental colitis
models. J Parenter Enter Nutr 35: 188–197, 2011.
427. Yadav R, Angolkar T, Kaur G and Buttar HS. Antibacterial and
antiinflammatory properties of bovine colostrum. Recent Pat
Inflamm Allergy Drug Discov 10: 49–53, 2016.
428. Yombi JC, Schwab PE and Thienpont E. Neutrophil-to-lym-
phocyte ratio (NLR) distribution shows a better kinetic pattern
than C-reactive protein distribution for the follow-up of early
inflammation after total knee arthroplasty. Knee Surg Sports
Traumatol Arthrosc 24: 3287–3292, 2016.
429. Zamora-Ros R, Knaze V, Rothwell JA, Hémon B, Moskal A,
Overvad K, Tjønneland A, Kyrø C, Fagherazzi G, Boutron-
Ruault M-C, Touillaud M, Katzke V, Kühn T, Boeing H,
Förster J, Trichopoulou A, Valanou E, Peppa E, Palli D et al.
Dietary polyphenol intake in Europe: the European Prospec-
tive Investigation into Cancer and Nutrition (EPIC) study. Eur
J Nutr 55: 1359–1375, 2016.
430. Zella LA, Shevde NK, Hollis BW, Cooke NE and Pike JW.
Vitamin D-binding protein influences total circulating levels
of 1,25-dihydroxyvitamin D3 but does not directly modulate
the bioactive levels of the hormone in vivo. Endocrinology
149: 3656–3667, 2008.
431. Zittermann A. Vitamin D in preventive medicine: are we
ignoring the evidence? Br J Nutr 89: 552–572, 2003.
432. Zschaler J and Arnhold J. Impact of simultaneous stimulation
of 5-lipoxygenase and myeloperoxidase in human neutrophils.
Prostaglandins Leukot Essent Fatty Acids 107: 12–21, 2016.
433. Zuhl MN, Lanphere KR, Kravitz L, Mermier CM, Schneider
S, Dokladny K and Moseley PL. Effects of oral glutamine sup-
plementation on exercise-induced gastrointestinal permeabili-
ty and tight junction protein expression. J Appl Physiol 116:
183–191, 2014.
View publication stats
